Ryerson University

Digital Commons @ Ryerson
Theses and dissertations

1-1-2014

Genetic and Proteomic Analysis of Rna Polymerase Ii-Interacting Complexes Mediator and Integrator in the Ciliated Protozoan Tetrahymena Thermophila
Matthew D.R. Cadorin
Ryerson University

Follow this and additional works at: http://digitalcommons.ryerson.ca/dissertations Part of the Molecular genetics Commons Recommended Citation
Cadorin, Matthew D.R., "Genetic and Proteomic Analysis of Rna Polymerase Ii-Interacting Complexes Mediator and Integrator in the Ciliated Protozoan Tetrahymena Thermophila" (2014). Theses and dissertations. Paper 2015.

This Thesis is brought to you for free and open access by Digital Commons @ Ryerson. It has been accepted for inclusion in Theses and dissertations by an authorized administrator of Digital Commons @ Ryerson. For more information, please contact bcameron@ryerson.ca.

GENETIC AND PROTEOMIC ANALYSIS OF RNA POLYMERASE II-INTERACTING COMPLEXES MEDIATOR AND INTEGRATOR IN THE CILIATED PROTOZOAN TETRAHYMENA THERMOPHILA by Matthew D.R. Cadorin B.Sc., Biology, McMaster University, 2009

A thesis presented to Ryerson University in partial fulfillment of the requirements for the degree of Master of Science in the program of Molecular Science

Graduate program in Chemistry and Biology Ryerson University

Title Page

Toronto, Ontario, Canada © Matthew D.R. Cadorin, 2014

I hereby declare that I am the sole author of this thesis or dissertation. I authorize Ryerson University to lend this thesis or dissertation to other institutions or individuals for the purpose of scholarly research.

Matthew D.R. Cadorin

I further authorize Ryerson University to reproduce this thesis or dissertation by photocopying or by other means, in total or in part, at the request of other institutions or individuals for the purpose of scholarly research.

Matthew D.R. Cadorin

Author's declaration

ii

GENETIC AND PROTEOMIC ANALYSIS OF RNA POLYMERASE II-INTERACTING COMPLEXES MEDIATOR AND INTEGRATOR IN THE CILIATED PROTOZOAN TETRAHYMENA THERMOPHILA. Matthew D.R. Cadorin, Master of Science, Molecular Science, Ryerson University, 2014

Abstract
In most eukaryotes, the largest subunit of RNAPII, Rpb1, contains a conserved carboxyterminal domain (CTD) containing a canonical structure of heptapeptide repeats. Two protein complexes of interest, Mediator and Integrator, are known to interact with this CTD in all eukaryotic models they have been described in to date. Recently, orthologs of Mediator and Integrator subunits have been identified within the ciliated protozoan Tetrahymena thermophila; one of the few eukaryotic lineages to lack a canonically organized CTD. To begin to characterize putative Mediator and Integrator complexes within T. thermophila, I engineered appropriate macronuclear tagging and knockout cassettes. Although the Tetrahymena MED31 ortholog was unable to rescue the slow growth phenotype of a yeast MED31 knockout, or co-purify with yeast Med8-TAP, I identified subunit Med3 as a member of the Med31 interactome in T. thermophila through tandem affinity purification coupled with mass spectrometry. I also targeted the Tetrahymena INTS6 locus for knockout as determined by colony PCR. If Mediator and Integrator exist in Tetrahymena despite its divergent CTD of Rpb1, perhaps these complexes have CTD-independent functions beyond what can be effectively studied using conventional model systems.

iii

Acknowledgements
I express my great appreciation toward Dr. Jeffrey Fillingham for providing the wonderful opportunity to learn and grow under his supportive and stimulating guidance. I am also particularly grateful for the generous assistance and knowledgeable insight provided by Dr. Jyoti Garg throughout my research. I must also express my gratitude toward Dr. Ron Pearlman at York University for the equipment and facilities kindly made accessible by him, and to Dr. Jean Philippe Lambert at the Lunenfeld-Tanenbaum Research Institute for his expertise at mass spectrometry and eagerness to serve our needs. I would also like to recognize the contributions of the Natural Sciences and Engineering Research Council of Canada (NSERC) for funding this pursuit of knowledge and understanding. This journey would not have been as enjoyable without the mutual support, advice, and laughter shared with colleagues, particularly Syed Nabeel Hyder Shah, Ernest Radovani, Kanwal Ashraf, and Nora Saud Dannah. My gratitude extends to the staff of the Department of Chemistry and Biology of Ryerson University for their selfless efforts behind the scenes. I owe an immeasurable debt to my parents, Virginia and Derek, and my sister Megan for their unwavering and unconditional support, and for ensuring I always got to the bus on time. Lastly, I thank my friends and family for keeping me grounded through the unpredictable nature of science, and for their patience and encouragement throughout my endeavour, especially during the inevitable sacrifices it sometimes entailed.

iv

Table of Contents

Title Page ......................................................................................................................................... i Author's declaration ........................................................................................................................ ii Abstract .......................................................................................................................................... iii Acknowledgements ........................................................................................................................ iv List of Tables ................................................................................................................................. ix List of Figures ................................................................................................................................. x List of Appendices ........................................................................................................................ xii List of Abbreviations ................................................................................................................... xiii Chapter 1: Introduction ................................................................................................................... 1 1.1 RNA polymerase II ............................................................................................................... 1 1.1.1 RpbI................................................................................................................................ 1 1.2 Carboxy-terminal domain (CTD) ......................................................................................... 2 1.2.1 Phosphorylation code ..................................................................................................... 3 1.2.1.1 Serine2 and serine5 phosphorylation ....................................................................... 3 1.2.1.2 Serine7 phosphorylation .......................................................................................... 4 1.2.1.3 Serine phosphatases ................................................................................................ 5 1.3 Rpb1 CTD conservation ....................................................................................................... 6 1.4 Tetrahymena thermophila ..................................................................................................... 7 1.4.1 Nuclear dimorphism in Tetrahymena thermophila ........................................................ 8 1.4.2 Vegetative life cycle of Tetrahymena thermophila ....................................................... 8 1.4.3 Sexual reproduction in Tetrahymena thermophila ...................................................... 10 1.5 Programmed DNA rearrangements..................................................................................... 11 1.5.1 Breakage eliminated sites (BESs) ................................................................................ 12 1.5.2 Internal eliminated sequences (IESs) ........................................................................... 12 1.5.2.1 Scan RNA model .................................................................................................. 14 1.6 Tetrahymena thermophila: challenges and considerations ................................................. 15 1.6.1 Highly polyploid macronucleus ................................................................................... 15 1.6.2 AT-rich genome ........................................................................................................... 15 v

1.6.3 Codon usage in Tetrahymena....................................................................................... 16 1.7 Studying CTD-interacting proteins in Tetrahymena thermophila ...................................... 17 1.8 Mediator complex ............................................................................................................... 17 1.8.1 Structure and function of Mediator .............................................................................. 18 1.8.2 Mediator conservation ................................................................................................. 20 1.8.3 Identification of Tetrahymena Mediator ...................................................................... 21 1.9 Integrator complex .............................................................................................................. 22 1.9.1 Structure and function of Integrator ............................................................................. 23 1.9.2 Identification of Tetrahymena Integrator ..................................................................... 24 1.10 Tandem mass spectrometry and SAINT ........................................................................... 25 1.11 Rationale and project summary ........................................................................................ 27 Chapter 2: Materials and Methods ................................................................................................ 29 2.1 Equipment ........................................................................................................................... 29 2.2 Sequence alignments ........................................................................................................... 29 2.3 Growth conditions ............................................................................................................... 30 2.4 Media, buffers, solutions..................................................................................................... 31 2.5 Manual T. thermophila genomic DNA extraction .............................................................. 31 2.6 Manual E. coli plasmid DNA minipreparation (alkaline lysis miniprep) ........................... 32 2.7 Polymerase chain reaction (PCR) ....................................................................................... 33 2.8 DNA restriction digest/linearization ................................................................................... 33 2.9 Enzymatic cleanup and gel extraction ................................................................................ 34 2.10 DNA electrophoresis ......................................................................................................... 34 2.11 DNA ligation and transformation into competent E. coli ................................................. 34 2.12 Sequencing ........................................................................................................................ 35 2.12.1 E. coli plasmid DNA isolation for sequencing .......................................................... 35 2.13 DNA purifications ............................................................................................................. 36 2.13.1 PEG purification ........................................................................................................ 36 2.13.2 Ethanol purification ................................................................................................... 36 2.14 Construction of the 3xFLAG-TEV-ZZ (FZZ) tagging cassette ........................................ 37 2.15 Construction of the knockout cassette .............................................................................. 38 2.16 Biolistic transformation of T. thermophila ....................................................................... 39 vi

2.16.1 Preparation of T. thermophila cells ............................................................................ 39 2.16.2 Preparation of gold beads........................................................................................... 40 2.16.3 Preparation of flying discs ......................................................................................... 40 2.16.4 Assembly and operation............................................................................................. 40 2.16.5 Selection..................................................................................................................... 41 2.17 Rapid T. thermophila DNA extraction/colony PCR ......................................................... 41 2.18 Preparation of T. thermophila cell extracts (TCA extraction) .......................................... 42 2.19 Western blot analysis ........................................................................................................ 42 2.19.1 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) .............. 42 2.19.2 Western transfer ......................................................................................................... 43 2.19.3 Ponceau stain ............................................................................................................. 44 2.19.4 Blocking ..................................................................................................................... 44 2.19.5 Probing ....................................................................................................................... 44 2.20 Tandem affinity purification (TAP) in T. thermophila ..................................................... 45 2.20.1 Growing large cultures of T. thermophila.................................................................. 45 2.20.2 Preparation and clarification of T. thermophila whole cell extracts (WCEs) ............ 45 2.20.3 Preparation of IgG-Sepharose .................................................................................... 46 2.20.4 TEV cleavage ............................................................................................................. 47 2.20.5 Preparation of M2-agarose ......................................................................................... 48 2.20.6 Final elution ............................................................................................................... 48 2.21 Mass spectrometry ............................................................................................................ 48 2.22 Transformation of S. cerevisiae ........................................................................................ 50 2.23 Engineering of yeast and Tetrahymena MED31 expression vectors ................................ 51 2.24 Affinity purification in S. cerevisiae ................................................................................. 52 Chapter 3: Results ......................................................................................................................... 54 3.1 RNA polymerase II largest subunit Rpb1 lacks a canonical CTD in Tetrahymena ........... 54 3.2 Mediator subunit Med31 is conserved in eukaryotes ......................................................... 57 3.3 MED31 of T. thermophila does not rescue the slow-growth phenotype of S. cerevisiae deleted for MED31 .................................................................................................................... 58 3.4 12myc-Med31Tt does not co-purify with Med8Sc-TAP ...................................................... 61 3.5 Construction of 3xFLAG-TEV-ZZ tagging cassette .......................................................... 63 vii

3.5.1 PCR amplification of 5' and 3' homology sequences ................................................... 68 3.5.2 Diagnostic restriction digest ........................................................................................ 70 3.5.3 Confirmation of FZZ-tagging cassettes ....................................................................... 70 3.5.4 Linearization of tagging construct for transformation into T. thermophila ................. 71 3.6 Int4-FZZ and Med20-FZZ screening Western blots ........................................................... 72 3.7 Confirmation of FZZ tagging of Tetrahymena Med22 ....................................................... 73 3.8 Med22 affinity purification-mass spectrometry in Tetrahymena ....................................... 74 3.9 Med31 affinity purification-mass spectrometry in Tetrahymena ....................................... 76 3.10 Int11-FZZ affinity purification-mass spectrometry in Tetrahymena ................................ 79 3.11 Construction of the INTS6 knockout cassette ................................................................... 80 3.11.1 Successful knockout of INTS6 (colony PCR) ............................................................ 83 Chapter 4: Discussion ................................................................................................................... 90 4.1 Rpb1 of Tetrahymena RNA polymerase II lacks a canonical CTD.................................... 90 4.2 Med22 AP-MS .................................................................................................................... 92 4.3 Med31 AP-MS .................................................................................................................... 93 4.4 Int11 AP-MS ....................................................................................................................... 94 4.5 Speculative role of Tetrahymena Med31 in meiotic transcription...................................... 96 4.6 Tagging INTS6 with a C-terminal FZZ epitope tag in T. thermophila ............................... 98 4.7 Future prospective of Integrator knockout .......................................................................... 99 Conclusion .............................................................................................................................. 100 Appendix A: Fms1 and Vps75.................................................................................................... 102 Appendix B: Rtt109 .................................................................................................................... 106 Appendix C: Supplementary Material ........................................................................................ 111 References ................................................................................................................................... 128

viii

List of Tables

Table 1. PCR conditions for 2x PrimeSTAR Max DNA Polymerase (TaKaRa) ......................... 33 Table 2. Percent abundance of serine, threonine, tyrosine, and proline in various Rpb1 CTDs .. 57 Table 3. Mass spectrometry data for Tetrahymena Dss1-FZZ ..................................................... 66 Table 4. Tandem mass spectrometry data for Tetrahymena Med22-FZZ .................................... 75 Table 5. SAINT analysis of Tetrahymena Med31-FZZ affinity purification ............................... 78

ix

List of Figures
Figure 1. Schematic of dynamic CTD phosphorylation ................................................................. 6 Figure 2. Schematic of Tetrahymena nuclei progression through its different life cycles. ............ 9 Figure 3. Schematic of accelerated phenotypic assortment in Tetrahymena ................................ 11 Figure 4. Programmed DNA rearrangements in Tetrahymena ..................................................... 12 Figure 5. Interaction map of yeast Mediator complex .................................................................. 20 Figure 6. Multiple sequence alignment of the CTD of Rpb1 ....................................................... 56 Figure 7. Multiple sequence alignment of Med31 ........................................................................ 58 Figure 8. Growth of med31Sc yeast transformed with yeast and Tetrahymena MED31 ............ 60 Figure 9. Western blot of Med8-TAP affinity purification........................................................... 63 Figure 10. Schematic of Tetrahymena FZZ-tagging vector pBKS-FZZ ...................................... 67 Figure 11. Schematic of protein-tagging strategy in Tetrahymena............................................... 68 Figure 12. PCR products of 5' and 3' Mediator subunit homology sequences ............................. 69 Figure 13. Diagnostic restriction digest of representative FZZ tagging vectors........................... 70 Figure 14. Gel electrophoresis of representative linearized tagging construct ............................. 71 Figure 15. Western blot of Med20-FZZ and Int4-FZZ screening ................................................ 73 Figure 16. Western blot analysis of TCA-extracted putative Tetrahymena Med22-FZZ............. 74 Figure 17. Western blot analysis of putative Tetrahymena Med22 affinity purification.............. 75 Figure 18. Western blot analysis of Tetrahymena Med31 affinity purification ........................... 77 Figure 19. Western blot analysis of Tetrahymena Int11 affinity purification .............................. 79 Figure 20. Schematic of Tetrahymena knockout vector p4T2-1 .................................................. 81 Figure 21. Schematic of INTS6 knockout strategy in Tetrahymena ............................................. 82 Figure 22. INTS6KO diagnostic digests........................................................................................ 83

x

Figure 23. Schematic of expected colony PCR product sizes for testing presence of INTS6KO cassette .......................................................................................................................................... 86 Figure 24. INTS6KO colony PCR with KpnIF/SacIIR primer pair .............................................. 87 Figure 25. Schematic of expected colony PCR primer binding for testing correct INTS6KO integration ..................................................................................................................................... 88 Figure 26. INTS6KO colony PCR with KpnIF/H4neoR and UF/H4neoR primer pairs ............... 89

xi

List of Appendices

Appendix A: Fms1 and Vps75.................................................................................................... 102 Appendix B: Rtt109 .................................................................................................................... 106 Appendix C: Supplementary Material ........................................................................................ 111

xii

List of Abbreviations

Å AP APS BES BLAST bp CCBS CDK CTD ddH2O DMSO DNA EDTA ESI FZZ GFP GST HPLC IES IgG

angstrom (1.0 x 10-10 meters) affinity purification ammonium persulfate breakage eliminated site Basic Local Alignment Search Tool base pair carboxy chromosome breakage site cyclin-dependent kinase carboxy-terminal domain double distilled water dimethyl sulfoxide deoxyribonucleic acid ethylenediaminetetraacetic acid electrospray ionization 3x FLAG-ZZ epitope tag green fluorescent protein glutathione S-transferase high-performance liquid chromatography internal eliminated sequence immunoglobin G

xiii

kb kDa KO LTQ M MAC MDS MIC MP mRNA MS/MS  MW NNP-40 ORF PAGE PBS PCR PEG PMSF PSF psi

kilo base pair kilodalton knockout linear trap quadrupole molar macronucleus macronuclear destined sequences micronucleus minipreparation (DNA) messenger RNA tandem mass spectrometry micro molecular weight amino nonidet P-40 open reading frame polyacrylamide gel electrophoresis phosphate buffered saline polymerase chain reaction polyethylene glycol phenylmethanesulfonylfluoride penicillin streptomycin fungizone pounds per square inch

xiv

RNA RNAi rpm SAINT scnRNA SDS snRNA SPP SSM TAP TBE TEMED TEV UTR UV v/v WCE WT w/v YNB YPD YT

ribonucleic acid RNA interference rotations per minute significance analysis of interactome scan RNA sodium dodecyl sulfate small nuclear RNA sequestrin proteose peptone signature sequence motif tandem affinity purification tris/borate/EDTA tetramethylethylenediamine tobacco etch virus untranslated region ultraviolet volume/volume whole-cell extract wildtype weight/volume yeast nitrogen base yeast extract peptone dextrose yeast extract tryptone

xv

Chapter 1: Introduction
1.1 RNA polymerase II RNA polymerase (RNAP) is a DNA-dependent RNA polymerase that catalyzes the synthesis of RNA using DNA as a template in a process known as transcription. Five RNA polymerases exist in eukaryotes, each responsible for producing a unique subset of RNA products. RNAPI synthesizes precursors of large ribosomal RNA (pre-rRNA) involved in ribosome production (Russel and Zomwedijk, 2006). RNA polymerase II (RNAPII) is required for DNA transcription to produce the precursor messenger RNA (pre-mRNA) of all proteincoding genes, but also synthesizes small nuclear RNA (snRNA) and some micro RNA (miRNA) (Young, 1991; Lee et al., 2004; Egloff et al., 2008). In addition to its polymerase capacity, RNAPII also contains an associated exonuclease proofreading activity required for ensuring a high-fidelity product (Sydow and Cramer, 2009). RNAPIII is involved in the synthesis of a repertoire of non-coding RNAs including small nucleolar RNA (snoRNA), micro RNA, and transfer RNA (tRNA) (Dieci et al, 2007). RNAPIV and RNAPV are plant-specific, and while their precise mechanics are still enigmatic, they are known to synthesize transcripts involved in the small interfering RNA (siRNA)-dependent formation of condensed, transcriptionally silenced DNA known as heterochromatin. (Wierzbicki et al., 2008).

1.1.1 RpbI RNAPII is a protein complex composed of 12 subunits (Rpb1-Rpb12) in yeast and humans (Young, 1991; Armache et al, 2003). The largest subunit of RNAPII, Rpb1, is well

1

conserved across all domains of life, sharing eight homology regions (A-H) within eukaryotes, as well as with the ' subunit of RNAP in bacteria and the A' subunit of RNAP in Archaea (Allison, et al., 1985; Sidow et al., 1994). Following the last conserved homology region of Rpb1 (H domain) lies an amino acid extension termed the carboxy-terminal domain (CTD) connected to Rpb1 via a linker region (Matheny et al., 2002; Appendix C.1). The Rpb1 CTD plays important roles in all facets of transcriptional regulation from transcription initiation (Kim et al., 1994) through post-transcriptional 3' cleavage and polyadenylation (McCracken et al., 1997). It also functions in alternative splicing (de la Mata and Kornblihtt, 2006) and the expression of small nuclear RNA (snRNA) (Medlin and Uguen, 2003).

1.2 Carboxy-terminal domain (CTD) Transcription, the process of replicating a segment of DNA into an RNA transcript, is an elaborate and highly synchronized process involving the coordinated efforts of many interacting proteins. In most eukaryotes, the CTD of the Rpb1 subunit of RNAPII contains a tandem array of Tyrosine1-Serine2-Proline3-Threonine4-Serine5-Proline6-Serine7 (Y1S2P3T4S5P6S7) heptapeptide repeats, which are subject to extensive post-translational modification and serves as a scaffold for the systematic recruitment of transcription factors to RNAPII and the developing transcript (Allison et al., 1988; Phatnani and Greenleaf, 2006). The Rpb1 CTD contains 26 tandem repeats in yeast and 52 in humans (Allison et al., 1988), while other organisms such as Tetrahymena thermophila lack a definitive consensus sequence altogether (Stump and Ostrozhynska, 2013; Appendix C.2). The unique repeat structure of the Rpb1 CTD enables isomerization of the peptidyl-proline bonds (Wilcox et al., 2004), glycosylation (Kelly et al., 1993), ubiquitinylation (Li et al., 2007), and methylation (Sims et al., 2011), but it is the phosphorylation status of the 2

three serines, Ser2, Ser5, and Ser7, that mediates the sequential recruitment of specific nuclear factors (Bartkowiak et al., 2011).

1.2.1 Phosphorylation code Phosphorylation is achieved by a class of enzymes known as protein kinases, which transfer phosphate groups to amino acid substrates in a process central to a wide variety of cellular events (Taylor and Kornev, 2011). Alternately, dephosphorylation is carried out in a reverse process by phosphatases (Mumby and Walter, 1993). The high substrate specificity of protein kinases enables targeting of particular residues within a polypeptide based on their relative position, such that serine kinases can distinguish between Ser2, Ser5, and Ser7 of the CTD heptapeptides of Rpb1. Phosphorylation is differentially distributed across the serines in characteristic patterns corresponding to the position of RNAPII along the gene being transcribed. This phosphorylation code relates to particular events in the transcription cycle and provides a crucial mechanism for the temporal recruitment and displacement of CTD-interacting proteins lending a selective plasticity to the CTD (Komarnitsky et al., 2000).

1.2.1.1 Serine2 and serine5 phosphorylation Generally, phosphorylation of the Rpb1 CTD on Ser5 (Ser5P) is abundant near promoter regions of genes, while that of Ser2P is only seen in coding regions (Komarnitsky et al., 2000). Preceding transcription, RNAPII is hypophosphorylated and recruited to the promoter region of a gene during formation of the preinitiation complex (PIC) (Laybourn and Dahmus, 1989). CTD phosphorylation at this time is a negative regulator of PIC arrangement (Laybourn and Dahmus,

3

1990). Following the assembly of the transcription apparatus, phosphorylation of Ser5 mediated by the cyclin-dependent kinase 7 (CDK7) catalytic subunit of transcription factor IIH (TFIIH) signals for the recruitment of mRNA capping enzymes and facilitates transcription initiation through release of promoter-proximal pausing (Cho et al., 1997; Rodriguez et al., 2000). In comparison, Ser2 phosphorylation by the CDK9 catalytic subunit of the positive transcription elongation factor b (p-TEFb) grows more abundant as RNAPII nears the 3' end of genes, and marks the elongation and termination stages (Komarnitsky et al., 2000; Cho et al., 2001). Therefore, as RNAPII moves along DNA during transcription from initiation, through elongation, and into termination, the phosphorylation status shifts from Ser5P to Ser2P (Figure 1). Phosphorylation of both Ser2 and Ser5 can also be catalyzed by Cyclin C/CDK8 (Sun et al., 1998; Hsin and Manley, 2012), a member of the Mediator complex, although this action acts as a negative regulator of transcription by repressing TFIIH-mediated stimulation through CDK7 phosphorylation (Akoulitchev et al., 2000).

1.2.1.2 Serine7 phosphorylation The role of Serine7 phosphorylation has been more recently analyzed, and while both CDK7 and CDK9 have been shown to have Ser7 kinase activity (Glover-Cutter et al., 2009), its functional importance is still largely enigmatic (Figure 1). Despite being present during transcription of all RNAPII-transcribed genes, Ser7P does not appear to be essential for the transcription of protein-coding genes, as its substitution for unphosphorylatable alanine does not affect mRNA expression (Egloff et al., 2007). The phosphorylation of Ser7 is, however, essential for facilitating the expression of a class of non-coding RNAs known as small nuclear RNA (snRNA); a major component of the spliceosome (Egloff et al., 2007). Unlike their protein4

coding counterparts, snRNA-encoding genes are neither spliced nor polyadenylated, but rather contain a conserved RNA-processing element downstream of the gene in the form of a 3' box, which is cleaved by the Integrator protein complex (Hernandez, 1985; Baillat et al., 2005). Although the CTD of Rpb1 had been previously implicated in snRNA 3' processing, it was discovered that Ser7P in conjunction with Ser2P in a unique Ser2/Ser7 double phosphorylation mark across adjacent heptapeptide repeats was a prerequisite specifically recognized by Integrator for its binding to the CTD (Uguen et al., 2003; Egloff et al., 2010).

1.2.1.3 Serine phosphatases It is important to remember that it is not simply a matter of phosphorylation, but the dynamic dephosphorylation by serine phosphatases that contributes to the phosphorylation code of the CTD. Dephosphorylation is also necessary for the eventual recycling of RNAPII back to its hypophosphorylated state. To accomplish this, Fcp1 preferentially dephosphorylates Ser2P (Cho et al., 2001), while yeast Ssu72 and Rtr1 preferentially dephosphorylate Ser5P and are essential for the transition from Ser5P to Ser2P (Krishnamurthy et al., 2004; Mosley et al., 2009; Figure 1). The seemingly simple sequence of repeats in Rpb1 can therefore be viewed as an organizing center, which coordinates RNAPII-mediated transcription and effectively couples it with co-transcriptional RNA processing of mRNA and 3' end processing of snRNA.

5

Figure 1. Schematic of dynamic CTD phosphorylation A host of kinases and phosphatases modulate the dynamic phosphorylation status of the CTD to enable its selective recruitment of transcriptional proteins (adapted from Hsin and Manley, 2012).

1.3 Rpb1 CTD conservation The CTD of Rpb1 is conserved in metazoans from fungi to humans, and the number of tandem repeats seems to be correlated with genetic complexity and varies between species, with the budding yeast Saccharomyces cerevisiae containing 26, fruit fly Drosophila melanogaster with 44, and vertebrates containing 52 consensus repeats (Allison et al., 1988). Not all repeats strictly resemble the canonical Y1S2P3T4S5P6S7 sequence, and copies nearing the 3' end of the CTD often deviate to contain amino acid substitutions (Hsin and Manley, 2012; Appendix C.3). Interestingly, serial CTD truncations in both yeast and mice determined that these divergent repeats were dispensable for viability, and cells were still viable with CTDs consisting of only 50% of their original heptapeptides (Bartolomei et al., 1988; West and Corden, 1995). Below this threshold, cells are no longer viable in vivo most likely due to inadequate regulation of 6

mRNA transcription and RNA processing; processes mediated by the CTD of Rpb1. These same studies performed in vitro, however, revealed RNAPII still retains its ability to recognize promoter regions and initiate transcription (Zehring et al., 1988). Studies in the protist Trypanosoma brucei have shown that even non-canonical CTDs of Rpb1 can be essential for viability (Das and Bellofatto, 2009), and so perhaps divergent systems lacking canonical CTDs on Rpb1, such as the ciliated protozoan Tetrahymena thermophila, contain an equally divergent means of RNA processing.

1.4 Tetrahymena thermophila Tetrahymena thermophila is a single-celled, ciliated protozoan that lives freely in fresh water systems. It is a member of the phylum Ciliophora (Ciliates) together with other representative genera Paramecium, Oxytricha, and Ichthyophthirius. On a larger scale, the Ciliates, Dinoflagellates, Apicomplexa, and Chromerida phyla compose the Alveolates. The genus "Tetrahymena" is named after its four (tetra, Gr. = four) membrane-like (hymen, L. = membrane) oral structures: its primary undulating oral membrane and three oral "membranelles" of clustered cilia known as polykinetids (Lynn and Doerder, 2012). Ciliates diverged early in the eukaryotic lineage, before the establishment of metazoic fungi or animals (Baldauf, 2003). Despite being distantly related to humans, there are 2,280 human genes with orthologs in T. thermophila, 874 of which are not found in the yeast S. cerevisiae. In fact, there are more orthologs shared between humans and Tetrahymena than there are between humans and yeast (Eisen et al., 2006). As a defining feature of ciliates, Tetrahymena display many cilia that line the exterior of their cell membrane that are used as the basis for locomotion. Many studies have exploited this feature, but perhaps more remarkable is the involvement of T. thermophila in the 7

seminal discoveries of telomerase and catalytic RNA, both of which led to Nobel prizes (Kruger et al., 1982; Greider and Blackburn, 1985). Tetrahymena's impact as an experimental system can be attributed in part to experimentally favourable features including large cell size, a rapid doubling time of two hours, nuclear dimorphism, genetic tractability, and a general ease of culturing (Collins, 2012).

1.4.1 Nuclear dimorphism in Tetrahymena thermophila Characteristic of ciliates, Tetrahymena utilize nuclear dimorphism as a strategy to separate the functionally and structurally differing germline and somatic nuclei within a single cytoplasm. The smaller germ line micronucleus (MIC) is diploid and contains 5 pairs of chromosomes that are coiled into transcriptionally silent heterochromatin. (Gorovsky and Woodard, 1969). In comparison, the larger somatic macronucleus (MAC) is transcriptionally active and is highly polyploid, with approximately 45 copies of each of its ~225 chromosomes (Eisen et al., 2006).

1.4.2 Vegetative life cycle of Tetrahymena thermophila During the vegetative growth stage of Tetrahymena, the two nuclei replicate and divide independently of each other (Figure 2, stage V1). Only the micronucleus is capable of dividing by mitosis, and equally segregates to supply each of the two daughter micronuclei with identical genetic content (Ray, 1956; LaFountain and Davidson, 1980; Eisen et al. 2006). The chromosomes of the macronucleus are acentromeric (Cervantes et al., 2006) and thus lack the attachment point for the centriolar spindle fibers required to pull apart the duplicated chromosomes to produce two genetically equal nuclei. Instead, the macronucleus undergoes 8

amitosis, a process reminiscent of binary fission whereby genetic material is randomly partitioned between the two daughter nuclei. This is the foundation for phenotypic assortment (Figure 3), and heterozygotes under selective pressure can become homozygous for a particular gene within 100 generations (Orias and Newby, 1975). Researchers can exploit this unique macronuclear behaviour through accelerated phenotypic assortment via drug resistance by the cell to experimentally generate cells homozygous for a particular gene (Merriam and Bruns, 1988).

Figure 2. Schematic of Tetrahymena nuclei progression through its different life cycles. Tetrahymena nuclei divide independently of each other during vegetative growth and sexual stages (adapted from Orias et al., 2011).

9

1.4.3 Sexual reproduction in Tetrahymena thermophila When food supply is insufficient to permit vegetative growth and cell division, Tetrahymena undergo sexual reproduction with a cell of complimentary mating type (Figure 2, stage 1). Tetrahymena generates seven different mating types (I to VII), and mating must take place between cells of different mating types (Elliott and Hayes, 1953; Cervantes et al., 2013). The two nuclei differ in their outcome of sexual reproduction. In preparation for conjugation, the micronucleus divides by meiosis to produce four haploid nuclei (Figure 2, stage 2). One of the four is chosen while the other three are ablated. This gametic micronucleus then undergoes one round of mitosis to duplicate itself into two nuclei. Allogamy occurs next when mating cells exchange one of the two haploid pronuclei while the other remains within the parental cell (Figure 2, stage 3). Once migration of the nuclei has taken place, the parental and the inherited pronuclei fuse to form a zygotic product (Figure 2, stage 4). This diploid nucleus of micronuclear origin divides twice by mitosis to form four daughter diploid nuclei (Figure 2, stage 5); two daughter micronuclei and two which develop into macronuclei (figure 2, stage 6) through the elimination of germ line-specific DNA (Karrer et al., 1984; Karrer, 2012). The parental MAC is still present while the daughter MACs are developing, but it soon degenerates by what is proposed to be lysosomal autophagy (Figure 2, stage 7) (Akematsu et al., 2010). Macronuclear gene expression therefore switches from the parental macronucleus, which coordinates early conjugation, to the zygotic macronucleus, which assumes the responsibility in late conjugation. The vegetative nuclear organization is restored following the first postconjugation cell division (Figure 2, stage V1).

10

Figure 3. Schematic of accelerated phenotypic assortment in Tetrahymena The macronucleus divides by amitosis resulting in unequal segregation of chromosomes. Selective pressure drives increasing copies of particular alleles within each generation until homozygosity is achieved.

1.5 Programmed DNA rearrangements During later stages of conjugation, the developing somatic macronucleus undergoes extensive programmed DNA rearrangements, which accounts for elimination of around 15% of the macronuclear genome (Yao et al., 1984). The programmed DNA rearrangements consists of breakage eliminated sites (BESs) and internal eliminated sequences (IESs) (Figure 4).

11

Figure 4. Programmed DNA rearrangements in Tetrahymena Illustration of the result of both breakage eliminated sites (BESs) and internal eliminated sequences (IESs) on Tetrahymena macronuclear DNA (adapted from Mochizuki, 2012).

1.5.1 Breakage eliminated sites (BESs) Recognition by unknown endonucleases of highly conserved 15 base pair chromosome breakage sequences (CBSs) results in site-specific chromosome fragmentation (Fan and Yao, 2000). Small regions of DNA flanking the breakage site known as breakage eliminated sequences (BESs) are deleted and replaced with telomere repeats to effectively produce up to 300 macronuclear chromosomes from the original 5 of the micronucleus (Yao et al., 1990).

1.5.2 Internal eliminated sequences (IESs) A second type of rearrangement involves the RNA interference (RNAi) pathwaymediated removal of an estimated 6,000 DNA segments known as internal eliminated sequences 12

(IESs) ranging in size from 0.5kb to over 20kb (Yao et al., 1984; Mochizuki and Gorovsky, 2004). The non-coding repeat nature of IESs makes their sequences similar to the DNA contained within heterochromatin and transposons, and interestingly, IES removal shares resemblance to RNAi-mediated heterochromatin formation in other eukaryotes (Volpe et al., 2002; Fillingham et al., 2004). While most eukaryotes retain silenced DNA in dense heterochromatin regions, Tetrahymena utilizes an RNA interference (RNAi)-mediated process to remove these sequences completely from the genome in a case of "extreme silencing" (Mochizuki et al., 2002). The mechanisms involved in this large-scale genomic restructuring make Tetrahymena a useful model to study large-scale genomic rearrangements and RNA interference (Mochizuki and Gorovski, 2004; Yao and Chao, 2005; Mochizuki, 2010). Unlike the conserved breakage sites of BESs, IESs show no consistent recognition sequence, although cis-acting elements required for efficient programmed elimination have been identified within some IESs such as the mse2.9 IES (Fillingham and Pearlman, 2004) as well as the M and R deletion elements (Godiska and Yao, 1993; Chalker et al., 1999). Studies in T. thermophila in which DNA containing an IES was inserted into the parental macronuclear genome inhibited its elimination from the developing macronuclear anlage (Chalker and Yao, 1996). In similar studies in Paramecium, when an MDS was deleted in the parental macronucleus, it was also eliminated from the new macronucleus (Epstein and Forney, 1984). The scan RNA (scnRNA) model was proposed to account for the lack of specific IES recognition sequences and to accommodate the epigenetic influence between the old and new MAC, as the micronucleus is the sole progenitor of genetic material (Mochizuki and Gorovsky, 2004).

13

1.5.2.1 Scan RNA model In this model, the parental macronuclear genome is compared against that of the micronucleus in an effort to identify and remove inequalities from the developing macronucleus. The micronuclear chromosomes are transcribed bidirectionally during early conjugation to form double stranded RNAs (dsRNAs). These dsRNAs are digested at specific but uncharacteristic sites by the Dicer protein Dcl1 to create small RNAs known as scan RNAs (scnRNAs) (Mochizuki and Gorovsky, 2005), which complex with the protein Twi1; a member of the AGO1/Piwi-related protein family commonly involved in RNAi related gene silencing (Mochizuki and Gorovsky, 2004; Cenik and Zamore, 2011). The protein Giw1 transfers the scnRNA-Twi1 pair to the macronucleus (Noto, et al., 2010) whereupon the methyltransferase Hen1 stabilizes the scnRNA (Kurth and Mochizuki, 2009). The scnRNA-Twi1 pair aligns with its complementary macronuclear sequences with the aid of RNA helicase Ema1 (Aronica et al., 2008); an interaction that triggers the degradation of bound scnRNAs. The parental MAC is free of IESs, so only the scnRNAs encoding IES sequences remain. These segments represent the discrepancy between the parental IES-free macronucleus and the developing macronucleus containing IESs, and are transported to the developing macronucleus where they effectively bind and target every IES for elimination. This interaction induces methyltransferase Ezl1-mediated methylation of H3K9 and H3K27 (Liu et al., 2004b, 2007), which subsequently accumulate chromodomain proteins Pdd1 and Pdd3 in modifications characteristics of heterochromatin (Taverna et al., 2002). The IESs are ultimately excised by the transposase-like protein Tpb2 (Cheng et al., 2010), and flanking macronucleus destined sequences (MDSs) are ligated to maintain the number of chromosomes (Yao et al., 1984).

14

1.6 Tetrahymena thermophila: challenges and considerations Despite being a strong tool for many applications, there are inevitable challenges that must be taken into account when working with Tetrahymena. Its genome composition and unique codon usage impose complications in sequencing and genetic manipulation, and will be discussed forthwith.

1.6.1 Highly polyploid macronucleus During macronuclear development, a process consisting of multiple rounds of mitosis without subsequent nuclear division known as endocycling replicates the genome to around 45 copies (Eisen, et al., 2006). This highly polyploid transcriptional macronucleus complicates the generation of homozygous recombinants following transformation. Unlike haploid organisms which are homozygous after a single recombination event, Tetrahymena require phenotypic assortment to direct homozygosity. The incorporation of the paromomycin-resistance neo gene within transformation cassettes enables accelerated phenotypic assortment through manipulation of paromomycin concentration in the T. thermophila growth media.

1.6.2 AT-rich genome In line with the complications derived from a highly repetitive genome, the macronuclear genome of T. thermophila is enriched with nitrogenous bases adenine (A) and thymine (T). The average AT content of the macronucleus is 78%, with exonic DNA regions averaging around 72% and non-coding intronic and intergenic sequences peaking upwards of 83% (Eisen et al., 2006). To put this into perspective, humans have an average AT content of approximately 59% (International Human Genome Sequencing Consortium, 2001). It is not the abundance of adenine 15

and thymine specifically that poses a challenge, but with such a high proportion of the genome consisting of only two nucleotides there is less genetic variance. Simple tasks such as polymerase chain reaction (PCR) face interference when primers binding within introns or intergenic sequences are subject to low sequence complexity, and results in non-specific primer binding and variable products.

1.6.3 Codon usage in Tetrahymena Another peculiar feature of the Tetrahymena genome is its usage of a non-universal genetic code. In most eukaryotes, three universal stop codons signal the ribosome to terminate translation: UGA, UAG, and UAA. Instead, Tetrahymena UGA and UAG encode the amino acid glutamine (Q), while UGA is the only stop codon (Horowitz and Gorovsky, 1985). Although it may be the only stop codon in Tetrahymena, genetic evidence in T. thermophila uncovered a predicted UGA-decoding tRNA that is specific for the amino acid selenocysteine, which would make it the first organism in which all 64 triplet possibilities had the potential to code for an amino acid (Eisen et al., 2006). The functional consequence of the alternate codon usage in Tetrahymena is that if an exogenous gene terminating in TGA or TAG was transformed into Tetrahymena, it would be translated beyond its usual termination site and likely result in a misfolded protein product. Likewise, a Tetrahymena gene encoding TGA or TAG to specify glutamine would terminate prematurely if transformed into an organism employing canonical codon usage, resulting in a truncated and most likely misfolded protein as well. This can be bypassed when planning gene transformations between Tetrahymena and other common laboratory organisms such as bacteria or yeast with the use of synthetic genes that support the universal code, although this is a costly avenue for long genes. 16

1.7 Studying CTD-interacting proteins in Tetrahymena thermophila Improved annotation and advancements in tools to explore Tetrahymena are expanding their application within the laboratory to promote new research in exciting ways. The ability to transform the macronucleus with gene tagging or knockout constructs allows researchers to tag a protein with an epitope tag or knock it out completely (Gaertig et al., 1994). Despite being unicellular, the unique biology of Tetrahymena can benefit studies in human related biology in avenues for which the more traditional eukaryotic model systems such as the budding yeast Saccharomyces cerevisiae are unable to (Eisen et al., 2006; Collins, 2012). For instance, unique differences between the histone acetylation and chromatin states of the MIC and MAC have enabled exploration into the differences in histone composition and modification between heterochromatin and euchromatin (Vavra et al., 1982). Tetrahymena may also be a powerful tool to investigate the consequence of life without a canonical RNAPII CTD, as such a system may offer insight into unique CTD-independent roles of proteins that are not readily tractable in higher eukaryotes possessing canonical CTDs.

1.8 Mediator complex Transcription is an intricate series of events that is precisely modulated by a plethora of transcriptional regulators enabling transcription of certain genes to be widely up- or downregulated depending on the individual needs of the cell. Without this fluid regulation, genes would simply be constitutively "on" or "off", leading to over or under production of mRNA. Many transcriptional regulators are species specific as they have evolved concomitantly with the species to meet its unique needs. A few are evolutionarily conserved, however, and constitute a core set of general transcription factors (GTFs) that are necessary and sufficient along with 17

RNAPII for transcription. The RNAPII class of general transcription factors is comprised of the five general initiation factors TFIIB, TFIID, TFIIE, TFIIF, TFIIH that are required for transcriptional initiation and promoter release (Roeder, 1996), and Mediator, which plays major roles in post-initiation regulation and are required for diverse developmental pathways (Conaway et al., 2005; Hentges, 2011). Mediator is an RNAPII CTD-interacting multimeric protein complex consisting of 25 subunits in the budding yeast Saccharomyces cerevisiae in which it was discovered and purified (Kim et al., 1994). It was first identified as a necessary constituent for reconstituting RNAPII transcription in a system consisting only of purified RNAPII and general initiation factors, although many of the subunits had previously been identified in yeast mutation screens affecting transcription, and is now considered a classical eukaryotic transcriptional coactivator (Conaway, 2011).

1.8.1 Structure and function of Mediator Mediator is a fundamental component of the RNAPII transcription machinery. As its name suggests, it mediates communication between gene-specific DNA transactivators, the general transcription factors (GTFs) TFIID and TFIIH, and the CTD of RNAPII (Hengartner et al., 1995; Johnson et al., 2002; Kuras et al., 2003; Esnault et al., 2008; Borggrefe and Yue, 2011). As a CTD-interacting coactivator, Mediator does not directly bind DNA, and instead relays information from enhancer elements to the RNAPII general transcription machinery during transcription through coordinating phosphorylation of the CTD (Myers and Kornberg, 2000). In addition, Mediator also functions in post-initiation regulation including the recruitment of elongation factors and mRNA maturation (Conaway, 2011; Hentges, 2011). Although 18

facilitating activator dependent transcription is the main duty of Mediator, it can also stimulate RNAPII basal transcription in a system deprived of all but RNAPII and the general initiation factors (Kim et al., 1994). The overall architecture of the Mediator complex is modular and consists of the head, middle, tail, and kinase or Cdk8 modules (Figure 5). The head module is composed of Med6, Med8, Med11, Med17, Med18, Med19, Med20, and Med22. The function of the head is to bind RNAPII and certain general transcription factors. Since RNAPII is highly conserved between species, proteins of the of Mediator head module display the highest amount of homology between yeast, murine, and human Mediator complexes (Dotson et al., 2000). The middle module is made up of Med1, Med4, Med7, Med9, Med10, Med21, and Med31. The tail module consists of Med2,Med3, Med5, Med15, and Med16, and is the module responsible for binding sequence-specific DNA binding transactivators (Conaway, 2011), so it follows that the proteins composing the tail module of Mediator are divergent (Dotson et al., 2000). Cyclin-dependent kinase 8 (CDK8), cyclin C, Med12, and Med13 form the kinase module (Borggrefe et al., 2002). Originally, this module was believed only to act in an inhibitory role as its binding to Mediator prevented the recruitment of RNAPII and subsequent transcriptional activation (Hengartner et al., 1995). However, more recent studies have revealed that the kinase module has a stimulatory role in transcription activation in vitro and in vivo through phosphorylation of the CTD of Rpb1 to promote dissociation of the pre-initiation complex (PIC) and the transition of RNAPII into active transcription (Liu et al., 2004a).

19

Figure 5. Interaction map of yeast Mediator complex The Mediator complex is modular and is composed of the Head, Middle, Tail, and CDK8 or kinase module (adapted from Guglielmi et al., 2004).

1.8.2 Mediator conservation Given Mediator's fundamental roles in transcriptional regulation and its close association with RNAPII, it is conserved across animals, fungi, and land plants, and maintains an ancient evolutionary modular organization (Kim, 1994; Fondell et al., 1996; Bourbon, 2008; Mathur, 20

2011). Orthologs of 22 of the 25 yeast Mediator subunits and 13 Tetrahymena genes have been identified among the 33 mammalian subunits (Conaway, 2005; Bourbon, 2008). Since Mediator is implicated in the regulation of a variety of diverse pathways directing cell growth, development, and differentiation, it is not surprising that ineffectual regulation of its subunits in humans are linked with a variety of human diseases, as well as with specific developmental processes across a variety of organisms (Hentges, 2011; Spaeth et al., 2011). Some subunits are associated with more than one cancer type, such as the overexpression of Med28 (referred to as EG1) linked to cancers of the breast, prostate, and colon (Zhang et al., 2004). In other cases, the same subunit is linked to different types of cancer depending on its molecular disposition. Overexpression of Med1 is associated with breast and prostate cancers, while its underexpression is linked with lung melanoma (Spaeth et al., 2011). Other Mediatorlinked human maladies include cardiovascular and neurodevelopment disorders, and even foray into behavioral disorders such as Schizophrenia and psychosis (Spaeth et al., 2011). Interestingly, mutations of genes encoding different Mediator subunits within the same organism generate distinct phenotypes, as do mutations of genes encoding the same subunit within different organisms (Hentges, 2011).

1.8.3 Identification of Tetrahymena Mediator To compare a yeast protein query with a Tetrahymena protein database, NCBI's BLASTP was used. Mediator has not been experimentally defined in any protist, but bioinformatic sequence analysis of S. cerevisiae Mediator subunits using BLASTP identified Med31 as the sole identifiable Mediator subunit conserved in T. thermophila with a remarkable 33% identity over 64% of yeast Med31 (E= 1e-11) (Figure 6). In comparison, yeast and human Med31 share 44% 21

identity with 58% coverage (E= 2e-19). More interesting perhaps in lieu of the high conservation is that Med31 is non-essential in either yeast (Fan and Klein, 1994) or Tetrahymena (Garg and Fillingham, unpublished); a very unusual phenotype for a gene so evolutionarily conserved across diverse organisms. The high sequence conservation of MED31 combined with the apparent absence in the genome of other known Mediator subunits, the lack of a canonical CTD of RNAPII, and the non-essential nature of MED31 in Tetrahymena suggests a role independent of classic Mediator, and prompts further characterization of the Mediator complex in Tetrahymena.

1.9 Integrator complex The Integrator complex was initially identified and characterized in human cells based on its co-purification with Dss1; the gene product of a candidate tumor suppressor gene, deleted in split hand/split foot 1, implicated in the human limb malformation split hand/split foot. The gene product of DSS1 in human cells co-purifies with three major proteins: a Rad51-binding tumor suppressor known as BRCA2 implicated in breast cancer that plays a role in recombination and double-strand-break repair (Marston et al., 1999), the 19S subcomplex of the 26S proteasome involved in the regulation of protein concentrations by degrading unnecessary or damaged proteins (Krogan et al., 2004; Sone et al., 2004), and Integrator; an Rpb1 CTD-interacting protein complex required for the 3' end processing of RNAPII-transcribed uridine-rich (U) snRNAs U1 and U2 destined to become components of the spliceosome (Uguen and Murphy, 2003; Baillat et al., 2005). Integrator therefore links RNAPII transcription with snRNA processing.

22

1.9.1 Structure and function of Integrator The Integrator complex consists of 12 confirmed subunits in humans (Baillat et al., 2005), but further research in D. melanogaster has identified Asunder and CG4785 as additional Integrator subunits with orthologs in humans (Chen et al., 2012). Transcription of snRNAs continues for about 250bp beyond the coding region to form a 3'-extended snRNA precursor (Cuello et al., 1999). A cleavage specificity sequence known as the 3' box located 9-19bp downstream of the snRNA gene's coding region is necessary for proper 3' end processing (Hernandez, 1985). Integrator is recruited to these non-polyadenylated, 3'extended pre-snRNA molecules to initiate transcript cleavage just upstream of the 3' box (Baillat et al., 2005) through a unique Ser2/Ser7 double phosphorylation mark on the CTD of Rpb1, which to date remains the only confirmed purpose of Ser7P (Egloff et al., 2010). The mature snRNAs bind a number of proteins to form small nuclear ribonucleoproteins (snRNPs), which become the catalytic core of the spliceosome; a multi-megadalton protein complex involved in the removal of introns and alternative splicing during pre-mRNA processing (Will and Lührmann, 2011). Unrelated research into the Drosophila Integrator complex identified a requirement for CDK8/cyclin C-independent of Mediator in the 3'-end processing of snRNAs (Chen et al., 2012). The mechanism behind the 3'-end processing by Integrator is still largely ambiguous, but parallels between Integrator and the cleavage and polyadenylation specificity factor (CPSF) provides some insight. Metazoan CPSF is a protein complex involved in cleaving the 3' end of transcribed pre-mRNA prior to the addition of the characteristic polyadenine tail. CPSF-73 is the specific 3' endonuclease and forms a heterodimeric core complex with CPSF-100 (Mandel et al., 2006; Yang et al., 2009). Homology between most Integrator subunits and other characterized

23

eukaryotic proteins is minimal, but Integrator subunits Int9 and Int11 bear homology to CPSF100 and CPSF-73, respectively (Baillat et al., 2005). Interestingly, Int9 and Int11 also undergo a heterodimeric interaction required for snRNA 3' end formation analogous to CPSF-100 and CPSF-73 dimerization (Albrecht and Wagner, 2012). The depletion of Integrator's catalytic subunit Int11 resulted in the accumulation of unprocessed U1 and U2 snRNA transcripts, exemplifying the necessity for this subunit in proficient snRNA 3'-end formation (Baillat et al., 2005). Despite the apparent crossover of function between Integrator and the mRNA 3'-end processing apparatus, it is important to note that the two complexes do not share components and are maintained as separate systems (Ezzeddine et al., 2011). Further, subunit IntS6 had previously been identified by positional cloning to be the candidate tumour suppressor "deleted in cancer 1" (DICE1) in non-small cell lung carcinoma (Wieland et al., 1999). No other subunits had previously been identified through genetic screens, possibly due to the deleterious nature of these types of studies and the vital requirement of almost all of the Integrator subunits, as observed in Drosophila (Baillat et al., 2005; Ezzeddine et al., 2011).

1.9.2 Identification of Tetrahymena Integrator Tetrahymena encodes a homolog to human DSS1, which prompted an affinity purification that not only identified the 19S regulatory particle of the proteasome and a potential Tetrahymena BRCA2 ortholog, but novel peptides indicative of a potential Tetrahymena Integrator complex as well (Xiong et al., 2011; Fillingham, unpublished; Table 3). Integrator was believed to be metazoan-specific as no significant homologs could be detected through BLAST search of the GenBank database (Baillat et al., 2005; NCBI). Since Tetrahymena encodes 24

snRNA genes with homology to U1 and U2 snRNA, further investigation is required to characterize this potential snRNA 3'-end processing complex in Tetrahymena.

1.10 Tandem mass spectrometry and SAINT A powerful tool in the realm of proteomics and identification of proteins and proteinprotein interactions is tandem mass spectrometry (MS/MS), especially when coupled with affinity purification (AP-MS). The mass spectrometer works by using the difference in mass-tocharge ratio (m/z) of ionized protein fragments to separate peptides and quantitate them based on their relative abundance to determine the molecular mass and structural information of the protein. The organization of mass spectrometry is very modular and is essentially composed of three parts: an ionizer, a mass analyzer, and a detector. While different types of these components exist, the setup in the present study utilizes reversed-phase high-performance liquid chromatography (RP-HPLC) coupled with electrospray ionization (ESI) and a linear trap quadrupole (LTQ); abbreviated RP-HPLC-ESI-LTQ-MS/MS. Reversed-phase high-performance liquid chromatography is a means to separate molecules even before mass spectrometry based on hydrophobicity through differential affinity for the mobile and stationary phases. The sample is loaded into a capillary packed with silica modified with an octadecyl C18 carbon chain to make the silica less polar, and run under high pressure with a mobile phase consisting of 2% acetonitrile, a moderately polar solvent. The more hydrophobic compounds in the sample will bind the silica more often, thus retarding their migration through the capillary. The polarity of the mobile phase is then decreased by adding 98% acetonitrile. This reduces the affinity of the more hydrophobic compounds for modified

25

silica in favour of the solvent, eluting the remaining proteins. Eluted solvent is directed into the electrospray ionizer. Awarded a Nobel Prize in 2002 for its discovery (Grayson, 2011), electrospray ionization is a type of ionization source which relies on electricity for ion dispersion. Triggered by expulsion through a charged capillary, the protein sample is converted into an electrically charged mist of mostly positive ions. As the sample solvent evaporates, the charged droplets diminish in size, bringing ions closer together and increasing the surface charge density. Once a critical maximum is reached, the ions can no longer resist their repulsive forces toward one another and eject themselves into the gaseous phase and into the mass analyzer. Since proteins can be relatively large, polar, and thermally unstable, some ionization methods using heat to vaporize the sample would lead to sample fragmentation. ESI is considered a "soft ionization" technique as it does not break any chemical bonds, and for this reason is particularly useful for macromolecules such as proteins (Ho et al., 2003). Lastly, the linear trap quadrupole (LTQ) is a type of quadrupole ion trap mass analyzer used for trapping and ejecting ions with a particular mass-to-charge ratio on a two-dimensional field. The LTQ grants the ability to select particular ions for another round of mass spectrometry analysis, known as tandem mass spectrometry, without having to run another sample. An associated detector measures the characteristics of the ejected ions. The first MS analysis selects parent ions of certain m/z ratios for collision-induced dissociation (CID), which fragments the parent ion via collision with neutral molecules. The second MS analysis further evaluates the m/z ratio of these constituent fragment ions as they are ejected past the detector (March, 1997). The first time each fragment from a single peptide is detected by MS/MS it is counted as a unique

26

peptide, whereas subsequent identification of any of these fragments counts toward the total peptide number commonly referred to as spectral count (Kean et al., 2012). The leading computational challenge in mass spectrometry data analysis is filtering both false positives and non-specific protein binding from AP-MS datasets. In situations where protein concentrations are too low to effectively detect using methods such as silver staining, rigorous data analysis becomes more important due to the high sensitivity of mass spectrometry. In attempt to circumvent this, a recently developed computational tool known as Significance Analysis of INTeractome (SAINT) uses label-free quantification and assigns probabilistic confidence scores (0 to 1) to rate the probability that particular bait-prey interactions represent true interactions (Choi et al., 2011). Rather than simply comparing spectral counts between purified and untagged wildtype samples, SAINT uses a statistical algorithm incorporating interaction probability distributions specific to each bait-prey pair from all previously analyzed interactions, and models this data across negative control samples to produce a confidence value (Choi et al., 2011). Ultimately, this method becomes more accurate with each successive analysis, and currently is composed of a database of 16 untagged wildtype controls.

1.11 Rationale and project summary Although previous affinity purifications coupled with mass spectrometry have identified putative Mediator and Integrator subunits in T. thermophila, this organism lacks a canonical CTD on the largest subunit of RNA polymerase II that is necessary for the recruitment of these subunits to genes in humans and yeast. It was therefore my aim to explore the functional consequence of life with a highly divergent CTD through proteomic and genetic analysis of both complexes. 27

Given the high primary sequence similarity of Med31 between T. thermophila and yeast, I transformed a synthetic gene encoding Tetrahymena MED31 into yeast deleted for MED31 (med31) to determine whether the slow-growth phenotype associated with the MED31 knockout in S. cerevisiae could be rescued, and whether a common function for Med31 existed between the divergent species. In parallel, I explored the prospect of capitulating an interaction between yeast Med8 and Tetrahymena Med31 for the purpose of establishing a conserved molecular interaction. Neither Mediator nor Integrator is expected to exist in Tetrahymena, especially given the absence of canonical heptapeptide repeats in its CTD of Rpb1. Therefore, in the second stage of my research, I selected a number of putative Tetrahymena Mediator and Integrator subunits for which I engineered epitope tagging cassettes for tandem affinity purification coupled with massspectrometry in order to characterize their respective complexes. Lastly, I attempted to knock out putative Tetrahymena Integrator subunit INTS6 through exact gene replacement with a neo resistance gene to ascertain whether its gene product is essential or not for cell viability and to enable further investigation into its role in small RNA processing.

28

Chapter 2: Materials and Methods

2.1 Equipment All small-scale (1.5ml Eppendorf tube) centrifugations at room temperature were performed using an Eppendorf 5424 centrifuge, while small scale centrifugation at 4°C was carried out in a Sorvall Legend Micro 21R refrigerated microcentrifuge (Thermo Scientific). Centrifugation of 15ml and 50ml Falcon tubes at room temperature was performed with a Centra CL32 (IEC), and refrigerated spins using a Sorvall Legend RT. Large-scale centrifugation (500ml) of Tetrahymena cells for affinity purifications was performed with an Avanti J-30I (Beckman Coulter). Polymerase chain reactions (PCR) were performed using a GeneAmp PCR System 9700 (Applied Biosystems) or a GeneAmp PCR System 9600 (PerkinElmer).

2.2 Sequence alignments Sequences for all S. cerevisiae proteins were obtained from the Saccharomyces Genome Database (http://www.yeastgenome.org/). Sequences for all T. thermophila proteins were obtained from the Tetrahymena Genome Database (www.ciliate.org), see Appendix C.4 for accession numbers. FASTA sequences were aligned using Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/). The "ALN"-formatted alignment was then run through BoxShade (http://www.ch.embnet.org/software/BOX_form.html) version 3.21 and presented in RTF-new format to visually enhance alignment similarities.

29

2.3 Growth conditions E. coli transformed with the 12myc-pRb415, pBKS-FZZ, or p4T2-1 vectors were grown overnight on YT plates supplemented with ampicillin (50g/ml) at 37°C and stored at 4°C. For plasmid preparation, 3ml cultures were grown overnight by shaking at 250rpm at 37°C in YT media supplemented with the appropriate antibiotic. Glycerol stocks were prepared for long-term storage by transferring 0.8ml of overnight liquid culture to 0.8ml of sterile 50% glycerol in a 1.8ml CryoPure cryovial (Sarstedt) and stored at -80°C. S. cerevisiae transformed with the 12myc-pRb415 vector were grown on minimal media plates lacking leucine (YNB -leu) at 30°C and stored at 4°C. For genomic isolation, 3ml cultures were grown overnight by shaking at 225rpm at 30°C in the appropriate media. Glycerol stocks were prepared for long-term storage as above. T. thermophila in liquid culture were grown in flasks containing no more than 1/10 of its total volume of culture. Cultures were grown in the vegetative state overnight in sequestrin proteose peptone (SPP) media at 30°C with shaking at 90rpm. For selection and phenotypic assortment, transformed Tetrahymena strains were grown in 96-well microtitre plates (Sarstedt) in SPP supplemented with the appropriate concentration of the antibiotic paromomycin. Starvation was carried out by resuspending log phase cells in 10mM Tris-HCl, pH 7.4 overnight at 30°C without shaking. For freezing cell lines for long-term storage, 100ml of culture were grown overnight in SPP supplemented with penicillin-streptomycin-fungizone (PSF) and then centrifuged at 3,000rpm for 3 minutes at room temperature. Cells were resuspended in 100ml of 10mM Tris pH 7.4 and starved for 2 days at 30°C without shaking in a 1L Erlenmeyer flask. Cells were centrifuged again at 3,000rpm for 3 minutes and aspirated to 250l. To this, 10% DMSO (Sigma) in 10mM Tris pH 7.4 was immediately added (final DMSO concentration=8%)

30

and cells were re-suspended. Into individual 1.8ml CryoPure cryovials (Sarstedt), 0.5ml of cells in DMSO were aliquoted and frozen in liquid nitrogen.

2.4 Media, buffers, solutions Recipes of all media, buffers, and solutions used are listed in Appendix C.5.

2.5 Manual T. thermophila genomic DNA extraction Genomic DNA from T. thermophila was isolated from wildtype B2086 or CU428 strains as described by Gaertig et al. (1994). Tetrahymena were grown overnight at 30°C in 3ml SPP+PSF (16 hours). In a 1.5ml Eppendorf tube, 1ml of cells were harvested by centrifugation at 3,000rpm for 2 minutes at room temperature and the supernatant was discarded. The pellet was re-suspended in 500l Tetrahymena lysis solution and mixed until homogenous. Phenol:chloroform (1:1) extraction was performed twice as follows to remove proteins and lipids: First, 300l phenol and 300l chloroform was added to 600l cell suspension (100l cell lysate + 500l lysis solution) and mixed until the solution was homogenously white and opaque. The mixture was centrifuged at 13,000rpm for 1 minute at room temperature, and the top aqueous layer (~600l) was transferred to a new Eppendorf tube. Next, a chloroform extraction was performed as follows: 500l chloroform was added to 500l of sample (1:1) and mixed until the mixture was homogenously white and opaque. The sample was centrifuged at 13,000rpm for 1 minute at room temperature and the top aqueous layer was again transferred to a new Eppendorf tube. To 600l of sample, 200l of 5M NaCl was added, followed by 800l of isopropanol to precipitate the DNA. This was then centrifuged at 13,000rpm for 2 minutes at room temperature and the supernatant was removed. The DNA pellet was washed twice: 200l 31

of 70% ethanol was added followed by centrifugation at 13,000rpm for 2 minutes and removal of supernatant. The pellet was then desiccated in a vacuum desiccator for 20-30 minutes and then re-suspended in 100l ddH2O before adding 1l of RNase (10mg/ml) and incubating at 37°C for 1 hour. The sample was left overnight at 4°C to allow further dissolving and stored at -20°C.

2.6 Manual E. coli plasmid DNA minipreparation (alkaline lysis miniprep) Plasmid DNA was isolated from E. coli using a modified alkaline lysis minipreparation method based on that of Birnboim and Doly (1979). E. coli were grown overnight at 37°C in 2 ml of YT with appropriate selective drug. In a 1.5ml Eppendorf tube, 1.5ml of culture was harvested by centrifugation at 13,000rpm for 1 minute at room temperature (~21°C) and the supernatant was discarded. The pellet was re-suspended in 100l of miniprep solution 1 and vortexed until homogenous. Following a 5 minute incubation at room temperature, 200l of miniprep solution 2 was added and contents were mixed gently to lyse the cells. After another 5 minute incubation on ice, 200l of miniprep solution 3 was added, and the lysate was placed back in ice for 5 minutes. The sample was then centrifuged at 13,000rpm for 10 minutes to remove cellular debris, and the supernatant was transferred to a new Eppendorf tube. A secondary spin at 13,000rpm for 2 minutes was performed to further remove remaining debris, and the supernatant was transferred again to a new tube. To precipitate DNA, 1ml of 95% ethanol was mixed with the lysate by inversion and allowed to stand at room temperature for 10 minutes. DNA was first pelleted by centrifugation at 13,000rpm for 2 minutes at room temperature, followed by aspiration of the supernatant. The DNA pellet was washed with 200l 70% ethanol, spun at 13,000rpm for 5 minutes at room temperature, and the supernatant was aspirated away. This wash procedure was repeated once leaving just a DNA pellet which was 32

placed in a vacuum desiccator for 20-30 minutes to remove residual ethanol. Finally, to solubilize the dried DNA pellet and free it of RNA, it was re-suspended in 50l of ddH2O, treated with 1ml of RNase (10mg/ml), and incubated at 37°C for 1 hour.

2.7 Polymerase chain reaction (PCR) PCR reagents were added to 0.2ml thin-walled PCR tubes as follows (20l): 1l genomic DNA, 1l Forward Primer (30pmol/l), 1l Reverse Primer (30pmol/l), 7l ddH20 , 10l2x PrimeSTAR Max DNA Polymerase (TaKaRa).

Samples were run in the following thermal cycler program (30 cycles): Table 1. PCR conditions for 2x PrimeSTAR Max DNA Polymerase (TaKaRa)

Stage
Denaturation Annealing Elongation

Temperature
98°C 55°C 72°C

Time
10 seconds 15 seconds 30 seconds (~5 seconds/kb)

2.8 DNA restriction digest/linearization Enzymatic restriction digests of both plasmid and PCR product DNA were performed in accordance with manufacturer specifications for enzymatic conditions (New England BioLabs), using approximately one unit of restriction enzyme per microgram of DNA. Small-scale diagnostic digests were performed in 10l total volume for one to two hours, while large-scale digests including preparation of linearized DNA for biolistic applications were carried out in 400l reactions overnight. 33

2.9 Enzymatic cleanup and gel extraction Enzymatic cleanup following PCR was performed using an EZ-10 Spin Column PCR Products Purification Kit (Bio Basic). Cleanup of restriction digests of PCR products or restriction digests requiring gel extraction was performed with an EZ-10 Spin Column DNA Gel Extraction Kit (Bio Basic). All handling of DNA was in accordance with manufacturer specifications.

2.10 DNA electrophoresis Agarose gels (1% w/v) were made with 1X TBE, stained with ethidium bromide (0.1% v/v of 10mg/ml EtBr) for visualization under UV light, and electrophoresed at 100V in 1x TBE buffer. For DNA size determination, 5 of 1kb DNA Ladder (FroggaBio; Appendix C.6), range 250bp to 1,000bp was used as a standard molecular weight size marker. DNA samples were mixed with 6x DNA loading dye just prior to loading into agarose gel. Visualization was performed under UV light using either a Bio-Rad XRS+ Imager at Ryerson University or an Alpha Innotech FluorChem system in the Core Molecular Facility at York University.

2.11 DNA ligation and transformation into competent E. coli Molecular cloning was carried out in E. coli grown in YT supplemented with antibiotic corresponding to the plasmid's resistance gene. Vectors 12myc-pRb415, pBKS-FZZ, and p4T2-1 all contain an ampicillin resistance gene (AmpR), and were thus grown in YT+amp (50g/ml). Ligation reactions were performed in 10l total volume using 1l of T4 DNA Ligase (NEB). The ligation reaction was incubated at room temperature for 2 hours, after which 25l high-efficiency competent E. coli cells. (NEB 5-alpha, New England BioLabs) were added and transformation 34

followed the "High Efficiency Transformation Protocol" for "C2987" provided by New England BioLabs. The cells were incubated on ice for 30 minutes and then heat-shocked in a 42°C water bath for 30 seconds. After an additional 5 minute incubation on ice, 950l room temperature SOC media was added and cells were shaken at ~250rpm for 1 hour at 37°C. Cells were pelleted by centrifugation at 13,000rpm for 30 seconds, and all but 100l was aspirated. All 100l was plated on selective media and grown overnight at 37°C. As a negative control, ddH2O was substituted for DNA in the transformation reaction to ensure that competent cells were not naturally antibiotic resistant.

2.12 Sequencing Sequencing of 5' and 3' homology sequences was performed by ACGT Corporation, The Centre for Applied Genomics (MaRS, The Hospital for Sick Children), and Lee Wong (Sequencing Facility, York University). For a list of sequencing primers see Appendix C.7.

2.12.1 E. coli plasmid DNA isolation for sequencing DNA was isolated from 3ml cultures of E. coli grown overnight at 37°C using a HighSpeed Plasmid Mini Kit (GeneAid) and an EZ-10 Spin Column Plasmid DNA Minipreps Kit (Bio Basic) in accordance with manufacturer specifications.

35

2.13 DNA purifications For the purpose of Tetrahymena biolistics, DNA was usually purified using an EZ-10 Spin Column DNA Gel Extraction Kit (Bio Basic). When product yield was insufficient, DNA purification by either 13% PEG or ethanol precipitation was utilized.

2.13.1 PEG purification Following enzymatic digestion, an equal amount (1:1) of 13% polyethylene glycol (PEG) + 1M NaCl was added to the sample and incubated overnight at 4°C. Then it was centrifuged at 13,000rpm for 30 minutes at 4°C and the supernatant was discarded. The remaining DNA was washed with 500l 70% ethanol and centrifuged at 13,000 rpm for 5 minutes at room temperature (~21°C), again discarding the supernatant. Desiccation of the DNA was carried out in a vacuum desiccator for 20-30 minutes. The DNA pellet was re-suspended in 20l ddH2O and 1l of the final product was run on a 1% agarose gel to determine DNA concentration.

2.13.2 Ethanol purification Following enzymatic digestion, 1/10 volume (40l in 400l) of 3M NaOAc pH 5.2 was added to the sample followed by 2 volumes of 95% ethanol (800l) at room temperature. Incubation was carried out either overnight at -20°C or 30 minutes at -80°C, followed by centrifugation at 13,000rpm for 15 minutes at 4°C. After discarding the supernatant, the DNA pellet was washed with 1ml of ice-cold 70% ethanol, dislodging the pellet, and centrifuged at 13,000 for 15 minutes at 4°C. The supernatant was discarded and the sample desiccated for 2030 minutes in a vacuum desiccator. The dried DNA pellet was re-suspended in 20l of ddH20, and 1l of final product was run on a 1% agarose gel to determine DNA concentration. 36

2.14 Construction of the 3xFLAG-TEV-ZZ (FZZ) tagging cassette The tagging cassette consisted of a triple FLAG tag fused to a tobacco etch virus cleavage site fused to two repeats of the Z domain of the Staphylococcus aureus protein A (3xFLAG-TEV-ZZ, or FZZ), and was designed to tag specific target genes at the C-terminus. The cassette also contained a neo2 gene, which endowed the transformed Tetrahymena with resistance to aminoglycosides such as paromomycin, a protein synthesis inhibitor (Mehta and Champney, 2003). The benefit of using neo is that it is not endogenous to Tetrahymena so there is no homologous site into which it can recombine. Directional cloning into the pBluescript vector of both 5' coding "5' homology sequence" and 3' untranslated region (3'UTR) "3' homology sequence" that were homologous to regions flanking the stop codon was required for each target gene. This ensured proper orientation of the linearized tagging cassette relative to the endogenous sequence into the Tetrahymena macronuclear genome during homologous recombination. The 5' sequence was constructed by PCR amplification of Tetrahymena genomic DNA using an upstream forward primer (UF) complimentary to 30bp of sequence 1kb 5' (upstream) of the stop codon of the target gene, and an upstream reverse primer (UR) complimentary to 30bp immediately upstream of the same stop codon. The 3' sequence was similarly constructed by PCR amplification of Tetrahymena genomic DNA using a downstream forward primer (DF) complimentary to 30bp immediately downstream of the target gene's stop codon and a downstream reverse primer (DR) complimentary to 30bp of sequence 1kb 3' (downstream) of the stop codon. The UF primer contained a KpnI restriction site while the UR primer contained a XhoI restriction site so the final 1kb PCR product had flanking restriction sites and could be digested and cloned into the 37

complimentary digested FZZ vector. Likewise, the downstream forward (DF) and reverse (DF) primers contained NotI and SacI restriction sites, respectively (Appendix C.8). Diagnostic digests were performed after each cloning step to assess proper insertion of the homology sequence by analyzing the size of the digested fragments. Since the 5' and 3' homology sequences were around 1kb long, a digested fragment of this size indicated a potential correct insertion. Sequencing of both 5' and 3' homology sequences was carried out to confirm their identity and to verify that the 5' sequence was in frame with the tag. The primer M13R was used for sequencing into the 5' sequence. When insufficient sequencing data was returned to confirm in-frame fusion with the FZZ tag, primer HN111, which binds the tagging region, was utilized for sequencing across the 5' sequence/FZZ junction to ensure in-frame fusion. The 3' sequence was sequenced with the M13F primer, which sequences from the backbone of the plasmid across the junction into the 3' homology sequence. The DNA sequences of all sequencing primers are available in Appendix C.7. Lastly, linearization of the tagging cassette prior to biolistic transformation was achieved by digesting the vector with KpnI and SacI restriction enzymes. The digestion products were separated on an agarose gel to ensure two bands were observed; one matching the 3kb vector and the other matching the 4.5kb tagging cassette.

2.15 Construction of the knockout cassette The knockout cassette involved two-step directional cloning into the p4T2-1 vector. Primers were designed to amplify 1kb regions immediately upstream of the start codon (3' UTR) and immediately downstream of the stop codon (5'UTR) of the target gene using T. thermophila genomic DNA as a template. Cloning was verified by diagnostic restriction enzyme digest, and 38

sequencing was achieved using the primer H4neo reverse (H4neoR), which binds the H41 promoter region of the cassette for sequencing across the junction into the 5' sequence, and primer BTU2R which binds the BTU2 region of the cassette for sequencing across the junction into the 3' sequence. Linearization was performed as above with KpnI and SacII restriction enzymes. 2.16 Biolistic transformation of T. thermophila Macronuclear exact gene replacement by particle bombardment and homologous recombination was achieved though biolistic transformation of Tetrahymena as described by Bruns and Cassidy-Hanley (2000) using a biolistic PDS-1000/He Particle Delivery System (BioRad). This system uses helium pressure to accelerate DNA-coated gold particles into Tetrahymena.

2.16.1 Preparation of T. thermophila cells Two days before the planned transformation, 50ml of B2086 or CU428 wildtype Tetrahymena cells per transformation were grown in sterilized 500ml Erlenmeyer flasks by shaking overnight at 30°C in SPP+PSF. All 50ml were collected by centrifugation for 3 minutes at 5,000rpm at room temperature in 50ml Falcon tubes, washed with 50ml of 10mM Tris pH 7.4, and centrifuged again. After discarding the supernatant, the cell pellet was re-suspended in 10mM Tris pH 7.4 and transferred into a new sterilized 500ml Erlenmeyer flasks and starved for 16 hours at 30°C. Cells were collected again by centrifugation, this time at 1,000rpm for 5 minutes at room temperature as cells are under stress following starvation. All but 0.5-1ml of supernatant was aspirated and the cells were re-suspended in the remaining supernatant.

39

2.16.2 Preparation of gold beads All gold preparation steps should be performed at 4°C. To prepare 1.0m gold beads (Bio-Rad) for transformation, bath sonication to separate individual gold particles was followed by aliquoting 25l of gold beads per transformation into low-retention 1.5ml Eppendorf tubes (Axygen). Under constant vortexing, constituents were added in the following order to precipitate DNA onto the beads: 3-4l of linearized tagging-cassette DNA (1g/l), 25l of icecold 2.5M calcium chloride (CaCl2), and 10l of cold 0.1M spermidine (Sigma). The gold pellet was then washed twice and pulsed down in the centrifuge at 14,000rpm for 5 seconds between each wash. The first wash was with 200l of ice-cold 70% ethanol, and the second was with 200l of ice-cold 100% ethanol. Lastly the pellet was re-suspended in 20l of cold 100% ethanol.

2.16.3 Preparation of flying discs Flying discs (Bio-Rad) were dipped in 95% ethanol and let air dry in the laminar hood before being inserted into the ring holder. The 20l of prepared gold beads+DNA were bath sonicated and vortexed, and spotted onto the middle of the disc. The disc and holder were placed into a desiccator to dry the gold.

2.16.4 Assembly and operation The gene gun parts were washed first with ddH2O and then 70% ethanol to sterilize and the helium pressure was set to 1,100psi. The gene gun was assembled from the top down. A 900psi rupture disc (Bio-Rad) was dipped in isopropanol and fitted into the holder which was screwed into place with a torque tool. Next, the flying disc and holder were inverted and placed 40

on top of a stopping screen (Bio-Rad) which was fitted into the flying disc platform and secured with a screw cap. This assemblage was inserted into the top slot of the gene gun. A piece of Whatman filter paper and 2ml of 10mM Tris pH 7.4 was added to the lid of a Petri plate, whereupon the 0.5-1ml of prepared Tetrahymena cells for transformation were added and placed in the second slot from the bottom in the gene gun. Vacuum pressure within the gun was allowed to reach 25-26psi, and the starved Tetrahymena cells were bombarded with the DNA-coated gold beads at around 900psi. The filter paper and remaining buffer were transferred to 500ml Erlenmeyer flasks containing 50ml of prewarmed (30°C) SPP+PSF and incubated at 30°C for 4 hours with shaking to recover.

2.16.5 Selection Following incubation, all 50ml of cells were centrifuged in a 50ml Falcon tube at 1,000rpm for 5 minutes and all but 15ml of supernatant was aspirated. The pellet was resuspended and 12l of 100mg/ml of paromomycin was added to a final concentration of 80g/ml paromomycin. All 15ml were plated in a 96-well microtitre plate, 200l per well, and incubated at 30°C for 72 hours. Cells were assessed for robust growth before being put on a regimen of increasing paromomycin concentrations.

2.17 Rapid T. thermophila DNA extraction/colony PCR Tetrahymena were grown overnight by shaking at 30°C in 1ml SPP+PSF (16 hours). To 50l of cells, 500l Proteinase K buffer was added in a 1.5ml Eppendorf tube and incubated in a 55°C water bath for 1 hour. Samples were then boiled for 10 minutes and incubated on ice for 5 minutes. For PCR purposes, 5l was used per PCR reaction and run at previous conditions. 41

2.18 Preparation of T. thermophila cell extracts (TCA extraction) Tetrahymena were grown overnight by shaking at 30°C in 3ml of SPP+PSF (16 hours). In 1.5ml Eppendorf tubes, 1ml of culture was harvested by centrifugation at 13,000rpm for 3 minutes at room temperature (~21°C). After discarding the supernatant, cells were washed once with 1ml 10mM Tris pH 7.4 and spun again at 13,000rpm for 3 minutes. The total volume was aspirated down to 100l, and 10l of 100% trichloroacetic acid (TCA) was added and mixed by inversion (final TCA concentration = 10%). The sample was placed on ice for 30 minutes and centrifuged at 12,000rmp for 2 minutes at room temperature. After discarding the supernatant the cell pellet was re-suspended in 100l 2x SDS buffer. At this stage the solution sometimes turned yellow due to high acidity. To counteract this, 1l at a time of 1N NaOH was added until the original dark blue colour was restored. The sample was boiled for 5 minutes and incubated on ice for 2 minutes. The supernatant was transferred to a fresh 1.5 ml Eppendorf tube, centrifuged at 13,000rpm for 30 seconds, and kept on ice until gel loading.

2.19 Western blot analysis To observe target proteins in a heterogeneous protein sample, they were electrophoretically separated by size on a sodium dodecyl sulfate (SDS) polyacrylamide gel, transferred to a polyvinylidene fluoride (PVDF) membrane, and probed with antibodies in a 2step detection process.

2.19.1 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) SDS-PAGE was used to denature and separate proteins based on size. The polyacrylamide gel was composed of 1ml of 5% stacking gel was layered on top of 5ml of 10% 42

running gel using a Mini-PROTEAN Tetra Cell Casting Module (Bio-Rad) using a 1mm comb for well formation. Sample loading consisted of 5l of PiNK Plus Prestained Protein Ladder (Genedirex; Appendix C.6), range 10-175kDa, and 20l of prepared protein sample. The gel was electrophoresed in 1x Western buffer in a Mini-PROTEAN Tetra Cell (Bio-Rad) at a constant voltage of 100V.

2.19.2 Western transfer A PVDF membrane (Bio-Rad) was prepared by washing it in 100% methanol for 5 minutes, a rinse in ddH2O for 3 minutes, then washed in 1x Western transfer buffer for 3 minutes. For wet transfer of proteins, a "sandwich" saturated in 1x Western buffer was set up in the following order from cathode (negative) to anode (positive): a sponge, two pieces of Whatman filter paper, the SDS-PAGE gel, one PVDF membrane, two more pieces of Whatman paper, lastly followed by another sponge. Transfer was carried out in a water-cooled gel running apparatus filled with 1x Western transfer buffer at 80V for one hour or 15V overnight. For semidry transfer, a Trans-Blot SD semi-dry electrophoretic transfer cell (Bio-Rad) was used. Layers were stacked bottom (anode) to top (cathode) as follows: two pieces of Whatman paper, PVDF membrane, SDS-PAGE gel, followed by two more pieces of Whatman paper, all saturated in Western transfer buffer. No additional buffer was used in this setup, and transfer was run at 10V for one hour.

43

2.19.3 Ponceau stain The PVDF membrane was incubated with 0.1% Ponceau stain for 5 minutes and destained with 1x PBS to check for proper transfer of proteins. The membrane was de-stained with three 10-minute washes in 1x PBS solution at room temperature.

2.19.4 Blocking To reduce non-specific binding of subsequent antibody probes, blocking was performed post-transfer by incubating the blot in 5% milk solution (BLOTTO) for one hour at room temperature or overnight at 4°C. Three 10-minute washes were performed in 1x PBS at room temperature to remove unbound milk protein.

2.19.5 Probing Unless otherwise noted, Western blots were incubated in monoclonal mouse -FLAG (Sigma-Aldrich) primary antibody diluted 1:500 in 5% milk solution, or monoclonal mouse actin (GenScript) primary antibody diluted 1:1000 in 5% milk, for one hour at room temperature or overnight at 4°C. Washing was carried out three times in 1x PBST for 10 minutes each at room temperature. Incubation with horseradish peroxidase-conjugated polyclonal goat  -mouse (Cedarlane) secondary antibody diluted 1:3000 in 1% milk solution for one hour at room temperature or overnight at 4°C. Visualization was achieved by incubating the blot in Luminato Crescendo Western HRP Substrate (Millipore) according to manufacturer specifications, and developed on HyBlot autoradiography film (Denville Scientific).

44

2.20 Tandem affinity purification (TAP) in T. thermophila Tandem affinity purification (TAP) was performed to isolate FZZ-tagged proteins in Tetrahymena along with their interacting partners.

2.20.1 Growing large cultures of T. thermophila Sterilized 250ml Erlenmeyer flasks containing 25ml SPP+PSF were inoculated with 1ml of overnight Tetrahymena culture and grown for another 16 hours (overnight) at 30°C. The 25ml of culture were then added to 750ml of SPP+PSF in sterile 1L glass vessels and aerated by bubbling overnight at 30°C. Harvesting was done in 500ml plastic screw-lid containers by centrifugation at 5,000rpm for 5 minutes at 4°C. Cells were washed twice with 10mM Tris-HCl, pH 7.4, and concentrated into 50ml Falcon tubes upon the second wash. Cells were centrifuged once more at 5,000rpm for 3 minutes, all supernatant was aspirated away, and the resulting 35ml cell pellet was immediately frozen at -80°C for storage until ready for TAP.

2.20.2 Preparation and clarification of T. thermophila whole cell extracts (WCEs) Frozen cell pellets were thawed by alternately rotating the tubes by hand in room temperature water for 30 seconds and placing them on ice for 30 seconds, and then stored on ice. At this time, 500l of protease inhibitors (Sigma) and 200l of 100mM PMSF made in isopropanol was added to 25ml of 2x lysis buffer. Each cell pellet was resuspended in an equal volume of ice-cold 2x lysis buffer+protease inhibitors and then adjusted to 15ml with 1x lysis buffer+protease inhibitors. To this, 300l of 10% NP-40 (final [C]=0.2% v/v) and 5l of benzonase nuclease (Sigma) was added. Tubes were rotated end-to-end for 1 hour at 4°C to allow benzonase to digest all released genomic DNA. 45

The 15ml of whole cell extracts (WCEs) were then divided into 10 separate 1.5ml Eppendorf tubes and centrifuged at 13,000rpm for 30 minutes at 4°C. The supernatant was transferred to new Eppendorf tubes and the centrifugation was performed again to remove remaining debris.Clarified WCEs were then pooled into 15ml Falcon tubes. Affinity purifications were recurrently afflicted by what was believed to be insoluble lipids and carbohydrates in the elute. This appeared to interfere with IgG binding or TEV cleavage as samples with the characteristic cloudy supernatant during immunoprecipitation would consistently produce poor final elute signals in Western blots. Prevention was seemingly by chance since the cause was not certain, however, overgrown cell cultures would present this most often. In attempt to circumvent the negative effects, overnight cell cultures were often grown for less time or with less inoculation volume, cell pellets were washed and aspirated more vigorously prior to starvation, and whole cell extracts were subject to an additional low speed centrifugation at 5,000rpm. Following the last centrifugation, 100µl of WCE was transferred to a fresh Eppendorf tube and immediately stored at -80°C to be used as input material for affinity purification. The remaining ~15ml of WCE was added directly to the 50ml Falcon tubes containing 250µl of IgGSepharose slurry (see below) and rotated end-to-end for 4 hours at 4°C.

2.20.3 Preparation of IgG-Sepharose IgG-Sepharose beads (GE Healthcare) were supplied in 0.05M sodium phosphate and 20% ethanol as preservative, and had to be washed immediately prior to use. Each purification required 250µl of suspended IgG-Sepharose beads, so for four tubes, 1ml was transferred to a 1.5ml Eppendorf tube (cut P1000 tips were used for all handling and transferring of IgG46

Sepharose beads). The beads were washed three times by centrifugation at 2,000rpm for 2 minutes at 4°C, followed by aspiration of the supernatant and resuspension of the beads in 500µl of 1x lysis buffer to create a 1:1 beads: buffer slurry. Four 50ml Falcon tubes were set up on ice, and 250µl of slurry was added to each. 2.20.4 TEV cleavage Following 4 hour rotation with IgG-Sepharose, samples were centrifuged at 4,000rpm for 5 minutes at 4°C. The beads were washed once with 20ml of IPP300 and twice with 15ml of 1x TEV buffer. During each wash, tubes were rotated for 5 minutes at 4°C, centrifuged at 3,000rpm for 2 minutes at 4°C, and the supernatant was carefully aspirated. After the final aspiration, the beads were transferred to separate 1.5ml Eppendorf tubes along with 750µl of 1x TEV buffer and washed once more as above in 1ml of 1x TEV buffer. Beads were then resuspended in an equal volume of 1x TEV buffer, and 8µl of TEV protease (2mg/ml; gift from J. Greenblatt lab) was added to cleave the TEV cleavage site of the FZZ epitope tag. This frees the protein from the two A domains and the bound IgG-Sepharose. The tubes were wrapped in parafilm to prevent leakage and rotated end-to-end overnight at 4°C. Following overnight incubation, samples were centrifuged at 2,000rpm for 2 minutes at 4°C, and the supernatant (TEV elute) was transferred to individual ice-cold 1.5ml Eppendorf tubes. To collect all remaining protein, 600µl of IPP100 was added to the remaining beads. This was then mixed by inversion, centrifuged as above, and the supernatant was added to the previous supernatant in the ice-cold 1.5ml Eppendorf tubes.

47

2.20.5 Preparation of M2-agarose For each purification, 30µl of M2-agarose was used. Since this is packaged as a 1:1 mixture with ethanol, 60µl of slurry was required for each purification. To prepare M2-agarose for four samples, 300µl of slurry was centrifuged at 3,000rpm for 2 minutes at 4°C. The supernatant was aspirated away and the pellet was resuspended in 1ml of IPP100 buffer with rotation. This process of washing and aspirating was repeated four times to ensure all ethanol is washed away. The final pellet was resuspended in an equal volume of IPP100 buffer, which was around 150µl, and 60µl of this slurry was aliquoted into four pre-chilled Eppendorf tubes. The TEV elute was added to the slurry and the tubes were rotated end-to-end for three hours at 4°C.

2.20.6 Final elution Following the 3-hour M2-agarose bead binding, samples were washed twice as above (centrifuged at 3000rpm for 2 minutes at 4°C, aspirated, and resuspended in 1ml of buffer) with IPP100 buffer, and then twice in IPP100 buffer made without NP-40 detergent. The pellet was then washed with 750µl of 2mM CaCl2/20mM Tris and centrifuged at 5000rpm for 1 minute at room temperature. After removing the supernatant, the pellet was rotated with 500µl of 0.5M NH4OH and rotated at room temperature for 20 and then centrifuged at 5000rpm for 2 minutes at room temperature. The supernatant was transferred into new pre-chilled Eppendorf tubes and frozen at -80°C to be used for Western Blots and mass spectrometry.

2.21 Mass spectrometry Affinity purification coupled to mass spectrometry (AP-MS) is an effective and broadly applicable method for exploring protein-protein interactions. Reversed-phase high-performance 48

liquid chromatography electrospray ionization linear trap quadrupole tandem mass spectrometry (HPLC-ESI-LTQ-MS/MS) was carried out by Dr. Lambert in the Lunenfield-Tanenbaum Research Institute at Mount Sinai Hospital. Following tandem affinity purification (TAP), purified proteins eluted in 0.5M NH4OH were centrifugally evaporated in a vacuum concentrator (SpeedVac). The proteins were digested with trypsin; a serine protease which cleaves peptide bonds C-terminal of lysine (K) and arginine (R). Digested protein fragments were pneumatically "bomb-loaded" into a 75m capillary column packed with silica modified with an octadecyl C18 carbon chain. This reversed-phase high-performance liquid chromatography column was placed in-line with a linear trap quadrupole (LTQ) mass spectrometer via an electrospray ionization delivery system. The ionized species were analyzed by tandem mass spectrometry (MS/MS). Data-dependent acquisition limited tandem mass spectrometry to the 5 most abundant ions per peak "centroid" and the resulting data files were analyzed by the statistical evaluation program Mascot version 2.3 against the T. thermophila RefSeq protein database (NCBI). The fragment mass tolerance was 0.6Da with an average mass window of +/- 3Da. The ion score cutoff parameter was set to 35 and a protein was considered a hit only if it produced two "bold, red" peptides; red indicating the peptide was the top scoring match, and bold indicating the protein was the highest scoring match the peptide was found in. To rate the probability of identified proteins and identify significant interactions, SAINT analysis by SAINT version 3 was performed. Each peptide identified is novel, and had not been previously identified in mass spectrometry data from 16 wildtype purifications (J.P. Lambert, personal communication, August 14, 2013).

49

2.22 Transformation of S. cerevisiae Gene replacement by homologous recombination was performed as described by Schiestl and Gietz (1989). After growing an inoculation of yeast in 2mls of YPD overnight at 30°C, cells were diluted to an optical density of 0.2OD in 100ml of YPD and grown at 30°C until an OD of approximately 1.0 was achieved. Cells from 50mls of media were harvested in a 50ml Falcon tube by centrifugation at 4,000rpm for 4 minutes at 4°C. Cells were then washed once with 10mls of sterilized ddH2O and centrifuged again as above. After removal of the supernatant, the cell pellet was re-suspended in 1ml of 100mM lithium acetate (LiOAc), transferred to a 1.5ml Eppendorf tube, and centrifuged at 13,000 for 10 seconds. Since there was approximately 100l of cells after removal of the supernatant, 400l of 100mM LiOAc was added to re-suspend the cells in a 4:1 ratio of LiOAc:cell pellet. Each transformation reaction requires 50l of this cell slurry, which was pipetted into separate Eppendorf tubes and centrifuged at 13,000rpm for 10 seconds so lithium acetate could be aspirated away. To the pellets, 240l of 50% polyethylene glycol (PEG) was gently added to protect the cells from the permeabilizing effect of lithium acetate. Next, 36l of 1M LiOAc pH 7.2 was layered on top, followed by 50l of 2mg/ml salmon sperm carrier DNA (10mg/ml, Invitrogen) which was denatured prior to use by boiling for 5 minutes. If the PCR product was being transformed, 50l of PCR product was added next, otherwise 2l of plasmid DNA in 48l of ddH2O was added. For a negative control, 50l of ddH20 was added instead of plasmid DNA to ensure the cells could not produce leucine without plasmid transformation. Digested empty vector was also transformed (2l in 48l of ddH2O) as a control for self-ligation of the digested plasmid and for downstream affinity purification purposes to ensure the vector itself does not have affinity for the target protein. The tubes were vortexed until the cell suspension was

50

homogenous, and then placed at 30°C for 20 minutes. Following incubation, cells were centrifuged at 13,000rpm for 10 seconds at room temperature (~21°C) and the supernatant is removed. Finally, the cell pellet was re-suspended in 50l of ddH2O. If the cells were being transformed with 12myc-pRb415, this entire volume was spread-plated onto YNB -leu minimal media lacking leucine. If the cells were being transformed with pFA6a-13myc-kanMX6 PCR product, transformed cells were first plated onto non-selective YPD media overnight at 30°C, and then replica plated onto YPD supplemented with geneticin (G418) sulfate and incubated at 30°C for 48 hours.

2.23 Engineering of yeast and Tetrahymena MED31 expression vectors Both MED31Sc and synthetic MED31Tt were cloned into the CEN-based plasmid 12mycpRb415 (AmpR/Leu+) with BamHI and SalI restriction endonucleases and transformed into NEB 5-  competent E. coli to tag Med31 with an N-terminal 12xmyc epitope tag. MED31Sc was previously knocked out in the yeast Med8-TAP strain (OB+/Med8-TAP), originally obtained from the Open Biosystems yeast TAP-fusion library (Thermo Scientific). The strain used to construct this library was Open Biosystems S288C, designated OB+ for short. Minipreparations of 12myc-MED31Sc and 12myc-MED31Tt were transformed into the yeast strain Med8-TAP/med31Sc (See Materials and Methods). Empty digested 12myc-pRB415 vector (+P) was transformed into Med8-TAP/med31Sc and OB+/Med8-TAP as negative controls for growth and affinity purification. Transformants were plated on YPD media for recovery and incubated for 48 hours at 30°C and then replica plated onto minimal -leu media and incubated for 1-2 days at 30°C for selection.

51

2.24 Affinity purification in S. cerevisiae Affinity purification in yeast was performed using a modified one-step process based on that of Keogh et al. (2006). Purification relies on the affinity of the TAP epitope tag for immunoglobin G (IgG). The TAP tag is composed of three sections: the calmodulin binding peptide (CBP), a tobacco etch virus (TEV) protease cleavage site, and protein A from Staphylococcus aureus, with the TEV site in the middle linking CBP and protein A. During affinity purification, IgG recognizes and binds to protein A, allowing "pull down" from solution of recombinant protein fused to TAP tag along with all associating proteins. After growing an inoculation of yeast in 10mls of YPD overnight at 30°C, cells were diluted to an optical density of 0.2OD in 200ml of YPD and grown at 30°C until an OD of approximately 1.0 was achieved. Cells are harvested by centrifugation at 4,000rpm for 4 minutes at 4°C in 50ml Falcon tubes. Next, cells were washed once with 10mls of ice cold AP wash buffer and centrifuged again as above before removing the supernatant. At this stage, cell pellets can be frozen in liquid nitrogen or dry ice and ethanol and stored at -80°C. Each purification requires 25l of packed IgG-sepharose beads (GE Healthcare), and since they are supplied 1:1 in 20% ethanol, 50l of slurry was used per purification. Beads were pipetted using a cut P1000 tip into a 1.5ml Eppendorf tube, and then centrifuged at 2,000rpm for 2 minutes at 4°C for removal of the ethanol. The beads were then washed three times by adding 750l cold AP wash buffer, mixing gently by inversion, centrifuging at 2,000rpm for 2 minutes at 4°C, and discarding supernatant. After the final wash, AP wash buffer was added in a 1:1 ratio to packed bead volume, the slurry was mixed, and 50l was aliquoted to 1.5ml Eppendorf tubes using a cut P200 tip.

52

Cells were thawed on ice and re-suspended in 850l of AP lysis buffer and transferred into 2ml conical tubes containing 1ml of glass beads. Cell lysis was performed via bead beating in a Mini-BeadBeater-16 (BioSpec Products) using a regimen of beating for 30 seconds at room temperature followed by 2 minutes on ice for 7 cycles, as deemed experimentally optimal for S. cerevisiae by my own analysis. Holes were poked through the bottom of the plastic conical tubes with a 25Gx5/8 in. PrecisionGlide syringe (BD) and whole cell extracts were filtered into a 15ml Falcon tube by centrifugation at 4,400rpm for 1 minute at 4°C. Pellets were re-suspended and transferred to 1.5ml Eppendorf tubes before being centrifuged at 14,000rpm for 20 minutes at 4°C. The supernatant was transferred to a new Eppendorf tube, and 25l was stored at -80°C as an input control. The remaining supernatant (~800l) was transferred to a tube containing the IgG-sepharose beads and AP wash buffer, and the tubes were rotated for 2 hours at 4°C. Following rotation, the beads were, then washed three times by adding 750l cold AP wash buffer, rotating for 5 minutes at 4°C , centrifuging again at 2,000rpm for 2 minutes at 4°C, then discarding the supernatant. During one of these washes, beads and buffer were transferred to a new Eppendorf tube to separate from beads potentially bound to the tube. After the last wash, all AP buffer was removed and 50l of 2x SDS buffer was added, while 25l of 2x SDS was added to input samples. Samples were boiled for 5 minutes whereupon they were ready to be run on SDS-PAGE gels or stored at -80°C.

53

Chapter 3: Results

3.1 RNA polymerase II largest subunit Rpb1 lacks a canonical CTD in Tetrahymena In most eukaryotes, the largest subunit of RNA polymerase II, Rpb1, contains a canonical carboxy-terminal domain consisting of Tyrosine1-Serine2-Proline3-Threonine4-Serine5-Proline6Serine7 (Y1S2P3T4S5P6S7) heptapeptide repeats which are necessary for generating the phosphoserine code required for the recruitment of many major regulatory proteins (Phatnani and Greenleaf, 2006). To elucidate the nature of the CTD of Rpb1 in Tetrahymena, I aligned the translated open reading frame (ORF) of the last 40 peptides of the H domain of RPB1 onward from the budding yeast S. cerevisiae (S.c.), human (H.s.), and the ciliated protozoa P. tetraurelia (P.t.) and T. thermophila (T.t.) using Clustal Omega (EBI) (Figure 6). The resulting sequence alignment illustrates the divergence and lack of the canonical repeat structure in the CTD of Tetrahymena Rpb1. In preparing the alignment, the H-domain and linker regions were included for reference, and the indicated CTD heptapeptide repeats were outlined and numbered based on the human Rpb1 sequence as described by Hsin and Manley (2012). The formatting of this alignment including its organization around the human CTD region was modeled after a similar sequence alignment illustrating the lack of conservation in the RNAPII CTD of the protist Trypanosoma brucei presented by Das and Bellofatto (2009). As such, the first heptapeptide repeat in this alignment does not necessarily correspond to such in other organisms. The sequence alignment data is inclusive to the last amino acid of the Tetrahymena RPB1 sequence. Although the primary amino acid sequence of the Tetrahymena Rpb1 CTD did not reveal a visible canonical heptapeptide repeat structure, I calculated the abundance of serine, threonine, 54

tyrosine, and proline in order to assess whether it had a similar composition to the CTD of yeast and human, and could perhaps harbour the capacity to perform functions comparable to a canonical CTD. Serine abundance was pertinent, as they are the primary phosphorylation targets of the Rpb1 CTD (Bartkowiak, 2011). Threonine and tyrosine are also phosphorylatable amino acids, and their phosphorylation on the CTD of Rpb1 has been linked with 3' end processing of histone mRNA (Hsin et al., 2011) and transcriptional elongation (Mayer et al., 2012), respectively. Proline abundance was included due to its role in peptidyl-proline bond isomerization involved in fine-tuning the CTD phosphorylation state through Ssu72-mediated dephosphorylation of Ser5P (Werner-Allen et al., 2011). The sequences used for calculating amino acid abundance were derived from the "CTD" region in Figure 6, and included the first amino acid of the first repeat through to the end of each respective sequence (Appendix C.9). Compared to S. cerevisiae, T. thermophila contains 24% less serines, 41% less threonines, 27% less tyrosines, and half the level of prolines. In relation to humans, T. thermophila contains 21% less serines, 54% less threonines, 36% less tyrosines, and 53% less prolines (Table 3; see Appendix C.9 for calculations). As a comparison, the differences in serine, threonine, tyrosine, and proline abundances in the Rpb1 CTD of T. thermophila compared to that of P. tetraurelia were calculated as 7.3%, 6.3%, 39.7%, and 5.2%, respectively. Although the Tetrahymena CTD is not enriched for serine, the position of available serines may permit sufficient phosphorylation. While approximately 67% of serines in the Tetrahymena CTD (26/39) are present in the 2nd, 5th, or 7th residue position, there is no observable regularity to suggest they encode a potential phosphorylation pattern.

55

S.c. H.s. P.t. T.t.

1401 1431 1487 1488

H-domain -----------------------------------------------------/====== SFEETVEILFEAGASAELDDCRGVSENVILGQMAPIGTGAFDVMIDEESLVKYMPEQ-KI SFEETVDVLMEAAAHGESDPMKGVSENIMLGQLAPAGTGCFDLLLDAEKCKYGMEIPTNI SFEETVEILYDAAVFSEIDHMRGLSENIIFGQLCPHGTGCFELMVNAKNVKEFKLKSSHA SFEETVDILNTAAIFFEKDDLKGVTENIIFGQNCDIGTGCFDLLVDLNKVGEFKTKRQVE Linker ============================================================ TEIEDG------------QDGGVT----PYSNESGLVNADLDVKDELMFSPLVDSGSNDA PGLGAAGPTGMFFGSAPSPMGGISPAMTPWNQGAT--------PAYGAWSPSVGSGMTPG DKFTQGGE--------------YLAEQSPYDQNQQ--------------TPLMLNTPGPG QTLEME----------------------DYSENESS---------RYENTPSHFQTPGPG

S.c. H.s. P.t. T.t.

1460 1461 1547 1548

S.c. H.s. P.t. T.t.

1504 1513 1579 1577

=======================================================/1 MAGGFTAYGGA-----D-----------YG------------------------E----AA-GFSPSAAS-----DASGFSPGYSPAWSPTPGSPGSPGPSSPYIPSPGGAMSPSYSPT VSQGFIENSPYTPYHKSPANFATPFGREYTPNSSHCSPFYPNTPLMP------------LVSAYPN---------------------SIRTVQHAGSFTPTTPYLNSPGYNMSTPISYS CTD (human) 2 3 4 5* 6 7 8 9 --ATSPFGAYGEAPTSPGFGVS--SPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTS SPAYEPRSPGGYTPQSPSYSPT--SPSYSPTSPSYSPTSPNYSPTSPSYSPTSPSYSPTS ------NDPYQLSPVGSDSGIQQSVQKQANVSDSHSPGSPHYTSHTNSP---SPSYRSSE N-TYNQTRSSQYSPQTGNNSPFVPSPNYSPPS--HTPAGS-TSPANASPYASSPQYKSSS

S.c. H.s. P.t. T.t.

1519 1567 1626 1616

S.c. H.s. P.t. T.t.

1575 1625 1677 1672

10 11 12 13 14 15 16 17 PSYSPTSPSYSPTSPSYSPTSPSYSPTS------PSYS-PTSPSYSPTSPSYSPTSPSYS PSYSPTSPSYSPTSPSYSPTSPSYSPTS------PSYS-PTSPSYSPTSPSYSPTSPSYS RATS--GQRSSSISISLSPPSPNYTSS--------VYN-------SPLSPTN-----TGS LSG---------------AHSPSYTSPSQVRYNSPSYQNPHASSSSPLDRSKS-------

S.c. H.s. P.t. T.t.

1628 1678 1715 1710

18 19 20 21 22 23 24 25 PTSPSYSPTSPS-------YSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSP PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPNYTPTSPSYSPTSP PRVPTGSPHSP----QGSIFTTYSPVYQPGGG----TGNQYEQEQ----------------AYMGSQQSPQYM----------------------SSPHYEQRTTPMTRNI----KSET

26 27 28 29 30 31 32 33 S.c. 1681 SYSPTSPSYSPTSPNYSPTSPSYSPTSPGYSPGSPAYSPKQDEQKHNENENSR------H.s. 1738 SYSPTSPNYTPTSPNYSPTSPSYSPTSPSYSPTSPSYSPSSPRYTPQSPTYTPSSPSYSP P.t. -----------------------------------------------------------T.t. 1742 SYNPT-----------------------------------EERESEESDSDQD-------

Figure 6. Multiple sequence alignment of the CTD of Rpb1 Alignment of the C-terminal region of Rpb1 encoded by human (H.s), yeast (S.c.), Paramecium (P.t.) and Tetrahymena (T.t.) was achieved using Clustal Omega (EBI) and shaded with BoxShade 3.21 (ExPASy). The first 33 human heptapeptide repeats are labeled. "5*" indicates the first yeast heptapeptide repeat. The linker region and last 40 residues of the H domain are included for reference. The alignment is inclusive of the last amino acid of Tetrahymena Rpb1. 56

Table 2. Percent abundance of serine, threonine, tyrosine, and proline in various Rpb1 CTDs Percentage of serine and proline residues contained in the heptapeptide repeat region of the CTD of Rpb1 was compared between yeast, human, Paramecium, and Tetrahymena. Serine % Yeast (S.c.) Human (H.s.) Paramecium (P.t.) Tetrahymena (T.t.) 34.9 (75/215) 33.6 (127/378) 24.6 (31/126) 26.4 (39/148) Threonine % 12.6 (27/215) 16.1 (61/378) 7.9 (10/126) 7.4 (11/148) Tyrosine % 12.1 (26/215) 13.8 (52/378) 6.3 (8/126) 8.8 (13/148) Proline % 25.6 (55/215) 27.5 (104/378) 13.5 (17/126) 12.8 (19/148)

3.2 Mediator subunit Med31 is conserved in eukaryotes Subunit Med31 of the Mediator complex is the only Mediator subunit with homology in Tetrahymena. I generated a sequence alignment of the entire translated ORF of MED31 from the budding yeast S. cerevisiae, fission yeast S. pombe, human, mouse, and Tetrahymena with Clustal Omega (EBI) to show coverage of sequence similarity over the entire gene (Figure 7). Protein BLAST analysis revealed 53% sequence identity between Tetrahymena and human Med31 covering 56% of the gene, and 33% sequence identity across 64% of the gene between that of Tetrahymena and yeast. In comparison, human and yeast Med31 share 44% identity with a coverage of 69%. When other Mediator subunits were queried against the Tetrahymena protein database using BLASTP, no identified proteins or "hits" were found. Such high sequence similarity is very interesting since Med31 is non-essential for cell viability in either yeast or T. thermophila, and other Mediator subunits that are less conserved tend to be essential for yeast viability.

57

S.c. S.p. H.s. M.m. T.t.

1 1 1 1 1

* ***** * ** * ----------------MSSTNGNAPATPSSDQNPLPTRFEVELEFIQSLANIQYVTYLLT ----------------------METKWLLSKVPDDKSRFEIELEFVQMLSNPWYLNFL-A ---------------------MAAAVAMETDDAGNRLRFQLELEFVQCLANPNYLNFL-A ---------------------MAAAVAMETDDAGNRLRFQLELEFVQCLANPNYLNFL-A MMQHQMSMQIQSQNQQDQSQQANQDLMNFRSDFEQYQRFQLDLEFVNMLANPYYILQL-Q ** ** * * ** **** QQQIWKSPNFKNYLKYLEYWCNPPYSQCIVYPNCLFILKLLNGFMESAIVNEDGLLEGLD QHKYFEDEAFLQYLEYMEYWREPEYVKFIIYPTCLHMLTLLKNPQFRNDISRADLSKQVN QRGYFKDKAFVNYLKYLLYWKDPEYAKYLKYPQCLHMLELLQYEHFRKELVNAQCAKFID QRGYFKDKAFVNYLKYLLYWKEPEYAKYLKYPQCLHMLELLQYEHFRKELVNAQCAKFID EYDYFSNERFQNYLKYLSYFKQPEYFKFVKYPLGIKMLDLIQQDKFIENLSNNGIELANK

S.c. S.p. H.s. M.m. T.t.

45 38 39 39 60

S.c. S.p. H.s. M.m. T.t.

105 98 99 99 120

ELPKIIQLQGPQWMNEMVERWAN------------------------D----EI--YYEWLGKGLQQYGSADDATLSQPQQEEDEKKVDVKKENE E----QQ--ILHWQHYSRKRMRLQQALA-EQQQQNNTSGK-------E----QQ--ILHWQHYSRKRVRLQQALA-EQQQQNNTAGK-------MN--IQNTYTKQFLNYLAKKSSLQKDIKKE----------------EN

Figure 7. Multiple sequence alignment of Med31 Alignment of the entire translated ORF of MED31 from budding yeast (S.c.), fission yeast (S.p.), human (H.s.), mouse (M.m.), and Tetrahymena (T.t.) by Clustal Omega. Shading by BoxShade 3.21. "*" represents the Med31/Med7 interaction sites as described by Koschubs et al. (2009). Evalues in relation to S. cerevisiae Med31 calculated by BLASTP against each organism's database: S.p.=5.5e-14, M.m.=3.8e-13, H.s.=5e-14, T.t.= 8e-07.

3.3 MED31 of T. thermophila does not rescue the slow-growth phenotype of S. cerevisiae deleted for MED31 The high sequence similarity between MED31 of S. cerevisiae (MED31Sc) and T. thermophila (MED31Tt) prompted an investigation into whether the two proteins share similar attributes. To do this, I tested the ability of Tetrahymena MED31 to rescue the slow-growth phenotype characteristic of yeast deleted for MED31 (med31Sc). Wildtype OB+ strains (Open Biosystems) were used as the background for all transformations. In order to synthesize a myc-tagged version of Med31, I cloned MED31Tt and MED31Sc into 12myc-pRb415 vectors with BamHI and SalI restriction enzymes. When cloned into this 58

vector, an N-terminal epitope tag is added to the target gene. Next, I transformed the constructs into a Med8-TAP yeast strain deleted for MED31 (Med8-TAP/med31Sc). Since the nature of this investigation was whether Tetrahymena MED31 could substitute for yeast MED31, it was imperative that I started with a yeast strain deleted for MED31 by which to directly compare the effect of adding Med31Tt. The Med8-TAP strain transformed with empty 12myc-pRb415 vectors acted as a control for wildtype growth. Likewise, the transformation of knockout Med8TAP/med31Sc strain transformed with MED31Sc was a control for phenotypic rescue. The knockout Med8-TAP/med31Sc strain transformed with the same empty 12mycpRb415 vector was a negative control to ensure that any phenotypic rescue was a result of the MED31 gene product and not the vector itself. Cloning was confirmed by sequencing with primer HJ559 (Appendix C.7). The 12myc-pRb415 vector was not only used to impart an N-terminal 12xmyc epitope tag to target proteins, but because it is a CEN-based plasmid which contains a centromere sequence. In contrast to other vectors such as the high-copy 2 plasmids, the centromere sequence bestows the ability for CEN-based vectors to replicate and segregate akin to small chromosomes and maintain a relatively low copy number close to WT. This is useful to mimic expression levels as if from a single gene locus. This bypasses the need for genomic yeast Med31 for homologous recombination, as it is imperative for genomic Med31 to have been disrupted. The 12myc-pRb415 vector also contains a yeast origin of replication for selfreplication, a yeast ADH1 promoter for the expression of 12xmyc-tagged genes, and a leucine marker (leu+) which enables yeast to grow on minimal media lacking leucine (YNB -leu). The selection of such leucine autotrophs on -leu media in turn identifies positive transformants.

59

Observations of growth following a 48 hour incubation at 30°C on minimial -leu media revealed that MED31Tt failed to restore wildtype growth rates as compared to MED31Sc when they were both transformed into yeast strains deleted for MED31 (Figure 8). Med8TAP/med31Sc transformed with plasmid expressing 12myc-MED31Sc under the constitutive ADH1 promoter displayed wildtype growth phenotype comparable to Med8-TAP transformed with empty 12myc-pRb415 vector, but when transformed with plasmid expressing 12mycMED31Tt, wildtype growth was not rescued, and instead resembled the negative control Med8TAP/med31Sc transformed with empty 12myc-pRb415 vector (P).

Figure 8. Growth of med31Sc yeast transformed with yeast and Tetrahymena MED31 Colonies of Med8-TAP and Med8-TAP/med31Sc were transformed with 12myc-pRb415, and Med8-TAP/med31Sc was transformed with 12myc-MED31Sc and 12myc-MED31Tt. Cells were grown on -leu media for 48 hours at 30°C. 60

3.4 12myc-Med31Tt does not co-purify with Med8Sc-TAP Although Tetrahymena Med31 failed to rescue the phenotype of the yeast med31Sc deletion strain, this does not preclude its interaction with the yeast Mediator complex. To examine possible conservation of Mediator binding characteristics in Tetrahymena Med31, I tested its capacity to co-purify with yeast Mediator subunit Med8. Med8 was chosen for this analysis as it was shown to co-purify with many Mediator subunit peptides including Med31 in raw MS data provided by the Yeast TAP Project (http://tap.med.utoronto.ca/) and so was a prime candidate for determining whether it could interact with Tetrahymena Med31. The same strains used in the previously mentioned phenotypic rescue experiment were used for the co-purification study. Similar considerations were taken in using a yeast strain deleted for MED31 (med31Sc) to prevent native yeast Med31Sc from sequestering Med8-TAP during affinity purification. The input acts as a control to confirm all necessary protein constituents are present and expressed at the correct molecular weight corresponding to the protein plus epitope tag. These showed the presence of TAP and myc epitope tags in the starting material prior to affinity purification (Figure 9). Since all strains contained TAP-tagged Med8, it was expected that a signal representing Med8-TAP (~46kDa) would be present in all input samples as a control for proper expression of the Med8-TAP fusion protein and effective binding by the -TAP antibody, while only the two strains transformed with 12myc-Med31 would reveal probing by -myc antibody. Signals for myc were observed in strains transformed with 12myc-Med31Tt (32.6kDa) and 12myc-Med31Sc (29.1kDa) as expected. The visualization of the 12myc tag in the input acted as a loading control for later to signify that the absence of myc signal in affinity purified samples was due to inefficient binding between Med8 and Med31, and not the lack of expressed tagged protein.

61

One-step affinity purifications of Med8-TAP from Med8-TAP/med31Sc/12mycMED31Sc, Med8-TAP/med31Sc/12myc-MED31Tt, OB+/Med8-TAP and Med8-TAP/med31Sc transformed with empty 12myc-pRb415 vector revealed that yeast Med31 but not Tetrahymena Med31 can interact with Med8 of the S. cerevisiae Mediator complex (Figure 9). The presence of  -TAP signal in all affinity-purified samples was a control which indicated proper IgG binding and protein elution. In addition, the accompaniment of a signal for myc should only be present if Med8-TAP, being the bait bound to IgG, had successfully bound to the 12-myc-Med31 prey. It is known that Med31 and Med8 interact with each other in S. cerevisiae, so the appearance of a signal for 12myc-Med31Sc following Med8-TAP affinity purification was a control for ensuring that the N-terminal 12xmyc and the C-terminal TAP tags had not interfered with Med8-Med31 binding by altering the confirmation of the protein subunits or otherwise. Appropriate signal representing 12myc-Med31Sc but not 12myc-Med31Tt was observed in the affinity-purified samples and suggests that Tetrahymena Med31 cannot bind yeast Mediator. Transformation of 12myc-Med31Sc acted as a positive control in that it represented effective co-purification with Med8-TAP by which to compare Tetrahymena Med31 affinity purification. To dismiss the possibility of IgG binding Med31Sc directly, affinity purification should be carried out on an untagged wildtype strain that has been transformed with 12mycMed31Sc. Since 12myc-Med31 should not bind to IgG and would be washed away, no signal for myc would be expected. A positive signal would indicate 12myc-Med31Sc was purified by IgG without Med8-TAP as an intermediate and thus negate the validity of the study. Lack of slowgrowth rescue by Med31Tt in med31Sc or its interaction with Med8-TAP in yeast shows the inability of Tetrahymena MED31 to complement yeast knocked out for MED31, and precluded further analysis in yeast.

62

Figure 9. Western blot of Med8-TAP affinity purification Med8-TAP affinity purifications were performed in strains OB+/Med8-TAP +P, Med8TAP/med31Sc +P, Med8-TAP/med31Sc/12myc-MED31Tt, and Med8-TAP/med31Sc/12mycMED31Sc. Samples were separated by SDS-PAGE, transferred to PVDF membrane, and probed with monoclonal -TAP (1:1000) and -myc (1:3000) antibodies. Film exposure=1minute.

3.5 Construction of 3xFLAG-TEV-ZZ tagging cassette By using a cassette with an epitope tag fused to the resistance marker and carefully designing flanking regions with homology to the start or stop codon, an endogenous macronuclear gene can be tagged at the amino or carboxy terminus for downstream chromatographic or subcellular localization purposes. Of the 7 potential Mediator and 5 potential Integrator subunits previously identified by affinity purification-mass spectrometry of T. 63

thermophila Med31 and Dss1, respectively (Table 3; Fillingham, unpublished), I selected Med3, Med4, Med17, Med20, Med22, and all 5 of the Integrator subunits for epitope tagging in order to further characterize the Tetrahymena Mediator and Integrator complexes. In order to affinity purify putative Mediator and Integrator subunits from T. thermophila, I tagged the corresponding protein-encoding gene with a C-terminal triple FLAG epitope tag (3xFLAG) fused to a tobacco etch virus (TEV) protease cleavage site, fused to two repeats of the Z domain (ZZ) of the Staphylococcus aureus protein A (3xFLAG-TEV-ZZ, or FZZ). To accomplish this, I generated a tagging cassette by cloning 5' and 3' homologous sequences into a pBluescript-FZZ vector (pBKS-FZZ). The tagging cassette is depicted along with relevant features in a schematic I created using Microsoft Paint and Adobe Photoshop CS3 (Figure 10). I similarly designed a graphic representation of the tagging strategy (Figure 11). The two-step cloning of homologous DNA sequences into the vector ensured proper orientation of the tagging construct relative to the endogenous sequence to allow the introduction of the neo resistance gene into the macronuclear genome. This was necessary for proper expression of gene fusion products as well as proper transcription of the neo gene required for paromomycin resistance. The neo gene is not endogenous to Tetrahymena, and therefore does not compete with target genes or target an ectopic site for recombination. Once the construct was within the macronucleus, it recombined homologously with the endogenous locus through recognition of the 5' and 3' homology sequences of their genomic counterparts to achieve exact gene replacement with everything between the flanking sequences. In this way, wildtype levels of gene expression were maintained as transcription remained under the control of the native promoter. The active histone H41 promoter directs high levels of neo gene transcription to ensure adequate resistance to paromomycin.

64

In transforming the macronucleus with a tagging or knockout cassette containing an antibiotic resistance marker (neo), it was required that at least one wildtype copy of the gene be replaced with this cassette through homologous recombination so that selection and phenotypic assortment of transformed cells could be achieved through antibiotics. Cells were only viable in antibiotic media if they contained enough neo transcript to meet the minimum threshold demands imposed by the drug. Since one of the two daughter cells after cell division invariably contained more copies of the tagged gene linked to the paromomycin resistance neo gene, phenotypic assortment accelerated by paromomycin (Figure 3) caused subsequent fission products to contain increased copies of neo transcript and thus the associated tagged gene. By gradually increasing the concentration of antibiotic for which the transformed cell carried minimal resistance to, cells were forced to contain increasing numbers of resistant copies in each generation until the macronucleus was homozygous for paromomycin resistance.

65

Table 3. Mass spectrometry data for Tetrahymena Dss1-FZZ Data from liquid chromatography-mass spectrometry (LC-MS) following affinity purification of Tetrahymena Dss1/Rpn15. Green=bait Dss1/Rpn15 peptide. Gene ID TTHERM_00227230 TTHERM_00339610 TTHERM_00442210 TTHERM_00446090 TTHERM_00578940 TTHERM_00378970 TTHERM_00191240
19S Proteasomal Proteins

# OF PEPTIDES 7 425 337 62 58 116 32 35 46 29 9 160 100 104 113 137 116 105 33 13 13 4 9 4 4 13 6 8 5 66

NAME Rpn15 Rpn1 Rpn2 Rpn3 Rpn5 Rpn6 Rpn7 Rpn8 Rpn9 Rpn10 Rpn11 Rpn12 Rpt1 Rpt2 Rpt3 Rpt4 Rpt5 Rpt6 Nas2/p27 Hsm3/S5b Txnl1 Scl1 Ribosomal fusion protein Brca2 Int2 Int4 IntS6 Int9 Int11

TTHERM_00267990 TTHERM_00388440 TTHERM_00471830 TTHERM_00049450 TTHERM_00649110 TTHERM_00279670 TTHERM_01014660 TTHERM_00068110 TTHERM_00469100 TTHERM_00136360 TTHERM_00551090 TTHERM_00188860 TTHERM_00954210 TTHERM_00040320 TTHERM_00106960 TTHERM_00339620 TTHERM_00437260 TTHERM_00532780 TTHERM_00467840 TTHERM_01243440 TTHERM_01159920 TTHERM_00339790

19S Regulatory Particle Chaperones 20S Core Subunit Ubiquitin BRCA2

Integrator

Figure 10. Schematic of Tetrahymena FZZ-tagging vector pBKS-FZZ The pBKS-FZZ vector was designed to add a DNA sequence encoding a C-terminal FZZ epitope tag to protein-encoding genes in T. thermophila, selectable through its neo resistance gene. Schematic designed with Microsoft Paint and Adobe Photoshop CS3.

67

Figure 11. Schematic of protein-tagging strategy in Tetrahymena Representation of the two-step directional cloning strategy used for generating FZZ-tagging cassettes to tag putative T. thermophila Mediator and Integrator subunits. Illustration designed with Microsoft Paint and Adobe Photoshop CS3.

3.5.1 PCR amplification of 5' and 3' homology sequences The assembly of the C-terminal FZZ-tagging cassette for a particular gene involved twostep cloning to ensure collinearity of the homologous sequences in the tagging cassette with the 68

genomic locus for the homologous recombination in Tetrahymena. Thus, for each target gene it was necessary to PCR amplify 1kb sequences upstream and downstream of the stop codon, which ensures that translation after integration continues unhindered from the target gene through the FZZ tag to create a continuous gene fusion product. All PCR products were first separated on an agarose gel to ensure proper size and adequate concentration for downstream manipulation (Figure 12). The 3' sequence for MED17 was deliberately truncated upstream of a SacI restriction site as it would be cleaved at this site during cassette linearization anyway (Fig 9), but otherwise, all homology regions were designed to be approximately 1kb to ensure sufficient sequence homology for integration of DNA into the macronucleus.

Figure 12. PCR products of 5' and 3' Mediator subunit homology sequences As a representation of all 5' and 3' FZZ-tagging cassettes, 1l of 5' and 3' PCR products of Tetrahymena Mediator subunits MED3, MED4, MED17, and MED20 were electrophoresed on a 1% agarose gel at 80V. 5l of DNA ladder was loaded.

69

3.5.2 Diagnostic restriction digest After 5' and 3' homology sequences were cloned into the pBKS-FZZ vector, small-scale diagnostic restriction digests were performed to verify their correct integration. The samples were electrophoresed on an agarose gel (Figure 13), and only after confirmation that the released fragments were of the correct size (~1kb) were the plasmids submitted for sequencing.

Figure 13. Diagnostic restriction digest of representative FZZ tagging vectors pBKS-FZZ with cloned 3' sequences of MED3, INT4, and INTS6 were digested with NotI and SacI. 1l of each sample and 5l of 1kb DNA ladder were electrophoresed on a 1% agarose gel at 80V.

3.5.3 Confirmation of FZZ-tagging cassettes Sequencing of full FZZ-tagging vectors after the cloning of 5' and 3' homology sequences using primers M13R or HN111 (Figure 10; Appendix C.7) for confirmation of 5' sequence and primer M13F for confirmation of the 3' sequence was achieved for MED3, MED20, MED22, INT4, INTS6, and INT11.

70

3.5.4 Linearization of tagging construct for transformation into T. thermophila Homologous recombination by exact gene replacement required that the construct be linearized prior to transformation. Complete pBKS-FZZ vectors with both 5' and 3' homology sequences confirmed by DNA sequencing were linearized with KpnI and SacI restriction endonucleases to release the 4.5kb tagging cassette from the vector. The resulting digestion products were electrophoresed on a 1% agarose gel for confirmation of correct number and size of fragments prior to transformation into the Tetrahymena macronucleus via biolistics (see Materials and Methods). Upon linearization, samples including Int4-FZZ, IntS6-FZZ, Med4FZZ, and Med20-FZZ presented a 4.5kb signal representing the tagging cassette as well as a 3kb signal indicative of the resulting plasmid "backbone" (Figure 14).

Figure 14. Gel electrophoresis of representative linearized tagging construct Complete pBKS-FZZ vectors for Int4, IntS6, Med4, and Med20 were digested with KpnI and SacI to release linearized tagging cassettes. 1l was each sample and 5l of 1kb DNA ladder were separated on a 1% agarose gel at 80V. 71

3.6 Int4-FZZ and Med20-FZZ screening Western blots Western blots of TCA-extracted Int4-FZZ and Med20-FZZ were run to screen transformants for FZZ tagging (Figure 15). Due to the large molecular weight of Med20-FZZ (134kDa) and Int4-FZZ (145kDa), samples were run on 5% gels at 80V with a higher range protein ladder, Spectra Multicolor Broad Range Protein Ladder (Thermo Scientific; Appendix C.6), range 10-260kDa, until all fragments below 70kDa were run off the gel. After probing with primary -FLAG (Sigma-Aldrich) and -actin (Cedarlane) antibodies (see Materials and Methods), both Med20-FZZ and Int4-FZZ blots probed with -FLAG revealed a strong nonspecific band slightly larger than 100kDa in all lanes including wildtype. Although appropriate sized signals against -FLAG and -actin were seen for both Med20-FZZ and Int4-FZZ, a signal against -FLAG around 140kDa was apparent in the wildtype lane despite using another source for fresh wildtype culture and remaking protein extracts. This obstructed the validity of the presence of the tag, and because a trustworthy blot was not achieved, Med20 and Int4 were not submitted for mass spectrometry.

72

Figure 15. Western blot of Med20-FZZ and Int4-FZZ screening A) Int4-FZZ screening of transformants reveals a band around 140kDa. A non-specific band near 100kDa is apparent in all lanes including wildtype. Signal for -actin was around 43kDa. B) Med20-FZZ screening of transformants reveals both 134kDa and 100kDa signal in all lanes. Signal for -actin was around 43kDa. All samples were run on the same 5% SDSpolyacrylamide gel and transferred to a PVDF membrane, which was cut into the resulting four blots. Probing was performed with monoclonal -FLAG (1:500) and -actin (1:1000) antibodies. Film exposure=5 minutes.

3.7 Confirmation of FZZ tagging of Tetrahymena Med22 Following phenotypic assortment to generate homozygous Med22-FZZ strains, whole cell extracts (WCEs) were generated from Med22-FZZ using TCA precipitation. Western blot analysis of these WCEs using -FLAG (1:500 dilution) and -actin (1:1000 dilution) mouse monoclonal antibodies was performed to confirm the FZZ-tagging of Med22 in Tetrahymena (Figure 16). There was clear signal for FLAG around the predicted 41kDa in Med22-FZZ but not wildtype (WT) lanes probed with -FLAG antibody, indicating the bands for Med22-FZZ were not aberrant or non-specific, and representative of a 3xFLAG tag. The signal for actin was apparent around 43kDa in all lanes including wildtype probed with -actin antibody as expected, and was included as a loading control to signify that the vacancy of FLAG signal in wildtype sample was not due to absence of sample. 73

Figure 16. Western blot analysis of TCA-extracted putative Tetrahymena Med22-FZZ TCA extracts were run in a 10% SDS-polyacrylamide gel with a 5% stacking gel at 100V, transferred to PVDF membrane and probed with monoclonal -FLAG (1:500) and -actin (1:1000) antibodies.

3.8 Med22 affinity purification-mass spectrometry in Tetrahymena Three affinity purifications of Med22-FZZ were carried out, followed by Western blot analysis using -FLAG primary antibody (Sigma-Aldrich) at a 1:5000 dilution (see Materials and Methods). Correct size differentiation between input (IN) Med22-FZZ (~41kDa) and affinity purified Med22-3xFLAG following TEV cleavage and loss of the ZZ domain (~26kDa), as well as enrichment of signal intensity in immunoprecipitated Med22, suggests that Med22 had been successfully affinity purified (Figure 17). As there is not an associated blot probed with -actin to indicate whether wildtype WCEs contained protein, the absence of a signal in the wildtype immunoprecipitation (IP) does not contribute to the validity of the Med22 IP. The Med22 IP lane also appears to contain IgG heavy and light chains (53kDa and 23kDa, respectively). Samples from three affinity purifications of Med22-FZZ in Tetrahymena were submitted for analysis using tandem mass spectrometry (see Materials and Methods). In total, three peptides of the bait Med22 were identified, however, no other significant peptides were recognized (Table 4).

74

Figure 17. Western blot analysis of putative Tetrahymena Med22 affinity purification Western blots from two separate Med22 affinity purifications. A) Jan.22/2013 purification, monoclonal -FLAG antibody (1:5000), film exposure=1 minute, B) Feb. 8/2013 purification, monoclonal -FLAG antibody (1:5000), film exposure=5 minutes.

Table 4. Tandem mass spectrometry data for Tetrahymena Med22-FZZ The cumulative results of three sets of Med22-FZZ affinity purification-tandem mass spectrometry only identified three bait Med22 peptides. Green=bait Med22 peptide.

GENE ID TTHERM_00670380

SPECTRAL COUNT 3

MED SUBUNIT Med22

75

3.9 Med31 affinity purification-mass spectrometry in Tetrahymena To confirm and build on previous Tetrahymena Med31 affinity purification data (Fillingham, unpublished), I repeated tandem affinity purification in T. thermophila with the previously constructed strain of T. thermophila expressing Med31-FZZ. Whole cell extracts from my affinity purifications were subjected to Western blot analysis using -FLAG primary antibody (Sigma-Aldrich) at a 1:5000 dilution and -actin primary antibody (Cedarlane) also at 1:5000 dilution. Following exposure onto film, observed signals were close to the predicted 36kDa for input Med31-FZZ and 21kDa for Med31-3xFLAG following TEV cleavage and loss of the ZZ domain of the tag (Figure 18). Compounded with the clean -actin blot revealing proper loading of all input samples and subsequent loss of actin through purification, the Western blot suggests Med31 was successfully affinity purified. The lower ~23kDa signal in the Med31-FZZ -FLAG input lane is most likely a non-specific protease digestion product as a fragment half the size of the parent signal is sometimes observed. Cumulative mass spectrometry data from three sets of Med31 affinity purifications in Tetrahymena (Table 5) identified approximately 24 novel co-purifying proteins. Sequence analysis using BLASTP indicates that they do not share sequence similarity to anything in GenBank (NCBI), however, Position Specific Iterative (PSI)-BLAST-based bioinformatic analysis of Mediator in a variety of protists revealed that 8 of these 24 proteins are likely bona fide Tetrahymena Mediator orthologs (Bourbon, 2008). Also predicted by Bourbon (2008), these results revealed co-purification of putative Tetrahymena Med3; the first predicted Mediator subunit characterized in Tetrahymena belonging to the more divergent ancient tail module. Predicted Tetrahymena Mediator subunits 4, 7, 11, 17, 20, 21, and 22, which previously purified with Tetrahymena Med31-FZZ in an earlier pilot experiment (Fillingham, unpublished) were

76

again recovered with Med31-FZZ, reinforcing the composition of the Tetrahymena Med31 interactome. The "Gene ID" refers to the Tetrahymena accession number, while "spectral count" represents the number of total peptide spectra identified for a given peptide. Confidence scores of protein interactions are determined by significance analysis of interactome (SAINT) tool and given a probability of interacting with the bait ranging from 0 to 1; 0 signifying non-significance and 1 advocating statistical significance, and the peptides were considered significant if they met a probability cutoff value of 0.8. Peptides in Table 5 all had a SAINT score of 1 and therefore average probability was 1.

Figure 18. Western blot analysis of Tetrahymena Med31 affinity purification Tetrahymena Med31 affinity purification Western blots. A) Probing with monoclonal -FLAG antibody (1:5000), film exposure=30 seconds, B) Probing with monoclonal -actin antibody (1:5000), film exposure=30 seconds.

77

Table 5. SAINT analysis of Tetrahymena Med31-FZZ affinity purification Spectral count and SAINT analysis following three Med31-FZZ affinity purifications in Tetrahymena. Green=bait Med31 peptide, yellow=peptides previously identified as co-purifying with Tetrahymena Med31, orange= novel Med31 co-purifying peptide, red=potential Tetrahymena Mediator subunit identified in this study as predicted by Bourbon (2008).

GENE ID TTHERM_00355460 TTHERM_00467799 TTHERM_00691210 TTHERM_00028490 TTHERM_00334350 TTHERM_00918460 TTHERM_00829330 TTHERM_00732830 TTHERM_00490640 TTHERM_00444720 TTHERM_01002760 TTHERM_00295380 TTHERM_00316620 TTHERM_00752180 TTHERM_00989470 TTHERM_00052189 TTHERM_01014520 TTHERM_00780600 TTHERM_00147570 TTHERM_00670380 TTHERM_00922930 TTHERM_00419920 TTHERM_00657539 TTHERM_00490630 TTHERM_00052180

SPECTRAL COUNT 51|56|27 20|29|9 33|44|42 28|46|25 27|39|24 20|23|18 25|9|9 34|7|15 37|19|14 17|19|10 60|20|34 44|61|41 57|44|55 74|97|60 64|36|30 64|35|63 89|40|66 128|78|79 74|63|58 74|74|41 75|40|36 52|27|36 79|34|41 129|44|58 187|93|135

SAINT 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1

MED SUBUNIT MED31 MED4

MED11

MED21

MED17 MED7 MED22 MED20

MED3

78

3.10 Int11-FZZ affinity purification-mass spectrometry in Tetrahymena Western blots performed on Int11-FZZ affinity purified material (Figure 19) were subjected to probing with primary -FLAG (Sigma-Aldrich) and -actin (Cedarlane) antibodies, both at a dilution of 1:5000. Although the signal intensity for affinity purified Int11-3xFLAG was not enriched over its input, the isolation of a single, clean band in the vicinity of the expected 82kDa for Int11 IP probed with -FLAG was grounds for proceeding with mass spectrometry. Unfortunately, tandem mass spectrometry analysis of affinity purified Int11 identified no significant prey peptides or Int11 bait peptides, so affinity purification should be repeated.

Figure 19. Western blot analysis of Tetrahymena Int11 affinity purification A) Western blot probed with monoclonal -FLAG antibody (1:5000), film exposure=30 seconds. B) Western blot probed with monoclonal -actin antibody (1:5000), film exposure=30 seconds.

79

3.11 Construction of the INTS6 knockout cassette By flanking a neo resistance gene with loci homologous to the 5' and 3' UTRs of a target gene, all macronuclear copies of a gene can be knocked out through exact gene replacement by homologous recombination, provided that the gene is non-essential for viability. Of the 5 potential Integrator subunits previously identified in T. thermophila by affinity purification-mass spectrometry of Dss1Tt (Fillingham, unpublished), I selected putative Tetrahymena Integrator subunit IntS6 for knocking out. Transformation led to four potential transformant colonies, but phenotypic assortment was halted at 200g/ml paromomycin as cells did not flourish above this limit and died out at 500g/ml paromomycin. As a comparison, the FZZ-tagged lines flourished in paromomycin concentrations up to 1200g/ml. In order to generate a Tetrahymena INTS6 macronuclear knockout, directional cloning of 5' and 3' homology sequences flanking a neo1 containing cassette was required. I designed two sets of primers specifically intended to amplify 1kb regions immediately upstream of the start codon and immediately downstream of the stop codon of INTS6 to replace the entire INTS6 gene with a neo1 resistance gene through homologous recombination. A schematic I created of p4T21 and its relevant features (Figure 20) as well as a graphic representation of the knockout strategy (Figure 21) using Microsoft Paint and Adobe Photoshop CS3 provide a simplified overview of my knockout approach. Accurate two-step cloning of these INTS6-flanking sequences into the knockout vector p4T2-1 was confirmed by diagnostic digest (Figure 22) and subsequent sequencing using H4neo reverse (H4neoR) and BTU2R sequencing primers (Appendix C.7).

80

Figure 20. Schematic of Tetrahymena knockout vector p4T2-1 The p4T2-1 vector was used to replace protein-encoding genes in T. thermophila with a neo1 cassette. Schematic designed with Microsoft Paint and Adobe Photoshop CS3.

81

Figure 21. Schematic of INTS6 knockout strategy in Tetrahymena Representation of the directional cloning strategy used for knocking out putative T. thermophila Mediator and Integrator subunits. Illustration designed with Microsoft Paint and Adobe Photoshop CS3.

82

Figure 22. INTS6KO diagnostic digests INTS6KO cassette digested with KpnI/XhoI, BamHI/SacII, and KpnI/SacII to verify correct integration of 5' and 3' homology sequences and cassette linearization. Products were electrophoresed on a 1% agarose gel at 80V.

3.11.1 Successful knockout of INTS6 (colony PCR) To determine whether the knockout cassette had successfully replaced the INTS6 locus after homologous recombination, colony PCR was performed using 3 sets of primers. The first pair was composed of the same forward and reverse synthesis primers KpnIF and SacIIR originally used to create the homology sequence (Appendix C.8). These primers are homologous to the 5' and 3' UTRs of INTS6 found in the knockout cassette and the endogenous INTS6 gene locus, and therefore have the benefit of being able to report the presence of both the knockout cassette and the INTS6 gene (Figure 23). Since both transformed and wildtype samples were expected to produce a PCR product using these primers, distinguishing successful knockouts from wildtype was achieved by the size of the resulting PCR product. When run on a 1% agarose gel, primers bound the endogenous gene in the wildtype strain resulting in a signal that was close 83

to the predicted size of 5.4kb, while each of the four knockouts displayed a signal of approximately 3.5kb indicative of the knockout cassette as well as a faint signal around 5kb suggestive of endogenous INTS6 (Figure 24). The 5kb signal in the transformed cultures indicates the presence of full-length INTS6, which could be due to incomplete macronuclear knockout of INTS6 or perhaps micronuclear INTS6. A flaw in this experimental design exists in that the KpnIF/SacIIR primer pair is specific to the knockout cassette and thus only reports the presence of the cassette within the cell and not its correct integration into the INTS6 locus. This means that a smaller fragment indicative of the knockout cassette (3.4kb) would have been generated in all transformed strains regardless of where the cassette had correctly integrated, and was not completely indicative of an INTS6 knockout. The second pair of primers consisted of KpnIF paired with H4neoR (Apendix C.7), a reverse primer that bound the 5' HHF1 promoter region of the knockout cassette (Figure 25, A). Unlike the KpnIF/SacIIR primer pair that displayed a signal for wildtype strains, the intent behind the KpnIF/H4neoR primer pair was to specifically identify only transformed cells and reveal no signal for wildtype or untransformed strains since the H4neoR primer is specific to the knockout cassette. While this could verify the presence of the knockout cassette within the cell, again it did not establish correct integration into the INTS6 locus as these primers would bind all instances of the cassette. The key to establishing correct integration into the INTS6 locus rather than simply testing for the presence of the knockout cassette was to use a third pair of primers that coordinated in creating a PCR product that reported on the fusion of the endogenous locus with the cassette. I designed a forward primer designated "UF" (Appendix C.7) with homology specific to the endogenous genomic DNA greater than 1kb upstream of the stop codon (upstream of the 5'

84

homology sequence). In coordination with the UF primer was the cassette-specific H4neoR, and together these primers straddled the gene-cassette boundary to report on the integration status of the cassette within the INTS6 locus. The UF/H4neoR primer pair would not produce a signal for aberrant insertion of the knockout cassette since wildtype cells would not have an H4 promoter sequence directly upstream of the target gene, and an atypically inserted cassette would not have the target gene's 5' UTR directly upstream required for fragment amplification. Therefore, a fragment just over 1kb would be produced only if the IntS6 knockout cassette had successfully recombined with and replaced INTS6, otherwise there would be no PCR product (Figure 25, B and C). Two colonies potentially knocked out for INTS6 showed a band a little larger than 1kb using the Kpn1F/H4neoR primer pair to signify proper transformation and presence of the knockout cassette, while the UF/H4neoR primer pair identified bands of approximately 1kb in length for all tested colonies indicating successful insertion of the knockout cassette into the INTS6 locus (Figure 26). Wildtype strains in both cases were void of signal as expected.

85

Figure 23. Schematic of expected colony PCR product sizes for testing presence of INTS6KO cassette Possible PCR product sizes used to assess the knockout cassette insertion between different transformation possibilities. A) amplification of the cassette by primers KpnIF and SacIIR to produce a ~3.4kb product irrespective of where it is located in the cell. B) amplification of endogenous INTS6 to produce a ~5.5kb signal.

86

Figure 24. INTS6KO colony PCR with KpnIF/SacIIR primer pair Products of colony PCR from four potential INTS6 knockout strains and wildtype cells using KpnIF and SacIIR primers were electrophoresed on a 1% agarose gel. Signal around 5kb was present in all lanes (wildtype INTS6), while signal near 3.5 kb was only present in transformed strains (INTS6 knockout cassette).

87

Figure 25. Schematic of expected colony PCR primer binding for testing correct INTS6KO integration Following PCR in the above scenarios, a band around ~1kb representing the 5' homology sequence may be generated. A) Signal will be produced with KpnIF/H4neoR in any cells containing the knockout cassette. B) Signal will only be produced with UF/H4neoR in cells with proper recombination of the knockout cassette with the INTS6 locus. C) Aberrant insertion of the IntS6KO cassette will not produce signal.

88

Figure 26. INTS6KO colony PCR with KpnIF/H4neoR and UF/H4neoR primer pairs 1% agarose gel loaded with potential INTS6 knockout colony PCR products. The first set of products was amplified using primers KpnIF and H4neoR to determine only the presence of the IntS6KO knockout cassette. The second set was amplified with primers UF and H4neoR to determine the correct insertion of the cassette into the INTS6 locus.

89

Chapter 4: Discussion

In an effort to epitope tag or knock out putative Mediator and Integrator subunits in T. thermophila, 1kb sequences homologous to the genomic loci had to be cloned into the respective vectors. The primers used to amplify the 5' and 3' homology regions of the endogenous target genes were designed using raw, un-annotated sequence data based on gene model predictions generated by The Institute for Genomic Research (TIGR) (Stover et al., 2005) retrieved from the Tetrahymena Genome Database (www.ciliate.org). The use of such raw sequence data may negatively implicate downstream applications due to the targeting of incorrect gene loci. Granted this, considerations in primer design were given to ensure primers did not fall within introns and would not amplify a gene product with an internal restriction site corresponding to KpnI, XhoI, NotI, or SacI as these are the restriction endonucleases utilized in cassette assembly and would cleave the vector prematurely and incorrectly.

4.1 Rpb1 of Tetrahymena RNA polymerase II lacks a canonical CTD Although the canonical heptapeptide sequence of the CTD of Rpb1 is Y1S2P3T4S5P6S7, not all repeats conform to this strict consensus sequence. In fact, 6 of the 26 yeast repeats (~23%) and most of the human repeats (~60%) deviate by select amino acid substitutions. The nature of the sequence alignment in Figure 6 prioritized the strings of Y1S2P3T4S5P6S7 tandem repeats based on their high sequence identity, and since individual substitutions in the repeat sequence are not consistent across species (Appendix C.3), the CTDs were not necessarily aligned as a functional unit. For instance, the first yeast heptapeptide repeat ("5*" in Figure 6) was aligned 29 residues downstream of the first indicated human repeat due to variations early in 90

the CTD (Appendix C.3). As a result, modeling the alignment after the CTD of a single organism not only made it difficult to identify the uncharacterized CTD of Tetrahymena Rpb1, but potentially skewed calculations which were only inclusive of the elected CTD repeat region. By examining the relative abundance of amino acids in the CTD of Rpb1 in yeast and humans, it was my intent to uncover similarities in serine, threonine, tyrosine, and proline content in Tetrahymena despite its lack of canonical heptapeptad repeats. I initially supposed that a comparable level of these amino acids in Tetrahymena would indicate phosphorylation comparable to that of yeast and humans, and formally allow the recruitment of similar CTDinteracting proteins to the Tetrahymena Rpb1 CTD. This notion is not accurate, however, since even an abundance of these amino acids would not necessarily presuppose the existence of CTDinteracting proteins in Tetrahymena given the lack of CTD sequence regularity and the specificity of CTD-interacting proteins. Without sequence regularity it is difficult to visualize a phospho-serine code as it is not simply arbitrary serine phosphorylation that fosters protein recruitment, but the timely phosphorylation and dephosphorylation at specific positions on the CTD (Bartkowiak et al., 2011). Although there is no apparent pattern in the CTD sequence of Tetrahymena Rpb1, there is a bias for serines in the 2nd, 5th, or 7th position (~67%, 26/39). Furthermore, Tetrahymena encodes a homolog to an essential eukaryotic CTD-specific phosphatase Fcp1 (Figure 1) (NCBI; Ghosh et al., 2008). Due to the lack of a defined CTD combined with natural sequence divergence, further examination by computerized analysis may be able to calculate the optimal linker/CTD boundary of Tetrahymena RNAPII. Two other options to help elucidate the function of the Tetrahymena Rpb1 CTD and the dependence on it by Tetrahymena Mediator and Integrator complexes would be to epitope tag it and/or delete it.

91

In the first method, Tetrahymena Rpb1 could be epitope tagged at the N-terminus, perhaps with a glutathione S-transferase (GST) tag, so as not to interfere with the CTD. Affinity purification with immobilized glutathione, the natural substrate for GST, could be used in combination with mass spectrometry to determine if known Tetrahymena kinases co-purify (Harper and Speicher, 2011). In addition, chromatin immunoprecipitation could be performed with monoclonal antibodies H5, H14, and 8WG16, which recognize phosphorylated Ser2 and Ser5, and unphosphorylated CTD repeats, respectively (Komarnitsky et al., 2000) to establish whether there is an enrichment of Ser2P or Ser5P within the CTD of Tetrahymena Rpb1 as RNAPII progresses through transcription. Secondly, the described pBKS-FZZ vector could be engineered to replace the Tetrahymena Rpb1 CTD with an FZZ epitope tag. This would enable affinity purification of Tetrahymena Rpb1 lacking a CTD. Ideally, this would be used in conjunction with mass spectrometry along with affinity purified wildtype Tetrahymena Rpb1 to determine if certain proteins, namely those belonging to the Tetrahymena Mediator and Integrator complexes, depend specifically on the CTD for recruitment to Rpb1.

4.2 Med22 AP-MS Tandem mass spectrometry of affinity purified Med22 recovered 3 total peptides of the Med22 bait, but no associated peptides. This could have been due to low initial sample size as suggested by the minimal peptide recovery. Med22 would have been inherently enriched through affinity purification, but any loss of protein-protein interaction would have magnified the lack of associated peptides. There are a few speculations that could account for this result, the most elementary of which being that the epitope tag interfered with interactions between Med22 and 92

other Mediator subunits. This is possible on two accounts: firstly, the tag could have inhibited correct protein folding, and without proper conformation Med22 would have been unable to bind its regular repertoire of proteins, and secondly, the tag itself could have been physically obstructing Med22 from interacting with the rest of the Mediator complex. Alternatively, the low spectral count suggests that the epitope tag may not be accessible to binding by IgG-Sepharose, so perhaps another tagging strategy could be employed.

4.3 Med31 AP-MS Tandem mass spectrometry was performed with affinity purified Med31 to corroborate previous Med31 AP-MS/MS analysis (Fillingham, unpublished). In addition to the formerly acknowledged predicted Tetrahymena Mediator orthologs co-purifying with Med31 (Med 4, 7, 11, 17, 20, 21, and 22), this study identified Med3 for the first time as a member of the Tetrahymena Med31 interactome to raise the number of purified Tetrahymena Mediator subunits to 9 out of the 14 predicted by Bourbon (2008). Med3 is also the first subunit indentified in Tetrahymena belonging to the tail module of Mediator (Figure 6). This could be a result of a greater challenge in identifying Mediator tail module subunits by homology due to their naturally divergent nature arising from their tendency to interact with species specific DNA-binding factors. Considering Bourbon predicted an ancient core Mediator "proto-complex" consisting of 17 subunits and has only suggested 13 of such in T. thermophila, it is conceivable that a number of proteins identified in the current Med31 AP-MS are Tetrahymena Mediator subunits unrecognized due to evolution with minimal selective constraint (Stump and Ostrozhynska, 2013). To further this, the number of significant proteins identified in this Med31 AP-MS (25) is 93

perhaps coincidentally the same number of subunits recognized in the yeast Mediator complex. Also, Med3 is the most distally located subunit of the tail module (Figure 6), perhaps presupposing the existence of the intermittent Mediator subunits Med1, 2, 5, 9, 14, 15, and 16. Tetrahymena Med31 shares most of the Med31/Med7 interface contact residues as described in yeast by Koschubs et al. (2009) (Figure 7). This reinforces the Med31-FZZ AP-MS results identifying predicted Tetrahymena Mediator subunit Med7 (Table 4). Despite this lack of sequence conservation for other Tetrahymena Mediator subunits, there is another way to potentially identify this co-purifying set of peptides as the bona fide Mediator complex in Tetrahymena. Recent x-ray crystallography work in S. cerevisiae identified the unique structure of the 4.3Å head module of the yeast Mediator containing three domains: the neck, the moveable jaw, and the unmovable jaw (Imasaki et al., 2011). Electron microscopy previously identified the discrete modules of Mediator, and at a resolution of 4.3Å the 3D structure of the Tetrahymena head module could be examined with scrutiny by using scanning electron microscopy and assessed for similar structural qualities (Asturias et al., 1999). If the head module is conserved by its constraints to interact with RNAPII, perhaps a Tetrahymena Mediator complex could be identified on the same merits. 4.4 Int11 AP-MS Affinity purification-tandem mass spectrometry of Int11-FZZ identified no significant peptides. Probing the Western blots with monoclonal -FLAG antibody revealed appropriately sized signal for Int11-FZZ following purification, although it was not definitive. This could have been another situation where the epitope tag interfered with protein-protein interaction, but provided that no bait Int11-FZZ peptides were identified, it is possible that the tag was internalized by the complex and thus became inaccessible to IgG. This would have appeared the 94

same on a Western blot since protein complexes were disrupted and denatured during subsequent SDS-PAGE, which would have enabled access and probing by the -FLAG antibody. An alternate speculation is that there was an insufficient amount of protein in the sample. To establish this, SDS-PAGE could be combined with protein staining such as silver staining or Coomassie brilliant blue to visualize all proteins in the sample. Considering the potential for low protein concentrations, performing a colloidal Coomassie stain using G-250 instead of R-250 dye would allow for higher sensitivity (Dyballa and Metzger, 2012). Another scenario which Coomassie protein staining could contribute toward would be if adequate amount of protein was present but not all protein was tagged, although the 18kDa difference between FZZ-tagged and untagged protein could prove troublesome without adequate protein separation and a suitable protein marker provided the non-specific binding nature of Coomassie. Transformed Tetrahymena cultures had been serially passaged once a week on a typical paromomycin concentration regimen (i.e. 100g/ml 200g/ml, 400g/ml) up to their viable limit of 1200g/ml. At this stage it was expected that surviving cells had phenotypically assorted with all copies of INT11 fused to an FZZ epitope tag at the C-terminus and a neo2 gene. It is improbable that cells would have been able to survive at 1200g/ml paromomycin without all of their INT11 loci replaced with the tagging cassette, unless the cells had rejected the FZZ tag along with simultaneous retention of the neo2 gene. If the FZZ tag induced a dominant-negative phenotype when fused to INTS6, the cells would become faced with contradicting selective pressure. Retention of the neo2 gene would favour antibiotic resistance and cell viability while liberation from the tag would favour phenotypic rescue. In such cases, the affliction could have lead to the selection of a rare event whereby the FZZ tag is lost through homologous recombination with simultaneous retention of the neo2 gene. Cells would have been visually

95

indistinguishable and capable of surviving higher concentrations of paromomycin over time as they phenotypically assorted, however, the neo2 gene would be the only assorting factor, and INT11 would be left untagged.

4.5 Speculative role of Tetrahymena Med31 in meiotic transcription Sequence similarity of Mediator subunit Med31 between Tetrahymena and other organisms is surprisingly high over most of its primary amino acid sequence, especially considering it is the only Mediator subunit with any sequence similarity in T. thermophila. Its Nterminal glutamine (Q)-rich domain suggests Tetrahymena Med31 retains a role in transcription activation (Xiao and Jeang, 1998; Escher et al., 2000), but surprisingly, Med31 is non-essential for viability in either S. cerevisiae (Fan and Klein, 1994) or T. thermophila (Garg and Fillingham, unpublished). Its high sequence conservation in conjunction with its non-essential nature suggests there is selective pressure to retain MED31, and insinuates that it may have a redundant role in a separate but fundamental pathway, perhaps interacting with other wellconserved proteins. Immunofluorescence in Tetrahymena revealed that Med31 localizes to micronuclei during conjugation (Garg and Fillingham, unpublished), and while deletion of MED31 does not affect nuclear division during vegetative growth, mating between two Tetrahymena MED31 knockout strains was accompanied by the inability for cells to complete conjugation (Garg, unpublished). A role for Med31 in development is supported by the gene expression profile of MED31 (Appendix C.10), and from the timing of expression I postulate a function in meiotic transcription.

96

Transcription elongation factor IIS (TFIIS) is encoded by DST1 in yeast (http://www.yeastgenome.org/). TFIIS is known to interact with RNA polymerases I, II, and III, and is required for recruiting RNAPII to certain promoters (Schnapp et al., 1996; Wind and Reines, 2000; Guglielmi et al,. 2007; Ghavi-helm et al., 2008). BLASTP of yeast TFIIS against the Tetrahymena Genome Database (www.ciliate.org) contains an annotation for TFIIS (TTHERM_00691200). In yeast, TFIIS acts in conjunction with Med31 for cell viability, as the deletion of DST1 is synthetic lethal with med31. Interestingly, TFIIS has an Rpb1-binding domain specifically required for viability only in the absence of Med31, and is otherwise dispensable under wildtype Med31 conditions (Guglielmi et al., 2007). In essence it seems that both TFIIS and Med31 are able to recruit RNAPII, perhaps in a redundant manner by interacting with the same part of RNAPII. In dst1/med31 yeast strains, supplementation with the Dst1 Rpb1-binding domain alone was sufficient to rescue the synthetic lethal phenotype. Conversely, when the ability of TFIIS to recruit RNAPII directly was eliminated by mutation of its Rpb1-binding domain in wildtype Med31 strains, it appeared that TFIIS was still able to do so via recruitment of Med31. Although current Tetrahymena purification data does not reveal an interaction between Med31 and TFIIs, if Med31 can be found to interact with this established active participant in meiosis, the micronuclear localization of Med31 during conjugation and the concomitant disruption of conjugation imparted by a MED31 knockout would conceivably support a role for Med31 in meiotic transcription. To draw a parallel with the aforementioned yeast study, both Med31 and TFIIS could be knocked out in Tetrahymena to determine whether this is also a lethal combination.

97

4.6 Tagging INTS6 with a C-terminal FZZ epitope tag in T. thermophila A full FZZ-tagging vector specific to Tetrahymena INTS6 was constructed and verified through sequencing, however, multiple attempts at tagging this gene through biolistics were unsuccessful, and cells would perish during transfer to paromomycin concentrations of 100g/ml. I speculate that cell death was caused by the prevention of recruitment of Integrator subunit IntS6 to the Integrator complex imparted by the epitope tag, either through interference of protein-protein interactions or conformational change to IntS6, compounded with the essential requirement for Integrator subunits for cell viability. Therefore, it may be possible to overcome the encumbrance of the FZZ tag on IntS6 if it was added to the N-terminus of INTS6 without disrupting upstream regulatory regions. IntS6 was previously recognized as the candidate tumor suppressor "deleted in cancer 1" (DICE1) in human non-small cell lung carcinoma (Wieland et al., 1999). It is interesting that an Integrator subunit, a deletion of which would inhibit proper snRNA formation, could be implicated in tumorigenesis. Absence of a signal motif suggests intracellular functionality (Chen and Wagner, 2010), but the presence of an N-terminal von Willebrand factor A is a regular feature of proteins with diverse roles, and so suggests a similar role for Tetrahymena IntS6 (Whittaker and Hynes, 2002). Interrupted oogenesis and increased apoptosis in C. elegans strains knocked out for the INTS6 homolog DIC-1 (Han et al., 2006) compounded by the vital necessity for INTS6 in T. thermophila (current study) promotes the hypothesis that IntS6 is essential for cellular development, and that any factor inhibiting recruitment of IntS6 to the Integrator complex could lead to cell inviability.

98

4.7 Future prospective of Integrator knockout The gene expression profile for INTS6 in Tetrahymena (Appendix C.10) peaks in very early-mid conjugation, supporting a role in 3' snRNA processing, however future experiments are required to confirm this potential role. Furthermore, the temporal occurrence of this peak corresponds with a peak observed in the gene expression profile of Tetrahymena DSS1 (Appendix C.10), which reinforces the importance of the T. thermophila Dss1 purification data and in turn suggests that a Tetrahymena Integrator complex may exist. Following colony PCR with the KpnIF and SacIIR primer pair (Figure 24), the appearance of a larger ~5.4kb band indicative of wildtype INTS6 in the same strains where correct cassette integration had occurred (Figure 26) supports an essential role for IntS6 as it suggests that despite being under such selective pressure that cells are dying, not all macronuclear copies of INTS6 were able to be replaced with the neo1 gene. However, as previously mentioned, this faint higher molecular weight band could represent micronuclear INTS6. Also, these cells did not flourish in paromomycin concentrations above 200g/ml, and would survive only up to 400g/ml. This is a very low drug concentration as homozygous cells with a neo gene on all of its 45 copies of a gene survived up to and beyond 1mg/ml paromomycin (current study). This suggests that IntS6 is essential for cell viability, and as increasing drug concentration increased the selective pressure on the cells to replace more copies of INTS6 with neo1, a minimum threshold for INTS6 was attained and cells perished. These findings are supported by INTS6/DIC-1 knockout experiments in C. elegans (Han et al., 2006). To fully elucidate the functional consequence of knocking out the Tetrahymena Integrator complex, it is necessary to evaluate the extent of INTS6 knockout in the macronucleus to determine whether it is essential for cell viability. The immediate undertaking would be to test

99

whether the knockout of INTS6 is a complete null by running a Southern blot using probes against Tetrahymena INTS6 to detect its presence. Considering there are approximately 45 copies of INTS6 in the wildtype Tetrahymena macronucleus and phenotypic assortment did not advance considerably, it is likely that native INTS6 was still present within the cell and would be detectable in a Southern blot. If micronuclear INTS6 copies are interfering with Southern blot analysis, the nuclei could be centrifugally separated based on density. Alternatively, reverse transcriptase (RT)-PCR on isolated Tetrahymena INTS6KO RNA using primers internal to INTS6 could be employed to determine gene expression. These primers could even be engineered to flank the intron in INTS6, which would allow distinction of PCR template between micronuclear DNA and cDNA synthesized from intron-free macronuclear mRNA for further distinction. To determine whether snRNA processing was affected in T. thermophila provided the amount of INTS6 present determined by a Southern blot, a Northern blot using probes against Tetrahymena U1 and U2 snRNA could be used to detect whether snRNA expression is affected in an INTS6 knockout.

Conclusion The goal of this study was to elucidate and characterize RNA polymerase II-interacting complexes Mediator and Integrator in the ciliated protozoan Tetrahymena thermophila for the first time by performing affinity purification coupled with mass spectrometry. RNA polymerase II is the core protein complex essential for production of messenger RNA in eukaryotes. In most eukaryotes, the largest subunit of RNAPII, Rpb1, contains a canonical C-terminal domain that acts as a platform for protein-protein interactions, and has been implicated in a multitude of 100

mRNA processing events. Sequence alignment of Rpb1 of RNAPII was unable to identify the canonical Y1S2P3T4S5P6S7 heptapeptide repeat structure for the CTD in Tetrahymena thermophila. Two RNAPII-interacting protein complexes, Mediator and Integrator, elicit their influence on RNAPII during transcription through direct binding to the CTD of Rpb1. Recent affinity purifications coupled with mass spectrometry in T. thermophila have uncovered potential Mediator and Integrator subunits in this organism lacking a canonical CTD on RNAPII. Mediator subunit Med31, was identified through BLASTP as the only Mediator subunit with any sequence conservation in T. thermophila despite being the only identified Mediator subunit that is not essential for viability in either T. thermophila or S. cerevisiae. Despite a primary sequence identity of 33% between yeast and Tetrahymena Med31, Tetrahymena Med31 was not able to rescue the slow growth phenotype resulting from a knockout of MED31 in yeast, nor did it capitulate an interaction with yeast subunit Med8. Affinity purification coupled with mass spectrometry in T. thermophila identified Med3 for the first time as an interacting partner of Med31 and a potential Tetrahymena Mediator subunit, while AP-MS using other Mediator or Integrator subunits was inconclusive. Exact gene replacement of INTS6 loci with a neo1 knockout cassette was confirmed through colony PCR, however, the inability of these cells to thrive in paromomycin concentrations above 200g/ml supports an essential role for the INTS6 gene product in T. thermophila. It was my hope that the data described can be extrapolated in the long-term to determine whether these complexes serve a purpose in Tetrahymena comparable to higher eukaryotes to gain insight into the functional consequence of life without a canonical CTD. The CTD of Tetrahymena Rpb1 therefore requires further investigation into potential phosphorylation and protein recruitment.

101

Appendix A: Fms1 and Vps75

To maintain the organization, stability, and integrity of DNA while meeting the size limitations imposed by the nucleus, eukaryotic DNA is strategically coiled into a higher order structure called chromatin (Shahbazian and Grunststein, 2007). In order to achieve this arrangement, an octomer of histone proteins (two H2A-H2B dimers and an H3-H4 tetramer), is wrapped with 147 base pairs of DNA to form a nucleosome (Luger et al., 1997). Covalent histone modification such as acetylation by histone acetyltransferases (HATs) plays a major role in chromatin remodeling necessary for effective transcription, replication, and repair by relaxing the tightly wound DNA and granting accessibility by the appropriate factors (Shahbazian and Grunstein, 2007). In yeast, one such histone acetyltransferase is Rtt109, which acetylates histone H3 on lysines 9, 27, and 56 (H3K9, H3K27, and H3K56, respectively). The histone chaperone protein Vps75 (Selth and Svejstrup, 2007) forms a stable complex with Rtt109 to stabilize it and enhance its histone acetyltransferase activity (Krogan et al., 2006; Fillingham et al., 2008). Raw affinity purification-mass spectrometry data from S. cerevisiae reveals that Vps75 co-purifies with polyamine oxidase Fms1 (tap.med.utoronto.ca). Fms1 oxidizes polyamine spermine to generate spermidine, which is necessary for the hypusine modification of eukaryotic translation initiation factor 5A (eIF-5A); the only protein known to carry this unique amino acid (Landry and Sternglanz, 2003; Zanelli et al., 2006; Wolff et al., 2007; Park et al., 2010). Polyamines such as spermine can incorporate covalently into chromatin and repress transcription (Tabor and Tabor, 1984; Igarashi and Kashiwagi, 2000), and histone acetylation has been shown to overcome this

102

repression (Pollard et al., 1999). Perhaps Fms1 interacts with Vps75 to utilize the polyamines as they are freed from chromatin following histone acetylation by Rtt109. Interestingly, a potential Rtt109 consensus sequence consisting of lysine-serine-threonine (KST) common within the most highly acetylated lysine residues of H3 also exists within Fms1, suggesting that perhaps Fms1 can be acetylated by Rtt109 (Fillingham, unpublished). It was therefore of interest to investigate whether Fms1 interacts with the Rtt109-Vps75 complex through Vps75, or whether it was acetylated by Rtt109 on the KST consensus sequence, effectively linking biosynthesis with transcriptional regulation. To recapitulate the Fms1-Vps75 interaction, a C-terminal 13xmyc epitope tag was fused to Fms1 in a Vps75-TAP background. PCR amplification of plasmid pFA6a-13myc-kanMX6 as described by Longtine et al. (1998) using primers with 40bp homologous to the 3' end of FMS1 flanking the stop codon and 20bp homologous to the vector synthesized a tagging cassette that was able to insert itself into the haploid yeast genome through homologous recombination to generate a homozygous Fms1-13myc strain. The kanMX6 module carried on the tagging vector conferred resistance to G418/geneticin, and was of E. coli in origin as to prevent aberrant homologous recombination into the yeast genome (Longtine et al., 1998). The tagging vector was introduced into wildtype (OB+) and Vps75-TAP strains and a one-step affinity purification using IgG-sepharose was performed followed by a Western blot probed with -FLAG (1:2000) and -myc (1:3000). Unfortunately, while the Western blot suggested Vps75 and Fms1 were tagged appropriately, as determined by the input fragment sizes (Vps75-TAP=51kDa and Fms113myc=73.4kDa), and that sufficient Vps75 was affinity purified, there was not a signal specific to the appropriate strains corresponding to Fms1-13myc in the affinity purification samples

103

(Figure A1). A signal for -myc appeared in all affinity purified samples despite the fact that OB+ and Vps75-TAP strains are free of a myc tag as supported by the input. Until the Fms1Vps75 interaction can be recapitulated, this project is suspended.

Figure A1. Western blot of Vps75-TAP affinity purification. Western blot depicting input and affinity purified OB+, OB+/Fms1-13myc, Vps75-TAP, and Vps75-TAP/Fms1-13myc. Non-specific binding was present in all lanes of affinity purified sample probed with -myc. Blots were probed with -FLAG (dilution 1:1000, exposure=1 second) and -myc (dilution 1:3000, exposure=5 minutes).

104

If the interaction can be confirmed, an in vitro HAT assay would be performed. The ~1,500bp coding sequence of FMS1 would be PCR amplified with primers pertaining to pET28a expression vector so that product FMS1 could be cloned in. This would add a 6x histidine (6x HIS) epitope tag to facilitate the purification of Fms1 from E. coli for the detection of Fms1 acetylation. The importance of Fms1 acetylation in spermidine biosynthesis could be elucidated by subsequent site directed mutagenesis of the KST consensus sequence followed by a reevaluation of histone acetyltransferase activity on Fms1.

105

Appendix B: Rtt109

Histone chaperones Asf1 and Vps75 form a poorly understood complex with fungal histone acetyltransferase (HAT) Rtt109 in the process of histone H3 acetylation at positions 9 and 56 (H3K9ac and H3K56ac, respectively) during chromatin remodeling for genetic stability and transcriptional regulation (Bannister and Kouzarides, 2011). Investigation into the role of the evolutionarily conserved C-terminal tail of Rtt109 (Rtt109C) and of its auto-acetylation at lysine 290 (K290) generated clearer insight into Asf1 and Vps75 regulation of Rtt109-mediated acetylation.

My contribution to this paper involved transforming yeast strains deleted for RTT109 and containing a C-terminally TAP-tagged Vps75 (rtt109/Vps75-TAP) with different iterations of Rtt109. Firstly, wildtype RTT109 contains a lysine at residue 290 and a basic patch at its carboxy terminus. One Rtt109 alternative was K290R, which encoded Rtt109 with an arginine (R) in place of the lysine 290 residue and was unable to be acetylated, but still contained a positive charge characteristic of lysine. Alternately, K290Q had glutamine (Q) substituted for lysine at this position and mimicked a constitutively acetylated lysine. I generated a second set of each of these three versions of Rtt109 using a primer that would truncate Rtt109 to effectively delete the carboxy-terminal basic. Each version of RTT109 was cloned into the 12myc-pRb415 106

plasmid for the addition of an N-terminal 12xmyc epitope tag to Rtt109. I then performed affinity purifications and subsequent Western blots to determine if Rtt109 lysine 290 was required for its interaction with Vps75 and how the basic carboxy terminal played into this interaction. This information was also used as a cross reference during downstream HAT assays to compare the ability of Vps75 to bind mutated K290 with H3K9 and H3K56 acetylation status to determine how the K290 position was implicated in acetylation. My affinity purifications helped reveal that while mutating Rtt109 lysine 290 to arginine or glutamine did not affect binding of Vps75 to full-length Rtt109, K290R and K290Q strains showed significantly reduced acetylation of H3K9 (Figure B1).

107

Figure B1. Rtt109 lysine 290 is necessary for optimal H3K9 acetylation. Lysine 290 of Rtt109 is important for in vivo H3K9 acetylation by Rtt109, but does not affect binding of Vps75 to Rtt109.

In the other strains bearing a deletion of the basic patch at the carboxy terminus of Rtt109, binding by Vps75 was again not affected by the truncation in conjunction with lysine 290 modification, however, acetylation of H3K56 in K290R and K290Q mutants was reduced, suggesting this basic patch is necessary for enhanced H3K56ac (Figure B2). Since binding by Vps75 was not affected in either case, but K290 played an important role in acetylation status,

108

this paper showed that in vivo Vps75-mediated H3 acetylation by Rtt109 is affected by lysine 290; the first evidence for an in vivo role for Vps75 in H3K56 acetylation.

Figure B2. Rtt109 lysine 290 is important for optimal H3K56 acetylation. Lysine 290 of Rtt109 is important for optimal H3K56 acetylation by Rtt109 in vivo in the absence of the carboxy terminal patch on Rtt109, but does not affect binding of Vps75 to Rtt109.

109

The fundamental importance of this study arises from Rtt109 being involved in the pathogenicity of C. albicans (Lopes et al., 2010). Its lack of sequence homology to any identified histone acetyltransferase Rtt109 makes it an excellent candidate target for anti-fungal therapeutics, and elucidating its underlying mechanisms could be a step forward in achieving a therapeutic strategy.

110

Appendix C: Supplementary Material

C.1. Schematic of Rpb1 depicting the eight homology regions A-H and the CTD (Matheny et al. 2002).

C.2. Length of Rpb1 C-terminal extension following last conserved homology region from a variety of species (Stump and Ostrozhynska, 2013).

111

112

C.3. CTD sequences (Hsin and Manley, 2012)

113

C.4. TTHERM accession numbers Gene Med3 Med4 Med17 Med20 Med22 Med31 Int2 Int4 IntS6 Int9 Int11 Rpb1 Rpn15/Dss1 Fcp1 Brca2 TTHERM accession number TTHERM_00490630 TTHERM_00691210 TTHERM_00780600 TTHERM_00922930 TTHERM_00670380 TTHERM_00355460 TTHERM_00532780 TTHERM_00467840 TTHERM_01243440 TTHERM_01159920 TTHERM_00339790 TTHERM_00538940 TTHERM_00227230 TTHERM_00277390 TTHERM_00437260

C.5. Composition of all media, buffers, and solutions used Item 1% Agarose Gel (w/v) (50ml) Composition 0.5g agarose 50ml 1xTBE 5l ethidium bromide (EtBr) (10mg/ml) 0.5M Ammonium Hydroxide (NH4OH) 1ml 14.5M NH4OH 28ml ddH2O 10% APS (Ammonium persulfate) (w/v) 0.1g ammonium persulfate 1ml ddH2O AP Lysis Buffer 10ml AP wash buffer 1 tablet complete protease inhibitor (Roche) 114

50l phenylmethylsulfonyl fluoride (PMSF) AP Wash Buffer 0.5ml 1M Tris pH 8.0 1.5ml 5M NaCl 0.5ml 10% NP40 47.5ml ddH2O 1M CaCl2 (1L) Determine which of the following hydrated forms is available: CaCl2 = 110.99g/mol CaCl2. 2 H2O (Dihydrate) = 147.02g/mol CaCl2.4 H2O (Tetrahydrate) = 183.04g/mol CaCl2.6 H2O (Hexahydrate) = 219.08g/mol To 1 mole of CaCl2 add ddH20 to 1L 2mM CaCl2/20mM Tris 100l 1M CaCl2 1ml 1M Tris pH 8.0 48.9ml ddH2O 0.5M EDTA, Iron (III) Sodium Salt pH 8.0 (500ml) 91.78g Na2EDTA (367.1g/mol) ddH2O to 500ml, pH to 8.0 with NaOH Fillingham's 2x Lysis Buffer (50ml) 2ml 1M Tris pH 8.0

115

6ml 5M NaCl 50l 1M MgCl2 42ml ddH2O 1M MgCl2 (M.W.=203.3g/mol) (100ml) 20.33g MgCl2 ddH2O to 100ml 1% Milk Solution (50ml) 10ml 5% milk solution 40ml 1x PBS 5% Milk Solution (BLOTTO) (w/v) (100ml) Miniprep Solution 1 (400ml) 5g skim milk powder 100ml PBS 10ml 1M TRIS pH 8.0 8ml 0.5 M EDTA 9ml 40 % glucose 373ml ddH2O Miniprep Solution 2 (10ml) 1ml 10% SDS 2ml 1N NaOH 7ml ddH2O Miniprep Solution 3 (500ml) 147.2g 3M potassium acetate 120.1g acetic acid 500ml ddH2O 100mM NaCl Wash Buffer (IPP100) 500l 1M Tris pH 8.0 1ml 5M NaCl 500l 10% NP-40 48ml ddH2O

116

300mM NaCl Wash Buffer (IPP300)

500l 1M Tris pH 8.0 3ml 5M NaCl 500l 10% NP-40 46ml ddH2O

5M NaCl (500ml)

146.1g NaCl ddH20 to 500ml

10% NP-40 (v/v)

2.5ml NP-40 22.5ml ddH2O

10x PBS pH 7.3 (1L)

82g NaCl 2.64g NaH2PO4 16g Na2HPO4 ddH20 to 1L, pH 7.3

1x PBST (500ml)

500ml 1x PBS 250µl Tween 20

13% PEG (w/v) (100ml)

13g PEG8000 1M NaCl to 100ml

100mM PMSF (10ml)

0.1742g PMSF 10ml isopropanol

Ponceau (0.1% w/v) (1L)

1g Ponceau S 50ml acetic acid ddH20 to 1L

Proteinase K Buffer

100l 10x TermoPol buffer (New England BioLabs)

117

10l Proteinase K (50g/ml) (New England BioLabs) 890l ddH2O 2x SDS Laemmli Sample Buffer 3g SDS 5ml beta-mercaptoethanol 10ml 100% glycerol 6ml 2M Tris-HCL pH 6.8 50mg bromophenol blue ddH20 to 100ml SPP (1L) 60mg sequestrin (Sigma) 2g bacto yeast extract 20g proteose peptone 4g glucose ddH20 to 1L SPP+PSF (Penicillin/Streptomycin/Fungizone) (1L) 5% Stacking Gel (5ml) 1L SPP 500 µl PSF (100x) 3.5ml ddH2O 0.625ml 1M Tris pH 6.8 0.95ml acrylamide 29:1 0.05ml 10% SDS 3.75l TEMED 31.25l 10% APS 10x TBE pH 8.0 (4L) 10g Tris base

118

5.5 Boric acid 0.93g EDTA 4L ddH2O Titrate with HCl until pH=8.0 Tetrahymena Lysis Solution (500ml) 210g urea 35ml 5M NaCl 5ml 1M Tris pH 7.4 10ml 0.5M EDTA 50ml 10% SDS ddH2O to 500ml 1x TEV Cleavage Buffer 500l 1M Tris pH 8.0 1ml 5M NaCl 500l 10% NP-40 50l 0.5M EDTA 48ml ddH2O 1M Tris-HCl pH 8.0 (500ml) 60.55g Tris ddH20 to 500ml, pH to 8.0 10mM Tris pH 7.4 (1L) 1.21g Tris ddH2O to 1L, pH to 7.4 4x Western Running Buffer (4L) 230.4g glycine 48g Tris 16g SDS ddH20 to 4L

119

Western Transfer Buffer (2L)

400ml methanol 6.05g Tris 28.84g glycine ddH20 to 2L, pH to 8.3

YNB -leu Media (1L)

20g glucose 6.74 YNB 0.7g -leu powder 17.5g agar for plates ddH2O to 1L

YPD Media (1L)

10g yeast extract 20g peptone 20g agar for plates 20g dextrose ddH20 to 1L

YPD+G418 (300g/ml)

1L YPD 300mg geneticin (G418) sulfate

YT Media (1L)

10g bacto-tryptone 5g yeast extract 5g NaCl 15g agar for plates 1L ddH20

YT+Ampicillin (50g/ml)

400ml YT 2ml ampicillin (10mg/ml)

120

YT+Kanamycin (50g/ml)

400ml YT 2ml kanamycin (10mg/ml)

C.6. DNA and protein ladders1 1kb DNA ladder scale (Frogga Bio) PiNK plus prestained protein ladder scale (Frogga Bio)

121

Spectra multicolor broad range protein ladder (Thermo Scientific)

C.7. Sequencing primers Sequencing primer
M13R HN111 M13F UF H4neoR BTU2R HJ559

Sequence
5'-CAGGAAACAGCTATGAC-3' 5'-TATCATCATCATCTTTGTAATCAATATC-3' 5'-TGTAAAACGACGGCCAGT-3' 5'-CTAGCTAAATGTTCCTTTAGCATTTAATTGCAC-3' 5'-TTCAGATTTTGATGCTTCAATAAG-3' 5'-GAGCTAACATGTATGTGAAGAGG-3' 5'-CGTTGTAAAACGACGGCCAG-3'

C.8. Homology sequence primers Med3-FZZ:
UF: UR: DF: DR: UF: UR: DF: DR: 5'-CCCGGTACCTAGCGTACAAGATTCTATTGATAATTTG-3' 5'-CCCCTCGAGATAAAATTCTTTCTCTTTAAAGCATTATGT-3' 5'-CCCGCGGCCGCAACTATTTATTTGTAAATTATTTATACATAC-3' 5'-CCCGAGCTCGTATAATTGATCTAATTTCTTCATTTTCAA-3' 5'-CCCGGTACCGGTACTAAAAGTTAAAAGATCTAAAAGGAG-3' 5'-CCCCTCGAGCTAATATCCCCAATCTACTGAACTTGAAGC-3' 5'-CCCGCGGCCGCTCCTAAAACTATAAATGAACAAAATCTTTATTATCA-3' 5'-CCCGAGCTCATATAATCATTCATAATGCTTGCATACTTC-3'

Med4-FZZ:

122

Med17-FZZ: UF:
UR: DF: DR:

5'-CCCGGTACCCTTTTTAACATAAATAACCATAAAACTTTA-3' 5'-CCCCTCGAGTTAAGGAGTTTATGCTGGCATCATCTATTA-3' 5'-CCCGCGGCCGCTGATTAATTCAATTTAATTTGAAATATTTAAAT-3' 5'-GCTTAAATGCTGCTTGAGCTCCTTACATTT-3' 5'-CCCGGTACCTATTATGTAAGTATGTACCTACCTAGCTAC-3' 5'-CCCCTCGAGTTTTGTAGCTGTTTCAATAAAATAGCTTTT-3' 5'-CCCGCGGCCGCTTTTAATTATTTAATGTGGATCTAAGTTTT-3' 5'-CCCGAGCTCGGCATATTAAAAATAATAAGATAGAATCTT-3' 5'-CCCGGTACCTTTTTTGAAAACATAAATAAATATATTGAA-3' 5'-CCCCTCGAGTTAATTTTAAGGATTTTATTATTGCTAATA-3' 5'-CCCGCGGCCGCTAGTAAAATCATCATCTTTCATTCATAAAC-3' 5'CCCGAGCTCTTTCTTTAATTAAATGTGCAAATTTCAACT-3' 5'-CCCGGTACCGTGAATGTTACTGCATTTTTCTTCGATTTT-3' 5'-CCCCTCGAGAATGACATATTAATAAGGCCTAAGAGCGAA-3' 5'-CCCGCGGCCGCTGAAAGAAGTTTATAAATAATTTACTTCA-3' 5'-CCCGAGCTCAAGTTGTTTAAATAAAGCAATATAATTAAG-3' 5'-CCCGGTACCAAAGCTAAAAGTCTGTTTCTGGGCCTCAGC-3' 5'-CCCCTCGAGGATTACCCTAGATTTTATAATTAAAGGAAA-3' 5'-CCCGCGGCCGCTGATTAAATCCTGGACAAAATAAATTTAAA-3' 5'-CCCGAGCTCCTCAATAATAAAAACATTGTCTATTGAGG-3' 5'-CCCGGTACCCTCAGTCATCTTCACCTGGTCAATTGTCTC-3' 5'-CCCCTCGAGCTTTTTTTCTTAGTAAACAATTTCAGAGAC-3' 5'-CCCGCGGCCGCGAAGGGTTGATTAAATCAAATTAATAATGA-3' 5'-CCCGAGCTCTGATACTTAAATGGATTACAAAAAGTAAAC-3' 5'-CCCGGTACCGTGAAAACCCTGAGAATCCCTTCTCAGCTT-3' 5'-CCCCTCGAGTTTTAACTCAACTATGTTGTAAAAACAAA-3' 5'-CCCGCGGCCGCCTTGAAAAGGATTAATAAAAAATATTATTTG-3' 5'-CCCGAGCTCCGAGAAGCTCTAATAAAAGCTGTAAATTAAG-3' 5'-CCCGGTACCGTTTTAATTTCATCTTTTTTTTTCCAGTTT-3' 5'-CCCCTCGAGTTTATTGTTATATATATTTAAAGCATTGAA-3' 5'-CCCGCGGCCGCCTAAAAATCAAATGAATTTTAATTGCAAGT-3' 5'-CCCGAGCTCACATAGAATCCAAAGTCAAAAAACTAGCAG-3' 5'-CCCGGTACCCTGCCAAATAACTGATAAAGTTAGTAAGCA-3' 5'-CCCCTCGAGTCTCTATTTTAAAATAAATTCAATTCCATT-3' 5'-CCCGGATCCGAAGGGTTGATTAAATCAAATTAATAATGA-3' 5'-CCCCCGCGGGAATAAGAAAAAGAATAAACTACAGAGGAG-3'

Med20-FZZ: UF:
UR: DF: DR:

Med22-FZZ: UF:
UR: DF: DR:

Int2-FZZ:

UF: UR: DF: DR: UF: UR: DF: DR: UF: UR: DF: DR: UF: UR: DF: DR: UF: UR: DF: DR: UF: UR: DF: DR:

Int4-FZZ:

IntS6-FZZ:

Int9-FZZ:

Int11-FZZ:

IntS6KO:

123

C.9. CTD calculations >S.c.
SFEETVEILFEAGASAELDDCRGVSENVILGQMAPIGTG AFDVMIDEESLVKYMPEQKITEIEDGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGG ADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPT SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAY SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPSYSPTSPGYSPGSPAYSPKQDEQKHNENENSR

Serine = 75/215x100 = 34.9% Threonine = 27/215x100 = 12.6% Tyrosine = 26/215x100 = 12.1% Proline = 55/215x100 = 25.6% T.t. vs. S.c. Serine: |34.9-26.4|/34.9x100 = 24.4% Threonine: |12.6-7.4|/12.6x100 = 41.3% Tyrosine: |12.1-8.8|/12.1x100 = 27.3% Proline: |25.6-12.8|/25.6x100 = 50%

>H.s.
SFEETVDVLMEAAAHGESDPMKGVSENIMLGQLAPAGTG CFDLLLDAEKCKYGMEIPTNIPGLGAAGPTGMFFGSAPSPMGGISPAMTPWNQGATPAYGAWSPSVGSGMTPGAAGF SPSAASDASGFSPGYSPAWSPTPGSPGSPGPSSPYIPSPGGAMSPSYSPTSPAYEPRSPGGYTPQSPSYSPTSPSYS PTSPSYSPTSPNYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPNYTPTSPSYSPTSPSYSPTSPNYT PTSPNYSPTSPSYSPTSPSYSPTSPSYSPSSPRYTPQSPTYTPSSPSYSPSSPSYSPTSPKYTPTSPSYSPSSPEYT PTSPKYSPTSPKYSPTSPKYSPTSPTYSPTTPKYSPTSPTYSPTSPVYTPTSPKYSPTSPTYSPTSPKYSPTSPTYS PTSPKGSTYSPTSPGYSPTSPTYSLTSPAISPDDSDEEN

Serine = 127/378x100 = 33.6% Threonine = 61/378x100 = 16.1% Tyrosine = 52/378x100 = 13.8% Proline = 104/378x100 = 27.5% T.t. vs. H.s. Serine: |33.6-26.4|/33.6x100 = 21.4% Threonine: |16.1-7.4|/16.1x100 = 54.0% Tyrosine: |13.8-8.8|/13.8x100 = 36.2% Proline: |27.5-12.8|/27.5x100 = 53.4%

124

>P.t.
SFEETVEILYDAAVFSEIDHMRGLSENIIFGQLCPHGTG CFELMVNAKNVKEFKLKSSHADKFTQGGEYLAEQSPYDQNQQTPLMLNTPGPGVSQGFIENSPYTPYHKSPANFATP FGREYTPNSSHCSPFYPNTPLMPNDPYQLSPVGSDSGIQQSVQKQANVSDSHSPGSPHYTSHTNSPSPSYRSSERAT SGQRSSSISISLSPPSPNYTSSVYNSPLSPTNTGSPRVPTGSPHSPQGSIFTTYSPVYQPGGGTGNQYEQEQ

Serine = 31/126x100 = 24.65 Threonine = 10/126x100 = 7.9% Tyrosine = 8/126x100 = 6.3% Proline = 17/126x100 = 13.5% T.t. vs. P.t. Serine: |24.6-26.4|/24.6x100 = 7.3% Threonine: |7.9-7.4|/7.9x100 = 6.3% Tyrosine: |6.3-8.8|/6.3x100 = 39.7% Proline: |13.5-12.8|/13.5x100 = 5.2%

>T.t.
SFEETVDILNTAAIFFEKDDLKGVTENIIFGQNCDIGTG CFDLLVDLNKVGEFKTKRQVEQTLEMEDYSENESSRYENTPSHFQTPGPGLVSAYPNSIRTVQHAGSFTPTTPYLNS PGYNMSTPISYSNTYNQTRSSQYSPQTGNNSPFVPSPNYSPPSHTPAGSTSPANASPYASSPQYKSSSLSGAHSPSY TSPSQVRYNSPSYQNPHASSSSPLDRSKSAYMGSQQSPQYMSSPHYEQRTTPMTRNIKSETSYNPTEERESEESDSD QD

Serine = 39/148 = 26.4% Threonine = 11/148x100 = 7.4% Tyrosine = 13/148x100 = 8.8% Proline =19/148 = 12.8%

125

C.10. Selected gene expression profiles Expression profiles compiled from 50 samples completed by Gorovsky, Miao, and Pearlman labs acquired from the Tetrahymena Functional Genomics Database (http://tfgd.ihb.ac.cn/). Blue line indicates data from 50 samples prepared by the Gorovsky and Miao labs. Red line indicates data from 50 samples prepared by the Gorovsky and Miao labs plus an additional 10 conjugation samples prepared by the Pearlman lab. Med31

IntS6

126

Dss1

127

References

Akematsu, T., Pearlman, R.E., Endoh, H. (2010). Gigantic macroautophagy in programmed nuclear death of Tetrahymena thermophila. Autophagy 6, 901-911. Akoulitchev, S., Chuikov, S., Reinberg, D. (2000). TFIIH is negatively regulated by cdk8containing mediator complexes. Nature 407(6800), 102-106. Albrecht, T.R. and Wagner, E.J. (2012). snRNA 3' end formation requires heterodimeric association of integrator subunits. Mol Cell Biol 32(6), 1112-1123. Allison, L.A., Moyle, M., Shales, M., Ingles, C.J. (1985). Extensive homology among the largest subunits of eukaryotic and prokaryotic RNA polymerases. Cell 42(2), 599-610. Allison, L.A., Wong, J.K., Fitzpatrick, V.D., Moyle, M., Ingles, C.J. (1988). The C-terminal domain of the largest subunit of RNA polymerase II of Saccharomyces cerevisiae, Drosophila melanogaster, and mammals: a conserved structure with an essential function. Mol Cell Biol 8(1), 321-329. Armache, K.J., Kettenberger, H., Cramer, P. (2003). Architecture of initiation-competent 12subunit RNA polymerase II. Proc Natl Acad Sci USA 100(12), 6964-6968. Aronica, L., Bednenko, J., Noto, T., Desouza, L.V., Siu, K.W., Loidl, J., Pearlman, R.E., Gorovsky, M.A., Mochizuki, K. (2008). Study of an RNA helicase implicates small RNA-noncoding RNA interactions in programmed DNA elimination in Tetrahymena. Genes Dev 22(16), 2228-2241. Asturias, F.J., Jiang, Y.W., Myers, L.C., Gustafsson, C.M., Kornberg, R.D. (1999). Conserved structures of mediator and RNA polymerase II holoenzyme. Science 283(5404), 985-987. Baillat, D., Hakimi, M.A., Näär, A.M., Shilatifard, A., Cooch, N., Shiekhattar, R. (2005). Integrator, a multiprotein mediator of small nuclear RNA processing, associates with the C-terminal repeat of RNA polymerase II. Cell 123(2), 265-276. Baldauf, S.L. (2003). The deep roots of eukaryotes. Science 300(5626), 1703-1706. Bannister, A.J. and Kouzarides, T. (2011). Regulation of chromatin by histone modifications. Cell Res 21(3), 381-395. 128

Bartkowiak B, Mackellar AL, Greenleaf AL. (2011). Updating the CTD Story: From Tail to Epic. Genet Res Int 2011, 623718. Bartolomei, M.S., Halden, N.F., Cullen, C.R., Corden, J.L. (1988). Genetic analysis of the repetitive carboxyl-terminal domain of the largest subunit of mouse RNA polymerase II. Mol Cell Biol 8(1), 330-339. Birnboim, H.C. and Doly, J. (1979). A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res 7(6), 1513-1523. Borggrefe, T., Davis, R., Erdjument-Bromage, H., Tempst, P., Kornberg, R.D. (2002). A complex of the Srb8, -9, -10, and -11 transcriptional regulatory proteins from yeast. J Biol Chem 277(46), 44202-44207. Borggrefe, T. and Yue, X. (2011). Interactions between subunits of the Mediator complex with gene-specific transcription factors. Semin Cell Dev Biol 22(7),759-768. Bruns P.J. and Cassidy-Hanley D. (2000). Biolistic transformation of macro- and micronuclei. Methods Cell Biol 62, 501-512. Buratowski, S. (2009). Progression through the RNA polymerase II CTD cycle. Mol Cell 36(4), 541-546. Cenik, E.S. and Zamore, P.D. (2011). Argonaute proteins. Curr Biol 21(12), R446-R449. Cervantes, M.D., Hamilton, E.P., Xiong, J., Lawson, M.J., Yuan, D., Hadjithomas, M., Miao, W., Orias, E. (2013). Selecting one of several mating types through gene segment joining and deletion in Tetrahymena thermophila. PLoS Biol 11(3), e1001518. Cervantes, M.D., Xi, X., Vermaak, D., Yao, M.C., Malik, H.S. (2005). The CNA1 histone of the ciliate Tetrahymena thermophila is essential for chromosome segregation in the germline micronucleus. Mol Biol Cell 17(1), 485-497. Chalker, D.L., La Terza, A., Wilson, A., Kroenke, C.D., Yao, M.C. (1999). Flanking regulatory sequences of the Tetrahymena R deletion element determine the boundaries of DNA rearrangement. Mol Cell Biol 19(8), 5631-5641.

129

Chalker, D.L. and Yao, M.C. (1996). Non-Mendelian, heritable blocks to DNA rearrangement are induced by loading the somatic nucleus of Tetrahymena thermophila with germ linelimited DNA. Mol Cell Biol 16(7), 3658-3667. Chen, J., Ezzeddine, N., Waltenspiel, B., Albrecht, T.R., Warren, W.D., Marzluff, W.F., Wagner, E.J. (2012). An RNAi screen identifies additional members of the Drosophila Integrator complex and a requirement for cyclin C/Cdk8 in snRNA 3'-end formation. RNA 18(12), 2148-2156. Chen, J. and Wagner, E.J. (2010). snRNA 3' end formation: the dawn of the Integrator complex. Biochem Soc Trans 38(4),1082-1087. Cheng, C.Y., Vogt, A., Mochizuki, K., Yao, M.C. (2010). A domesticated piggyBac transposase plays key roles in heterochromatin dynamics and DNA cleavage during programmed DNA deletion in Tetrahymena thermophila. Mol Biol Cell 21(10), 1753-1762. Cho, E.J., Kobor, M.S., Kim, M., Greenblatt, J., Buratowski, S. (2001). Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain. Genes Dev 15(24), 3319-3329. Cho, E.J., Takagi, T., Moore, C.R., Buratowski, S. (1997). mRNA capping enzyme is recruited to the transcription complex by phosphorylation of the RNA polymerase II carboxyterminal domain. Genes Dev 11(24), 3319-3326. Choi, H., Larsen, B., Lin, Z.Y., Breitkreutz, A., Mellacheruvu, D., Fermin, D., Qin, Z.S., Tyers, M., Gingras, A.C., Nesvizhskii, A.I. (2011). SAINT: probabilistic scoring of affinity purification-mass spectrometry data. Nat Methods 8(1), 70-73. Collins, K. (2012). Perspectives on the ciliated protozoan Tetrahymena thermophila. Methods Cell Biol 109, 1-7. Conaway, R.C. and Conaway, J.W. (2011). Origins and activity of the Mediator complex. Semin Cell Dev Biol 22(7),729-734. Conaway, R.C., Sato, S., Tomomori-Sato, C., Yao, T., Conaway, J.W. (2005). The mammalian Mediator complex and its role in transcriptional regulation. Trends Biochem Sci 30(5), 250-255. Cuello, P., Boyd, D.C., Dye, M.J., Proudfoot, N.J., Murphy, S. (1999). Transcription of the human U2 snRNA genes continues beyond the 3' box in vivo. EMBO J 18, 2867-2877. 130

Das, A. and Bellofatto, V. (2009). The non-canonical CTD of RNAP-II is essential for productive RNA synthesis in Trypanosoma brucei. PLoS One 4(9), e6959. de la Mata, M. and Kornblihtt, A.R. (2006). RNA polymerase II C-terminal domain mediates regulation of alternative splicing by SRp20. Nat Struct Mol Biol 13(11), 973-980. Dieci G, Fiorino G, Castelnuovo M, Teichmann M, Pagano A. (2007). The expanding RNA polymerase III transcriptome. Trends Genet 23(12), 614-622. Dotson, M.R., Yuan, C.X., Roeder, R.G., Myers, L.C., Gustafsson, C.M., Jiang, Y.W., Li, Y., Kornberg, R.D., Asturias, F.J. (2000). Structural organization of yeast and mammalian mediator complexes. Proc Natl Acad Sci USA 97(26), 14307-14310. Dyballa N. and Metzger S. (2012). Fast and sensitive coomassie staining in quantitative proteomics. Methods Mol Biol 893, 47-59. Egloff, S., O'Reilly, D., Chapman, R.D., Taylor, A., Tanzhaus, K., Pitts, L., Eick, D., Murphy, S. (2007). Serine-7 of the RNA polymerase II CTD is specifically required for snRNA gene expression. Science 318(5857),1777-1779. Egloff, S., O'Reilly, D., Murphy, S. (2008). Expression of human snRNA genes from beginning to end. Biochem Soc Trans 36(4), 590-594. Egloff, S., Szczepaniak, S.A., Dienstbier, M., Taylor, A., Knight, S., Murphy, S. (2010). The integrator complex recognizes a new double mark on the RNA polymerase II carboxylterminal domain. J Biol Chem 285(27),20564-20569. Eisen, J.A., Coyne, R.S., Wu, M., Wu, D., Thiagarajan, M., Wortman, J.R., Badger, J.H., Ren, Q., Amedeo, P., Jones, K.M., Tallon, L.J., Delcher, A.L., Salzberg, S.L., Silva, J.C., Haas, B.J., Majoros, W.H., Farzad, M., Carlton, J.M., Smith, R.K. Jr., Garg, J., Pearlman, R.E., Karrer, K.M., Sun, L., Manning, G., Elde, N.C., Turkewitz, A.P., Asai, D.J., Wilkes, D.E., Wang, Y., Cai, H., Collins, K., Stewart, B.A., Lee, S.R., Wilamowska, K., Weinberg, Z., Ruzzo, W.L., Wloga, D., Gaertig, J., Frankel, J., Tsao, C.C., Gorovsky, M.A., Keeling, P.J., Waller, R.F., Patron, N.J., Cherry, J.M., Stover, N.A., Krieger, C.J., del Toro, C., Ryder, H.F., Williamson, S.C., Barbeau, R.A., Hamilton, E.P., Orias, E. (2006). Macronuclear genome sequence of the ciliate Tetrahymena thermophila, a model eukaryote. PLoS Biol 4(9), e286.

131

Elliot, A.M. and Hayes, R.E. (1953). Mating types in Tetrahymena. Biological Bulletin 105(2), 269-284. Epstein, L. M. and Forney, J. D. (1984). Mendelian and non-mendelian mutations affecting surface antigen expression in Paramecium tetraurelia. Mol Cell Biol 4, 1583-1590. Escher, D., Bodmer-Glavas, M., Barberis, A., Schaffner, W. (2000). Conservation of glutaminerich transactivation function between yeast and humans. Mol Cell Biol 20(8), 2774-2782. Esnault, C., Ghavi-Helm, Y., Brun, S., Soutourina, J., Van Berkum, N., Boschiero, C., Holstege, F., Werner, M. (2008). Mediator-dependent recruitment of TFIIH modules in preinitiation complex. Mol Cell 31(3), 337-346. Ezzeddine, N., Chen, J., Waltenspiel, B., Burch, B., Albrecht, T., Zhuo, M., Warren, W.D., Marzluff, W.F., Wagner, E.J. (2011). A subset of Drosophila integrator proteins is essential for efficient U7 snRNA and spliceosomal snRNA 3'-end formation. Mol Cell Biol 31(2), 328-341. Fan, H.Y., Klein, H.L. (1994). Characterization of mutations that suppress the temperaturesensitive growth of the hpr1 delta mutant of Saccharomyces cerevisiae. Genetics 137(4), 945-956. Fan, Q. and Yao, M.C. (2000). A long stringent sequence signal for programmed chromosome breakage in Tetrahymena thermophila. Nucleic Acids Res 28(4), 895-900. Fillingham, J.S. and Pearlman, R.E. (2004). Role of micronucleus-limited DNA in programmed deletion of mse2.9 during macronuclear development of Tetrahymena thermophila. Eukaryot Cell 3, 288-301. Fillingham, J., Recht, J., Silva, A.C., Suter, B., Emili, A., Stagljar, I., Krogan, N.J., Allis, C.D., Keogh, M.C., Greenblatt, J.F. (2008). Chaperone control of the activity and specificity of the histone H3 acetyltransferase Rtt109. Mol Cell Biol 28(13), 4342-4353. Fillingham, J.S., Thing, T.A., Vythilingum, N., Keuroghlian, A., Bruno, D., Golding, G.B., Pearlman, R.E. (2004). A non-long terminal repeat retrotransposon family is restricted to the germ line micronucleus of the ciliated protozoan Tetrahymena thermophila. Eukaryot Cell 3(1), 157-169. Fondell, J.D., Ge, H., Roeder, R.G. (1996). Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc Natl Acad Sci USA 93(16), 8329-8333. 132

Gaertig, J., Gu, L., Hai, B., Gorovsky, M.A. (1994). High frequency vector-mediated transformation and gene replacement in Tetrahymena. Nucleic Acids Res 22(24), 53915398. Ghavi-Helm, Y., Michaut, M., Acker, J., Aude, J.C., Thuriaux, P., Werner, M., Soutourina, J. (2008). Genome-wide location analysis reveals a role of TFIIS in RNA polymerase III transcription. Genes Dev 22(14), 1934-1947. Ghosh, A., Shuman, S., Lima, C.D. (2008). The structure of Fcp1, an essential RNA polymerase II CTD phosphatase. Mol Cell 32(4), 478-490. Glover-Cutter, K., Larochelle, S., Erickson, B., Zhang, C., Shokat, K., Fisher, R.P., Bentley, D.L. (2009). TFIIH-associated Cdk7 kinase functions in phosphorylation of C-terminal domain Ser7 residues, promoter-proximal pausing, and termination by RNA polymerase II. Mol Cell Biol 29(20), 5455-5464. Godiska, R., James, C., Yao, M.C. (1993). A distant 10-bp sequence specifies the boundaries of a programmed DNA deletion in Tetrahymena. Genes Dev 7(12A), 2357-2365. Gorovsky, M.A. and Woodard, J. (1969). Studies on the nuclear structure and function in Tetrahymena pyriformis. J Cell Biol 42, 673-682. Grayson, M.A. (2011). John Bennett Fenn: a curious road to the prize. J Am Soc Mass Spectrom 22(8), 1301-1308. Greider, C.W. and Blackburn, E.H. (1985). Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405-413. Guglielmi, B., Soutourina, J., Esnault, C., Werner, M. (2007). TFIIS elongation factor and Mediator act in conjunction during transcription initiation in vivo. Proc Natl Acad Sci USA 104(41), 16062-16067. Hamatake, R.K., Dykstra, C.C., Sugino, A. (1989). Presynapsis and synapsis of DNA promoted by the STP alpha and single-stranded DNA-binding proteins from Saccharomyces cerevisiae. J Biol Chem 264(22), 13336-13342. Han, S.M., Lee, T.H., Mun, J.Y., Kim, M.J., Kritikou, E.A., Lee, S.J., Han, S.S., Hengartner, M.O., Koo, H.S. (2006). Deleted in cancer 1 (DICE1) is an essential protein controlling

133

the topology of the inner mitochondrial membrane in C. elegans. Development 133(18), 3597-3606. Harper, S. and Speicher, W. (2011). Purification of proteins fused to glutathione S-transferase. Methods Mol Biol. 691, 259-280. Hengartner, C.J., Thompson, C.M., Zhang, J., Chao, D.M., Liao, S.M., Koleske, A.J., Okamura, S., Young, R.A. (1995). Association of an activator with an RNA polymerase II holoenzyme. Genes Dev 9(8), 897-910. Hentges, K.E. (2011). Mediator complex proteins are required for diverse developmental processes. Semin Cell Dev Biol 22(7), 769-775. Hernandez, N. (1985). Formation of the 3' end of U1 snRNA is directed by a conserved sequence located downstream of the coding region. EMBO J 4(7), 1827-1837. Ho, C.S., Lam, C.W., Chan, M.H., Cheung, R.C., Law, L.K., Lit, L.C., Ng, K.F., Suen, M.W., Tai, H.L. (2003). Electrospray ionisation mass spectrometry: principles and clinical applications. Clin Biochem Rev 24(1), 3-12. Horowitz, S. and Gorovsky, M.A. (1985). An unusual genetic code in nuclear genes of Tetrahymena. Proc Natl Acad Sci USA 82(8), 2452-2455. Hsin, J.P. and Manley, J.L. (2012). The RNA polymerase II CTD coordinates transcription and RNA processing. Genes Dev 26(19), 2119-2137. Hsin, J.P., Sheth, A., Manley, J.L. (2011). RNAP II CTD phosphorylated on threonine-4 is required for histone mRNA 3' end processing. Science 334(6056), 683-686. Igarashi, K. and Kashiwagi, K. (2000). Polyamines: mysterious modulators of cellular functions. Biochem Biophys Res Commun 271(3), 559-564. Imasaki, T., Calero, G., Cai, G., Tsai, K.L., Yamada, K., Cardelli, F., Erdjument-Bromage, H., Tempst, P., Berger, I., Kornberg, G.L.,Asturias, F.J., Kornberg, R.D., Takagi, Y. (2011). Architecture of the Mediator head module. Nature 475(7355), 240-243. International Human Genome Sequencing Consortium. (2001). Initial sequencing and analysis of the human genome. Nature 409(6822), 860-921.

134

Johnson, K.M., Wang, J., Smallwood, A., Arayata, C., Carey, M. (2002). TFIID and human mediator coactivator complexes assemble cooperatively on promoter DNA. Genes Dev 16(14), 1852-1863. Karrer, K.M. (2012). Nuclear dualism. Methods Cell Biol 109, 29-52. Karrer, K., Stein-Gavens, S., Allitto, B.A. (1984). Micronucleus-specific DNA sequences in an amicronucleate mutant of Tetrahymena. Dev Biol 105(1), 121-129. Kean, M.J., Couzens, A.L., Gingras, A.C. (2012). Mass spectrometry approaches to study mammalian kinase and phosphatase associated proteins. Methods 57(4), 400-408. Kelly, W.G., Dahmus, M.E., Hart, G.W. (1993). RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. J Biol Chem 268(14), 1041610424. Keogh, M.C., Mennella, T.A., Sawa, C., Berthelet, S., Krogan, N.J., Wolek, A., Podolny, V., Carpenter, L.R., Greenblatt, J.F., Baetz, K., Buratowski, S. (2006). The Saccharomyces cerevisiae histone H2A variant Htz1 is acetylated by NuA4. Genes Dev 20(6), 660-665. Kim, Y.J., Björklund, S., Li, Y., Sayre, M.H., Kornberg, R.D. (1994). A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II. Cell 77(4), 599-608. Komarnitsky, P., Cho, E.J., Buratowski, S. (2000). Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev 14(19), 2452-2460. Koschubs, T., Seizl, M., Larivière, L., Kurth, F., Baumli, S., Martin, D.E., Cramer, P. (2009). Identification, structure, and functional requirement of the Mediator submodule Med7N/31. EMBO J 28(1), 69-80. Krishnamurthy, S., He, X., Reyes-Reyes, M., Moore, C., Hampsey, M. (2004). Ssu72 Is an RNA polymerase II CTD phosphatase. Mol Cell 14(3), 387-394. Krogan, N.J., Cagney, G., Yu, H., Zhong, G., Guo, X., Ignatchenko, A., Li, J., Pu, S., Datta, N., Tikuisis, A.P., Punna, T., Peregrin-Alvarez, J.M., Shales, M., Zhang, X., Davey, M., Robinson, M.D., Paccanaro, A., Bray, J.E., Sheung, A., Beattie, B., Richards, D.P., Canadien, V., Lalev, A., Mena, F., Wong, P., Starostine, A., Canete, M.M., Vlasblom, J., Wu, S., Orsi, C., Collins, S.R., Chandran, S., Haw, R., Rilstone, J.J., Gandi, K., 135

Thompson, N.J., Musso, G., St Onge, P., Ghanny, S., Lam, M.H., Butland, G., Altaf-Ul, A.M., Kanaya, S., Shilatifard, A., O'Shea, E., Weissman, J.S., Ingles, C.J., Hughes, T.R., Parkinson, J., Gerstein, M., Wodak, S.J., Emili, A., Greenblatt, J.F. (2006). Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature 440(7084), 637-643. Krogan, N.J., Lam, M.H., Fillingham, J., Keogh, M.C., Gebbia, M., Li, J., Datta, N., Cagney, G., Buratowski, S., Emili, A., Greenblatt, J.F. (2004). Proteasome involvement in the repair of DNA double-strand breaks. Mol Cell 16(6), 1027-1034. Kruger, K., Grabowski, P.J., Zaug, A.J., Sands, J., Gottschling, D.E., Cech, T.R. (1982). Selfsplicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena. Cell 31(1), 147-157. Kuras, L., Borggrefe, T., Kornberg, R.D. (2003). Association of the Mediator complex with enhancers of active genes. Proc Natl Acad Sci USA 100(24), 13887-13891. Kurth, H.M. and Mochizuki, K. (2009). 2'-O-methylation stabilizes Piwi-associated small RNAs and ensures DNA elimination in Tetrahymena. RNA 15(4), 675-685. LaFountain, J.R. Jr. and Davidson, L.A. (1979). An analysis of spindle ultrastructure during prometaphase and metaphase of micronuclear division in Tetrahymena. Chromosoma 75, 293­308. Landry, J. and Sternglanz, R. (2009). Yeast Fms1 is a FAD-utilizing polyamine oxidase. Biochem Biophys Res Commun 303(3), 771-776. Laybourn, P.J. and Dahmus, M.E. (1989). Transcription-dependent structural changes in the Cterminal domain of mammalian RNA polymerase subunit IIa/o. J Biol Chem 264(12), 6693-6698. Laybourn, P.J. and Dahmus, M.E. (1990). Phosphorylation of RNA polymerase IIA occurs subsequent to interaction with the promoter and before the initiation of transcription. J Biol Chem 265(22), 13165-13173. Lee, Y., Kim, M., Han, J., Yeom, K.H., Lee, S., Baek, S.H., Kim, V.N. (2004). MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23(20), 4051-4060.

136

Li, H., Zhang, Z., Wang, B., Zhang, J., Zhao, Y., Jin, Y. (2007). Wwp2-mediated ubiquitination of the RNA polymerase II large subunit in mouse embryonic pluripotent stem cells. Mol Cell Biol 27(15), 5296-5305. Liu, Y., Kung, C., Fishburn, J., Ansari, A.Z., Shokat, K.M., Hahn, S. (2004a). Two cyclindependent kinases promote RNA polymerase II transcription and formation of the scaffold complex. Mol Cell Biol 24(4), 1721-1735. Liu, Y., Mochizuki, K., Gorovsky, M.A. (2004b). Histone H3 lysine 9 methylation is required for DNA elimination in developing macronuclei in Tetrahymena. Proc Natl Acad Sci USA 101(6), 1679-1684. Liu, Y., Taverna, S.D., Muratore, T.L., Shabanowitz, J., Hunt, D.F., Allis, C.D. (2007). RNAidependent H3K27 methylation is required for heterochromatin formation and DNA elimination in Tetrahymena. Genes Dev 21(12), 1530-1545. Longtine, M.S., McKenzie, A. 3rd, Demarini, D.J., Shah, N.G., Wach, A., Brachat, A., Philippsen, P., Pringle, J.R. (1998). Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast 14(10), 953-961. Lopes da Rosa, J., Boyartchuk, V.L., Zhu, L.J., Kaufman, P.D. (2010). Histone acetyltransferase Rtt109 is required for Candida albicans pathogenesis. Proc Natl Acad Sci USA 107(4), 1594-1599. Luger, K., Mäder, A.W., Richmond, R.K., Sargent, D.F., Richmond, T.J. (1997). Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389(6648), 251-260. Lynn, D.H. and Doerder, F.P. (2012). The life and times of Tetrahymena. Methods Cell Biol 109, 9-27. Mandel, C.R., Kaneko, S., Zhang, H., Gebauer, D., Vethantham, V., Manley, J.L., Tong, L. (2006). Polyadenylation factor CPSF-73 is the pre-mRNA 3'-end-processing endonuclease. Nature 444(7121), 953-956. March, R.E. (1997). An introduction to quadrupole ion trap mass spectrometry. 32, 351-369. Marston, N.J., Richards, W.J., Hughes, D., Bertwistle, D., Marshall, C.J., Ashworth, A. (1999). Interaction between the product of the breast cancer susceptibility gene BRCA2

137

andDSS1, a protein functionally conserved from yeast to mammals. Mol Cell Biol 19(7), 4633-4642. Matheny, P.B., Liu, Y.J., Ammirati, J.F., Hall, B.D. (2002). Using RPB1 sequences to improve phylogenetic inference among mushrooms (Inocybe, Agraricales). Am J Bot 89(4), 688698. Mathur, S., Vyas, S., Kapoor, S., Tyagi, A.K. (2011). The Mediator complex in plants: structure, phylogeny, and expression profiling of representative genes in a dicot (Arabidopsis) and a monocot (rice) during reproduction and abiotic stress. Plant Physiol 157(4), 1609-1627. Mayer, A., Heidemann, M., Lidschreiber, M., Schreieck, A., Sun, M., Hintermair, C., Kremmer, E., Eick, D., Cramer, P. (2012). CTD tyrosine phosphorylation impairs termination factor recruitment to RNA polymerase II. Science 336(6089), 1723-1725. McCracken, S., Fong, N., Yankulov, K., Ballantyne, S., Pan, G., Greenblatt, J., Patterson, S.D., Wickens, M., Bentley, D.L. (1997). The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 385(6614), 357-361. Medlin, J.E., Uguen, P., Taylor, A., Bentley, D.L., Murphy, S. (2003). The C-terminal domain of pol II and a DRB-sensitive kinase are required for 3' processing of U2 snRNA. EMBO J 22(4), 925-934. Mehta, R. and Champney, W.S. (2003). Neomycin and paromomycin inhibit 30S ribosomal subunit assembly in Staphylococcus aureus. Curr Microbiol 47(3), 237-243. Merriam, E.V. and Bruns, P.J.(1988). Phenotypic assortment in Tetrahymena thermophila: assortment kinetics of antibiotic-resistance markers, tsA, death, and the highly amplified rDNA locus. Genetics 120(2), 389-395. Mochizuki, K. (2010). DNA rearrangements directed by non-coding RNAs in ciliates. Wiley Interdiscip Rev RNA 1(3), 376-387. Mochizuki, K. (2012). Developmentally programmed, RNA-directed genome rearrangement in Tetrahymena. Dev Growth Differ 54(1), 108-119. Mochizuki, K., Fine, N.A., Fujisawa, T., Gorovsky, M.A. (2002). Analysis of a piwi-related gene implicates small RNAs in genome rearrangement in tetrahymena. Cell 110(6), 689-699.

138

Mochizuki, K. and Gorovsky, M.A. (2004). Small RNAs in genome rearrangement in Tetrahymena. Curr Opin Genet Dev 14(2), 181-187. Mochizuki K, Gorovsky MA. (2005). A Dicer-like protein in Tetrahymena has distinct functions in genome rearrangement, chromosome segregation, and meiotic prophase. Genes Dev 19(1), 77-89. Mochizuki, K., Novatchkova, M., Loidl, J. (2008). DNA double-strand breaks, but not crossovers, are required for the reorganization of meiotic nuclei in Tetrahymena. J Cell Sci 121(13), 2148-2158. Mosley, A.L., Pattenden, S.G., Carey, M., Venkatesh, S., Gilmore, J.M., Florens, L., Workman, J.L., Washburn, M.P. (2009). Rtr1 is a CTD phosphatase that regulates RNA polymerase II during the transition from serine 5 to serine 2 phosphorylation. Mol Cell 34(2), 168178. Mumby, M.C. and Walter, G. (1993) Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol Rev 73(4), 673-699. Myers, L.C. and Kornberg, R.D. (2000). Mediator of transcriptional regulation. Annu Rev Biochem 69, 729-749. Noto, T., Kurth, H.M., Kataoka, K., Aronica, L., Desouza, L.V., Siu, K.W., Pearlman, R.E., Gorovsky, M.A. & Mochizuki, K. (2010). The tetrahymena argonaute-binding protein Giw1p directs a mature argonaute-siRNA complex to the nucleus. Cell 140(5), 692-703. Orias, E. and Newby, C.J. (1975). Macronuclear genetics of Tetrahymena. II. Macronuclear location of somatic mutations to cycloheximide resistance. Genetics 80(2), 251-262. Park, M.H., Nishimura, K., Zanelli, C.F., Valentini, S.R. (2010). Functional significance of eIF5A and its hypusine modification in eukaryotes. Amino Acids 38(2), 491-500. Petukhova GV, Romanienko PJ, Camerini-Otero RD. (2003). The Hop2 protein has a direct role in promoting interhomolog interactions during mouse meiosis. Dev Cell 5(6), 927-936. Phatnani, H.P. and Greenleaf, A.L. (2006). Phosphorylation and functions of the RNA polymerase II CTD. Genes Dev 20(21), 2922-2936.

139

Pollard, K.J., Samuels, M.L., Crowley, K.A., Hansen, J.C., Peterson, C.L. (1999). Functional interaction between GCN5 and polyamines: a new role for core histone acetylation EMBO J 18(20), 5622-5633. Radovani, E., Cadorin, M., Shams, T., El-Rass, S., Karsou, A.R., Kim, H.S., Kurat, C.F., Keogh, M.C., Greenblatt JF, Fillingham JS. (2013). The carboxyl terminus of Rtt109 functions in chaperone control of histone acetylation. Eukaryot Cell 12(5), 654-664. Ray, C. Jr. (1956). Preparation of chromosomes of Tetrahymena pyriformis for photomicrography. Stain Technol 31(6), 271-274. Rodriguez, C.R., Cho, E.J., Keogh, M.C., Moore, C.L., Greenleaf, A.L., Buratowski, S. (2000). Kin28, the TFIIH-associated carboxy-terminal domain kinase, facilitates the recruitment of mRNA processing machinery to RNA polymerase II. Mol Cell Biol 20(1), 104-112. Roeder, R.G. (1996). The role of general initiation factors in transcription by RNA polymerase II. Trends Biochem Sci 21(9), 327-335. Romanienko, P.J. and Camerini-Otero, R.D. (2000). The mouse Spo11 gene is required for meiotic chromosome synapsis. Mol Cell 6(5), 975-987. Russel, J. and Zomerdijk, J.C. (2006). The RNA polymerase I transcription machinery. Biochem Soc Symp (73), 203-216. Schiestl, R.H. and Gietz, R.D. (1989). High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr Genet 16(5-6), 339-346. Schnapp, G., Graveley, B.R., Grummt, I. (1996). TFIIS binds to mouse RNA polymerase I and stimulates transcript elongation and hydrolytic cleavage of nascent rRNA. Mol Gen Genet 252(4), 412-419. Selth, L. and Svejstrup, J.Q. (2007). Vps75, a new yeast member of the NAP histone chaperone family. J Biol Chem 282(17), 12358-12362. Shahbazian, M.D. and Grunstein, M. (2007). Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 76, 75-100. Sidow, A. and Thomas, W.K. (1994). A molecular evolutionary framework for eukaryotic model organisms. Curr Biol 4(7), 596-603.

140

Sims, R.J. 3rd., Rojas, L.A., Beck, D., Bonasio, R., Schuller, R., Drury W.J., 3rd., Eick, D., Reinberg, D. (2011). The C-terminal domain of RNA polymerase II is modified by sitespecific methylation. Science 332(6025), 99-102. Sone, T., Saeki, Y., Toh-e, A., Yokosawa, H. (2004). Sem1p is a novel subunit of the 26S proteasome from Saccharomyces cerevisiae. J Biol Chem 279(27), 28807-28816. Spaeth, J.M., Kim, N.H., Boyer, T.G. (2011). Mediator and human disease. Semin Cell Dev Biol 22(7), 776-787 Stover, N.A., Krieger, C.J., Binkley, G., Dong, Q., Fisk, D., Nash, R., Sethuraman, A., Weng, S., Cherry, M. (2006). Tetrahymena Genome Databse (GDB): a new genomic resource for tetrahymena thermophila researh. Nucleic Acids Res 34, D500-D503. Stump, A.D. and Ostrozhynska, K. (2013). Selective constraint and evolution of the RNA polymerase II C-Terminal Domain. Transcription 4(2), 77-86. Sugino, A., Nitiss, J., Resnick, M.A. (1988). ATP-independent DNA strand transfer catalyzed by protein(s) from meiotic cells of the yeast Saccharomyces cerevisiae. Proc Natl Acad Sci USA 85(11), 3683-3687. Sun X, Zhang Y, Cho H, Rickert P, Lees E, Lane W, Reinberg D. (1998). NAT, a human complex containing Srb polypeptides that functions as a negative regulator of activated transcription. Mol Cell 2(2), 213-222. Sydow, J.F. and Kramer, P. (2009). RNA polymerase fidelity and transcriptional proofreading. Curr Opin Struct Biol. 19(6), 732-739. Tabor, C.W. and Tabor, H. (1984). Polyamines. Annu Rev Biochem 53, 749-90. Taverna, S.D., Coyne, R.S. & Allis, C.D. 2002. Methylation of histone h3 at lysine 9 targets programmed DNA elimination in tetrahymena. Cell 110(6), 701-711. Taylor, S.S. and Kornev, A.P. (2011). Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem Sci 36(2), 65-77. Uguen, P. and Murphy, S. (2003). The 3' ends of human pre-snRNAs are produced by RNA polymerase II CTD-dependent RNA processing. EMBO J 22(17), 4544-4554.

141

Vavra, K.J., Allis, C.D., and Gorovsky, M.A. (1982). Regulation of histone acetylation in Tetrahymena macro- and micronuclei. J Biol Chem 257, 2591-2598. Volpe, T.A., Kidner, C., Hall, I.M., Teng, G., Grewal, S.I., Martienssen, R.A. (2002). Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 297(5588), 1833-1837. Werner-Allen, J.W., Lee, C.J., Liu, P., Nicely, N.I., Wang, S., Greenleaf, A.L., Zhou, P. (2011). cis-Proline-mediated Ser(P)5 dephosphorylation by the RNA polymerase II C-terminal domain phosphataseSsu72. J Biol Chem 286(7), 5717-5726. West, M.L. and Corden, J.L. (1995). Construction and analysis of yeast RNA polymerase II CTD deletion and substitution mutations. Genetics 140(4), 1223-1233. Whittaker, C.A. and Hynes, R.O. (2002). Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere. Mol Biol Cell 13(10), 3369-3387. Wieland, I., Arden, K.C., Michels, D., Klein-Hitpass, L., Böhm, M., Viars, C.S., Weidle, U.H. (1999). Isolation of DICE1: a gene frequently affected by LOH and downregulated in lung carcinomas. Oncogene 18(32), 4530-4537. Wierzbicki, A.T., Hagg, J.R., Pikaard, C.S. (2008). Noncoding transcription by RNA polymerase Pol IVb/Pol V mediates transcriptional silencing of overlapping and adjacent genes. Cell 135, 635-648. Wilcox CB, Rossettini A, Hanes SD. (2004). Genetic interactions with C-terminal domain (CTD) kinases and the CTD of RNA Pol II suggest a role for ESS1 in transcription initiation and elongation in Saccharomyces cerevisiae. Genetics 167(1), 93-105. Will, C.L. and Lührmann, R. (2011). Spliceosome structure and function. Cold Spring Harb Perspect Biol 3(7). Wind, M. and Reines, D. (2000). Transcription elongation factor SII. Bioessays 22(4), 327-336. Wolff, E.C., Kang, K.R., Kim, Y.S., Park, M.H. (2007). Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification. Amino Acids 33(2), 341-350.

142

Xiao, H., Jeang, K.T. (1998). Glutamine-rich domains activate transcription in yeast Saccharomyces cerevisiae. J Biol Chem 273(36), 22873-22876. Xiong J, Yuan D, Fillingham JS, Garg J, Lu X, Chang Y, Liu Y, Fu C, Pearlman RE, Miao W. (2011). Gene network landscape of the ciliate Tetrahymena thermophila. PLoS One 6(5), e20124. Yang, X.C., Sullivan, K.D., Marzluff, W.F., Dominski, Z. (2009). Studies of the 5' exonuclease and endonuclease activities of CPSF-73 in histone pre-mRNA processing. Mol Cell Biol 29(1), 31-42. Yao, M.C. and Chao, J.L. (2005). RNA-guided DNA deletion in Tetrahymena: an RNAi-based mechanism for programmed genome rearrangements. Annu Rev Genet 39, 537-359. Yao, M.C., Choi, J., Yokoyama, S., Austerberry, C.F., Yao, C.H. (1984). DNA elimination in Tetrahymena: a developmental process involving extensive breakage and rejoining of DNA at defined sites. Cell 36(2), 433-440. Yao, M.C., Yao, C.H., Monks, B. (1990). The controlling sequence for site-specific chromosome breakage in Tetrahymena. Cell 63(4), 763-772. Young, R.A. (1991). RNA polymerase II. Annu Rev of Biochem 60, 689-715. Zanelli, C.F., Maragno, A.L., Gregio, A.P., Komili, S., Pandolfi, J.R., Mestriner, C.A., Lustri, W.R., Valentini, S.R. (2006). eIF5A binds to translational machinery components and affects translation in yeast. Biochem Biophys Res Commun 348(4), 1358-1366. Zehring, W.A., Lee, J.M., Weeks, J.R., Jokerst, R.S., Greenleaf, A.L. (1988). The C-terminal repeat domain of RNA polymerase II largest subunit is essential in vivo but is not required for accurate transcription initiation in vitro. Proc Natl Acad Sci USA 85(11), 3698-3702. Zhang, L., Maul, R.S., Rao, J., Apple, S., Seligson, D., Sartippour, M., Rubio, R., Brooks, M.N. (2004). Expression pattern of the novel gene EG-1 in cancer. Clin Cancer Res 10(10), 3504-3508. Zhou, M., Halanski, M.A., Radonovich, M.F., Kashanchi, F., Peng, J., Price, D.H., Brady, J.N. (2000). Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol Cell Biol 20(14), 5077-5086. 143


